IT1225944B - Saggi immunometrici e di inibizione con l'impiego di anticorpi monoclonici - Google Patents

Saggi immunometrici e di inibizione con l'impiego di anticorpi monoclonici

Info

Publication number: IT1225944B
Authority: IT; Italy
Prior art keywords: immunometric; inhibition tests; monoclonic; antibodies; monoclonic antibodies
Prior art date: 1980-08-04

Application number

IT8123231A

Other languages

English (en)

Other versions

IT8123231A0 (it

Inventor

Gary Samuel David

Howard Edward Greene

Original Assignee

Hybritech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-08-04

Filing date

1981-07-29

Publication date

1990-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22639055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1225944(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1981-07-29 Application filed by Hybritech Inc filed Critical Hybritech Inc

1981-07-29 Publication of IT8123231A0 publication Critical patent/IT8123231A0/it

1990-12-10 Application granted granted Critical

1990-12-10 Publication of IT1225944B publication Critical patent/IT1225944B/it

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
- G01N2470/04—Sandwich assay format
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

IT8123231A 1980-08-04 1981-07-29 Saggi immunometrici e di inibizione con l'impiego di anticorpi monoclonici IT1225944B (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/175,133 US4376110A (en)	1980-08-04	1980-08-04	Immunometric assays using monoclonal antibodies

Publications (2)

Publication Number	Publication Date
IT8123231A0 IT8123231A0 (it)	1981-07-29
IT1225944B true IT1225944B (it)	1990-12-10

Family

ID=22639055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT8123231A IT1225944B (it)	1980-08-04	1981-07-29	Saggi immunometrici e di inibizione con l'impiego di anticorpi monoclonici

Country Status (5)

Country	Link
US (1)	US4376110A (it)
JP (2)	JPS57118159A (it)
BE (1)	BE889855A (it)
CA (1)	CA1281640C (it)
IT (1)	IT1225944B (it)

Families Citing this family (1529)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5643732A (en) *	1971-05-20	1997-07-01	Strahilevitz; Meir	Immunological assay methods
EP0146654A3 (en) *	1980-06-20	1986-08-20	Unilever Plc	Processes and apparatus for carrying out specific binding assays
US6406920B1 (en)	1980-06-20	2002-06-18	Inverness Medical Switzerland Gmbh	Processes and apparatus for carrying out specific binding assays
WO1982000364A1 (en) *	1980-07-16	1982-02-04	Jefferis R	Methods of immuno-analysis using monoclonal antibodies
NL185309C (nl) *	1980-07-28	1990-03-01	Akzo Nv	Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
US4376110A (en) *	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
US4879219A (en) *	1980-09-19	1989-11-07	General Hospital Corporation	Immunoassay utilizing monoclonal high affinity IgM antibodies
US4514507A (en) *	1980-11-07	1985-04-30	Secher David S	Assay for interferon
US4837167A (en) *	1981-01-30	1989-06-06	Centocor, Inc.	Immunoassay for multi-determinant antigens using high-affinity
US4680258A (en) *	1981-03-24	1987-07-14	Sloan-Kettering Institute For Cancer Research	Process for sex determination in man by use of monoclonal antibodies to the H-Y antigen
JPS585659A (ja) *	1981-06-24	1983-01-13	ハイブリテツク　インコ−ポレ−テツド	単クロ−ン性抗体を使用する免疫学的、抑制試験
US4474893A (en) *	1981-07-01	1984-10-02	The University of Texas System Cancer Center	Recombinant monoclonal antibodies
EP0072902B1 (de) *	1981-08-21	1985-04-24	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
US4661586A (en) *	1981-11-17	1987-04-28	The Board Of Trustees Of The Leland Stanford Junior University	Monoclonal anti-idiotype antibodies
GB2112779B (en) *	1981-12-11	1986-10-15	Welsh Nat School Med	Aryl acridinium esters as luminescent labelling materials
USRE32011E (en) *	1981-12-14	1985-10-22	Scripps Clinic And Research Foundation	Ultrapurification of factor VIII using monoclonal antibodies
US4444878A (en) *	1981-12-21	1984-04-24	Boston Biomedical Research Institute, Inc.	Bispecific antibody determinants
ES8504461A1 (es) *	1982-04-12	1985-04-16	Hybritech Inc	Un procedimiento para obtener un polidoma.
US4483929A (en) *	1982-05-03	1984-11-20	Liposome Technology Incorporated	Liposomes with glycolipid-linked antibodies
US4792528A (en) *	1982-05-21	1988-12-20	The Trustees Of Columbia University In The City Of New York	Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays
US4514505A (en) *	1982-05-21	1985-04-30	The Trustees Of Columbia University In The City Of New York	Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4443427A (en) *	1982-06-21	1984-04-17	Sidney Farber Cancer Institute, Inc.	Monoclonal antibody
US4623621A (en) *	1982-06-24	1986-11-18	Hoffmann-La Roche Inc.	Immunoassay for peptide and protein oligomers
DE3225027A1 (de) *	1982-07-05	1984-01-05	Boehringer Mannheim Gmbh, 6800 Mannheim	Immunchemisches messverfahren
US4471058A (en) *	1982-07-26	1984-09-11	Board Of Trustees Operating Michigan State University	Method for the detection and/or determination of a polyvalent antigen using at least two different monoclonal antibodies
US4879218A (en) *	1982-09-13	1989-11-07	Virginia Tech Intellectual Properties, Inc.	Antibody for C.difficile
JPS5954966A (ja) *	1982-09-22	1984-03-29	Mochida Pharmaceut Co Ltd	免疫学的測定試薬
US4596771A (en) *	1982-09-27	1986-06-24	Research Corporation	Monoclonal antibodies to vitamin B-6 and immunossay method
US4659678A (en) *	1982-09-29	1987-04-21	Serono Diagnostics Limited	Immunoassay of antigens
US4844966A (en) *	1982-10-13	1989-07-04	Minnesota Mining And Manufacturing Company	Assaying total IgE levels with fluorogenic enzyme labeled antibody
US4845027B1 (en) *	1982-10-13	1994-05-10	Biowhittaker Inc	Fluorometric assay of allergic reactions
US4539292A (en) *	1982-12-29	1985-09-03	Reid Michael J	Immunoassay technique for specific immunoglobulin E
WO1984002983A1 (en) *	1983-01-21	1984-08-02	Frederick James Primus	Specific cea-family antigens, antibodies specific thereto and their methods of use
US4818709A (en) *	1983-01-21	1989-04-04	Primus Frederick J	CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US4525452A (en) *	1983-01-24	1985-06-25	Btc Diagnostics Limited Partnership	Enzyme immunoassay with step of immersing sample in deionized water
US4994373A (en)	1983-01-27	1991-02-19	Enzo Biochem, Inc.	Method and structures employing chemically-labelled polynucleotide probes
US4849337A (en) *	1983-01-31	1989-07-18	Minnesota Mining And Manufacturing Company	Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
US4558006A (en) *	1983-02-04	1985-12-10	Kirin-Amgen, Inc.	A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
US5106760A (en) *	1983-02-04	1992-04-21	Kirin-Amgen	ATCC HB8209, its monoclonal antibody to erythropoietin and assay using same
US4474892A (en) *	1983-02-16	1984-10-02	Board Of Trustees Of The Leland Stanford Junior University	Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
FR2541304A1 (fr) *	1983-02-21	1984-08-24	Centre Nat Rech Scient	Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
US5084379A (en) *	1983-04-29	1992-01-28	Biowhittaker, Inc.	Fluorometric assay of chymopapain hypersensitivity and reagents therefor
US4851356A (en) *	1983-05-06	1989-07-25	The Trustees Of Columbia University In The City Of New York	Immunoassay for human chorionic gonadotropin
WO1984004598A1 (en) *	1983-05-06	1984-11-22	Univ Columbia	Immunoassay for human chorionic gonadotropin
US4642284A (en) *	1983-06-13	1987-02-10	Scripps Clinic And Research Foundation	Method and system for detection of complement pathway activation
GB8317124D0 (en) *	1983-06-23	1983-07-27	Ekins R P	Free ligand assay
USRE34405E (en) *	1983-08-01	1993-10-12	Abbott Laboratories	Determination of analytes in particle-containing medium
JPS60502202A (ja) *	1983-08-18	1985-12-19	クイデル	アレルギ−抑制因子
US4828981A (en) *	1983-08-24	1989-05-09	Synbiotics Corporation	Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
JPS6060557A (ja) *	1983-09-13	1985-04-08	Eisai Co Ltd	Ｐｉｖｋａ−２の測定方法および試薬
JPS6080768A (ja) *	1983-10-12	1985-05-08	Eisai Co Ltd	塩基性胎児蛋白の測定方法および試薬
US4595661A (en) *	1983-11-18	1986-06-17	Beckman Instruments, Inc.	Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US6846654B1 (en)	1983-11-29	2005-01-25	Igen International, Inc.	Catalytic antibodies as chemical sensors
US6057121A (en) *	1983-11-29	2000-05-02	Igen International, Inc.	Method of catalyzing stereochemical reactions
US5229272A (en) *	1989-04-25	1993-07-20	Igen, Inc.	Catalytic antibody components
US4839275A (en) *	1983-12-01	1989-06-13	The Jewish Hospital	Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
US4683196A (en) *	1983-12-12	1987-07-28	Meru, Inc.	Method and materials for the identification of lipopolysaccharide producing microorganisms
WO1985002685A1 (en) *	1983-12-12	1985-06-20	Meru, Inc.	Method and materials for the identification of lipopolysaccharide producing microorganisms
US4610960A (en) *	1983-12-21	1986-09-09	Wisconsin Alumni Research Foundation	Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
US4666865A (en) *	1984-01-13	1987-05-19	Centocor, Inc.	Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4757001A (en) *	1984-02-16	1988-07-12	Fujirebio Kabushiki Kaisha	Method of measuring biological ligand by utilizing amylase
GB8404368D0 (en) *	1984-02-20	1984-03-28	Cogent Ltd	Monoclonal antibodies to human cytomegalovirus
US4865997A (en) *	1984-02-23	1989-09-12	Becton Dickinson And Company	Assay for ligands by separating bound and free tracer from sample
US4690890A (en) *	1984-04-04	1987-09-01	Cetus Corporation	Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US4780401A (en) *	1984-04-09	1988-10-25	Ciba-Geigy Corporation	Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
GR850899B (it) *	1984-04-12	1985-11-25	Gen Hospital Corp
US5011771A (en) *	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
CA1260372A (en) *	1984-04-27	1989-09-26	Elazar Rabbani	Hybridization method for the detection of genetic materials
US4632901A (en) *	1984-05-11	1986-12-30	Hybritech Incorporated	Method and apparatus for immunoassays
ZA853756B (en) *	1984-06-01	1986-01-29	Miles Lab	Nucleic acid hybridization assay employing immobilized rna probes
US4731326A (en) *	1984-06-04	1988-03-15	Ortho Diagnostic Systems Inc.	Disease diagnosis by detection of shed normal tissue antigens
US4636478A (en) *	1984-07-16	1987-01-13	Becton, Dickinson And Company	Monoclonal antibodies recognizing L-thyroxine
AU4637185A (en) *	1984-08-01	1986-02-25	Advanced Biotechnology Associates Inc.	A salmonella specific analysis reagent
US4707438A (en) *	1984-08-22	1987-11-17	Tel Aviv University	Immunoassay for breast cancer employing monoclonal antibodies
WO1986001603A1 (en) *	1984-08-28	1986-03-13	Hybritech Incorporated	Article for diagnostic assays
US4745075A (en) *	1984-09-06	1988-05-17	Burroughs Wellcome Co.	Diagnostic test methods
WO1986002736A1 (en) *	1984-10-29	1986-05-09	Eks, Inc.	Immunoassay method for small molecules
ATE106565T1 (de) *	1984-10-31	1994-06-15	Alcon Lab Inc	Sandwich-immunotestverfahren für antigene bei ophthalmischen störungen.
US4713347A (en) *	1985-01-14	1987-12-15	Sensor Diagnostics, Inc.	Measurement of ligand/anti-ligand interactions using bulk conductance
JPH0672893B2 (ja) *	1985-08-16	1994-09-14	富士薬品工業株式会社	ヒト血中のヒトプロリルヒドロキシラーゼの放射性免疫学的測定法による定量法
DE3508384A1 (de) *	1985-03-08	1986-11-06	Boehringer Mannheim Gmbh, 6800 Mannheim	Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
DE3509958A1 (de) *	1985-03-20	1986-09-25	Bayer Ag, 5090 Leverkusen	Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
US4722889A (en) *	1985-04-02	1988-02-02	Leeco Diagnostics, Inc.	Immunoassays using multiple monoclonal antibodies and scavenger antibodies
US4707443A (en) *	1985-04-19	1987-11-17	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
US4935339A (en) *	1985-05-07	1990-06-19	Nichols Institute Diagnostics	Delayed solid phase immunologic assay
US4737456A (en) *	1985-05-09	1988-04-12	Syntex (U.S.A.) Inc.	Reducing interference in ligand-receptor binding assays
US5273882A (en) *	1985-06-13	1993-12-28	Amgen	Method and kit for performing nucleic acid hybridization assays
US4931385A (en) *	1985-06-24	1990-06-05	Hygeia Sciences, Incorporated	Enzyme immunoassays and immunologic reagents
US5112738A (en) *	1985-07-03	1992-05-12	Miles Inc.	Histamine derivatives, immunogen conjugates and antibodies raised thereto
US4910133A (en) *	1985-08-29	1990-03-20	Ube Industries, Limited	Diagnostic test drug comprising monoclonal antibody to human copper.zinc-superoxide dismutase and diagnostic test method using the same
US5063151A (en) *	1985-09-20	1991-11-05	Biometallics, Inc.	Immunoassay method and kit
US5595908A (en) *	1985-09-26	1997-01-21	University Of Southern Mississipi	Piezoelectric device for detection of polynucleotide hybridization
US4933275A (en) *	1985-10-24	1990-06-12	The General Hospital Corporation	Method for the detection of a polypeptide subunit in the presence of a quaternary protein containing the subunit
US6265176B1 (en)	1985-10-29	2001-07-24	Cordis Corporation	Dot immunoassay on plastic sheets
US4770993A (en) *	1985-10-31	1988-09-13	Beatrice Companies, Inc.	Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin
US5501949A (en) *	1985-12-10	1996-03-26	Murex Diagnostics Corporation	Particle bound binding component immunoassay
US4868108A (en) *	1985-12-12	1989-09-19	Hygeia Sciences, Incorporated	Multiple-antibody detection of antigen
US4810639A (en) *	1985-12-20	1989-03-07	E. I. Du Pont De Nemours And Company	Immunoassay for CK-MB using bound and soluble antibodies
US4772551A (en) *	1985-12-26	1988-09-20	Neogen Corporation	Method and test kit for detecting a trichothecene using novel monoclonal antibodies
US5175113A (en) *	1986-01-16	1992-12-29	Novo Nordisk A/S	Modified β2 -microglobulin
US4741999A (en) *	1986-02-26	1988-05-03	The Research Foundation Of State University Of New York	Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
JPS62231168A (ja)	1986-03-21	1987-10-09	ハイブリテツク・インコ−ポレイテツド	アナライト−レセプタ−分析用内部標準を設けるための改良法
AU7202887A (en) *	1986-03-26	1987-10-20	Murex Corp.	Device and method for determining microbial resistance to antimicrobic agents
US5426029A (en) *	1986-03-31	1995-06-20	T Cell Diagnostics, Inc.	Therapeutic and diagnostic methods using leukocyte surface antigens
US5292636A (en) *	1986-03-31	1994-03-08	T Cell Diagnostics, Inc.	Therapeutic and diagnostic methods using soluble T cell surface molecules
US5006459A (en) *	1986-03-31	1991-04-09	T Cell Sciences, Inc.	Therapeutic and diagnostic methods using soluble T cell surface molecules
US6881536B1 (en) *	1986-04-30	2005-04-19	Bioveris Corporation	Particle based electrochemiluminescent assays
US4963355A (en) *	1986-06-23	1990-10-16	Igen, Inc.	Production of antibody catalysts
US5120504A (en) *	1986-07-14	1992-06-09	Hybritech Incorporated	Apparatus for immunoassays with vent chennels in the container side wall
ATE120233T1 (de) *	1986-08-06	1995-04-15	Scripps Clinic Res	Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
US4935343A (en) *	1986-08-08	1990-06-19	Syntex (U.S.A.) Inc.	Monoclonal antibodies for interleukin-1β
US5316914A (en) *	1986-09-04	1994-05-31	Fuji Yakuhin Kogyo Kabushiki Kaisha	Method for determining human collagen peptides by way of enzyme immunoassay
JP2617299B2 (ja) *	1986-09-17	1997-06-04	ダイナボット株式会社	エラスターゼ１の免疫学的測定方法
US5763262A (en) *	1986-09-18	1998-06-09	Quidel Corporation	Immunodiagnostic device
US20010023075A1 (en) *	1992-04-03	2001-09-20	Siu-Yin Wong	A immunodiagnositc device having a dessicant incorporated therein
US4828986A (en) *	1986-09-29	1989-05-09	Scripps Clinic And Research Foundation	Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
US4804626A (en) *	1986-10-22	1989-02-14	The General Hospital Corporation	Immunometric assay for the detection of human chorionic gonadotropin
US4911909A (en) *	1987-01-02	1990-03-27	E. I. Du Pont De Nemours And Company	Method of controlling hypertension using monoclonal antibodies to angiotensin-II
US4940659A (en) *	1987-02-20	1990-07-10	Monoclonetics International, Inc.	Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome
US5789235A (en) *	1987-03-23	1998-08-04	Tackett; Scott E.	Modifying cell metabolism via extra-cellular nucleases
DE3714147A1 (de) *	1987-04-28	1988-11-17	Boehringer Mannheim Gmbh	Immunchemisches verfahren und reagenz zur bestimmung eines polyvalenten antigens in einer fluessigen probe
US4788138A (en) *	1987-04-30	1988-11-29	Beckman Instruments, Inc.	Method to achieve a linear standard curve in a sandwich immunoassay
US5474899A (en) *	1987-05-13	1995-12-12	Cistron Biotechnology, Inc.	Selective immunoassay for IL-1 β
US5149626A (en) *	1987-05-14	1992-09-22	Mclean Hospital Corporation	Multiple antigen immunoassay
FR2615622B1 (fr) *	1987-05-19	1994-05-06	Ire Medgenix Sa	Dosage plasmatique de monokines
US4971904A (en) *	1987-06-26	1990-11-20	E. I. Du Pont De Nemours And Company	Heterogeneous immunoassay
US5009998A (en) *	1987-06-26	1991-04-23	E. I. Du Pont De Nemours And Company	Method for performing heterogeneous immunoassay
US5179000A (en) *	1987-07-24	1993-01-12	Nippon Kayaku Kabushiki Kaisha	Method for assaying basic fetoprotein in urine and assay kit therefor
US5447837A (en) *	1987-08-05	1995-09-05	Calypte, Inc.	Multi-immunoassay diagnostic system for antigens or antibodies or both
DE3889041T2 (de) *	1987-09-02	1994-10-27	Igen Inc	Herstellung von Immunonähe-Katalysatoren.
US6461825B1 (en) *	1987-09-30	2002-10-08	Sanofi (Societe Anonyme)	Immunometric assay kit and method applicable to whole cells
US4859612A (en) *	1987-10-07	1989-08-22	Hygeia Sciences, Inc.	Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
US5231000A (en) *	1987-10-08	1993-07-27	The Mclean Hospital	Antibodies to A4 amyloid peptide
DE3734015A1 (de) *	1987-10-08	1989-04-20	Behringwerke Ag	Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b
US5217869A (en) *	1987-10-13	1993-06-08	Terrapin Technologies, Inc.	Method to produce immunodiagnostic reagents
US5300425A (en) *	1987-10-13	1994-04-05	Terrapin Technologies, Inc.	Method to produce immunodiagnostic reagents
US5256372A (en) *	1987-11-06	1993-10-26	Idexx Corporation	Dipstick test device including a removable filter assembly
US5094941A (en) *	1987-12-31	1992-03-10	Zymogenetics, Inc.	Monoclonal antibodies to PDGF
US4891313A (en) *	1988-01-21	1990-01-02	Boehringer Manheim Corporation	Method for determination of a component of a sample
WO1989009393A1 (en) *	1988-03-24	1989-10-05	Igen, Inc.	Luminescent chimeric proteins
US5202267A (en) *	1988-04-04	1993-04-13	Hygeia Sciences, Inc.	Sol capture immunoassay kit and procedure
US6702705B1 (en)	1988-05-04	2004-03-09	Igen International, Inc.	Prodrugs activated by targeted catalytic proteins
US5620845A (en) *	1988-06-06	1997-04-15	Ampcor, Inc.	Immunoassay diagnostic kit
US5173399A (en) *	1988-06-10	1992-12-22	Abbott Laboratories	Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
AU2684488A (en) *	1988-06-27	1990-01-04	Carter-Wallace, Inc.	Test device and method for colored particle immunoassay
CA1335880C (en)	1988-07-14	1995-06-13	Thomas P. O'connor	Detection of an antibody and antigen in an immunoassay
US5096809A (en) *	1988-07-25	1992-03-17	Pacific Biotech, Inc.	Whole blood assays using porous membrane support devices
US5059522A (en) *	1988-08-18	1991-10-22	Wayne Lawrence G	Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US5030555A (en) *	1988-09-12	1991-07-09	University Of Florida	Membrane-strip reagent serodiagnostic apparatus and method
DE3836348A1 (de) *	1988-10-25	1990-04-26	Boehringer Mannheim Gmbh	Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
EP0368674A3 (en) *	1988-11-11	1991-10-09	SANYO CHEMICAL INDUSTRIES, Ltd.	Immunoassay and test kits therefor
US6306594B1 (en)	1988-11-14	2001-10-23	I-Stat Corporation	Methods for microdispensing patterened layers
US5200051A (en) *	1988-11-14	1993-04-06	I-Stat Corporation	Wholly microfabricated biosensors and process for the manufacture and use thereof
US5322838A (en) *	1988-11-16	1994-06-21	Brigham & Women's Hospital	Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation
US5512657A (en) *	1988-12-12	1996-04-30	Bainbridge Sciences, Inc.	Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5264370A (en) *	1988-12-12	1993-11-23	Bainbridge Laboratories, Inc.	Detection of basement membrane components as diagnostic of cancer and other diseases
CA2008304C (en) *	1989-01-31	2001-03-27	Craig S. Hill	Assay for bone alkaline phosphatase
JPH04504199A (ja) *	1989-02-03	1992-07-30	コモンウェルスサイエンティフィックアンドインダストリアルリサーチオーガナイゼーション	単クローン性抗体およびその用途
US5106761A (en) *	1989-03-13	1992-04-21	International Canine Genetics, Inc.	Method for detecting molecules in a liquid medium
US5318897A (en) *	1989-04-25	1994-06-07	Igen, Inc.	Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
US6048717A (en) *	1989-04-25	2000-04-11	Igen International, Inc.	Inhibitors of catalytic antibodies
US5194585A (en) *	1989-04-25	1993-03-16	Igen, Inc.	Inhibitors of catalytic antibodies
US5236836A (en) *	1989-04-25	1993-08-17	Igen, Inc.	Autoantibodies which enhance the rate of a chemical reaction
US5599538A (en) *	1989-04-25	1997-02-04	Igen, Inc.	Autoantibodies which enhance the rate of a chemical reaction
US5658753A (en) *	1989-04-25	1997-08-19	Paul; Sudhir	Catalytic antibody components
US6258360B1 (en)	1989-05-04	2001-07-10	Igen International, Inc.	Prodrugs activated by targeted catalytic proteins
CA2056449A1 (en) *	1989-06-02	1990-12-03	Stanley J. Podlasek	Method for the detection of anti-streptokinase antibodies
WO1990015327A1 (en) *	1989-06-06	1990-12-13	Martin Gould	Immunoassay diagnostic kit
US5187068A (en) *	1989-06-09	1993-02-16	Nicolae Luca	Method for determination of lipid moiety and apolipoprotein expressed epitope immunoreactivity on intact lipoprotein
US5484735A (en) *	1989-08-23	1996-01-16	Northwestern University	Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids
US6008057A (en) *	1989-08-25	1999-12-28	Roche Diagnostics Corporation	Immunoassay system
US5196311A (en) *	1989-10-27	1993-03-23	Health Research, Incorporated	Elisa test for von willebrand factor
US5202264A (en) *	1989-10-27	1993-04-13	Health Research, Incorporated	ELISA using multi-species antibodies for detection of von Willebrand factor in multiple species
US5830709A (en) *	1989-10-27	1998-11-03	Benson; Roger E.	Detection method for homologous portions of a class of substances
CA2331088A1 (en) *	1989-11-03	1991-05-04	Donald L. Morton	Urinary tumor associated antigen, antigenic subunits uses and methods of detection
US5624898A (en)	1989-12-05	1997-04-29	Ramsey Foundation	Method for administering neurologic agents to the brain
US6407061B1 (en)	1989-12-05	2002-06-18	Chiron Corporation	Method for administering insulin-like growth factor to the brain
US5196324A (en) *	1989-12-15	1993-03-23	Eli Lilly And Company	Monoclonal antibodies reactive with a human atheroma associated antigen
KR910014706A (ko) *	1990-01-10	1991-08-31	원본미기재	세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
ATE120860T1 (de) *	1990-01-26	1995-04-15	Washington Res Found	Immunreaktivität gegenüber exprimierten aktivierten oncogenen zur diagnose und behandlung von bösartigen geschwülsten.
US5532135A (en) *	1990-02-02	1996-07-02	Cancer Research Fund Of Contra Costa	Solid-phase competitive assay utilizing a fusion protein
US6190885B1 (en)	1990-02-02	2001-02-20	Cancer Research Fund Of Contra Costa	Fusion protein containing HMFG Epitop E (S)
WO1991012333A1 (en) *	1990-02-07	1991-08-22	Kanebo, Ltd.	Antiprocollagenase monoclonal antibody and assay of procollagenase therewith
US5096837A (en) *	1990-02-08	1992-03-17	Pacific Biotech, Inc.	Immunochromatographic assay and method of using same
US5922615A (en)	1990-03-12	1999-07-13	Biosite Diagnostics Incorporated	Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5223220A (en) *	1990-03-27	1993-06-29	Pacific Biotech, Inc.	Solid phase immunoassay device and method of making same
CA2095642C (en) *	1990-08-02	1999-12-14	Howard C. Krivan	Adhesion receptors for pathogenic or opportunistic microorganisms
CA2072758A1 (en) *	1990-09-14	1992-03-15	Kenneth Francis Buechler	Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
JPH085920B2 (ja) *	1991-01-21	1996-01-24	富士薬品工業株式会社	抗ヒトストロムライシンモノクローナル抗体及び酵素免疫測定法
US5997878A (en)	1991-03-07	1999-12-07	Connaught Laboratories	Recombinant poxvirus-cytomegalovirus, compositions and uses
CA2055695C (en) *	1991-04-12	2004-04-13	Thomas Hyatt Duffy	Ca 195-like immunoreactive antigen from human amniotic fluid
US5223396A (en) *	1991-05-03	1993-06-29	Boehringer Ingelheim Pharmaceuticals, Inc.	Method for detecting organ transplant rejection
WO1992020820A1 (en) *	1991-05-15	1992-11-26	Vanderbilt University	Method to determine metastatic potential of tumor cells
US5607863A (en) *	1991-05-29	1997-03-04	Smithkline Diagnostics, Inc.	Barrier-controlled assay device
US5998220A (en)	1991-05-29	1999-12-07	Beckman Coulter, Inc.	Opposable-element assay devices, kits, and methods employing them
US5869345A (en) *	1991-05-29	1999-02-09	Smithkline Diagnostics, Inc.	Opposable-element assay device employing conductive barrier
US5468648A (en) *	1991-05-29	1995-11-21	Smithkline Diagnostics, Inc.	Interrupted-flow assay device
US5877028A (en)	1991-05-29	1999-03-02	Smithkline Diagnostics, Inc.	Immunochromatographic assay device
US6168956B1 (en)	1991-05-29	2001-01-02	Beckman Coulter, Inc.	Multiple component chromatographic assay device
WO1992022668A1 (en) *	1991-06-14	1992-12-23	Vanderbilt University	Method and compositions to assess oxidative stress in vivo
US5338660A (en) *	1991-07-12	1994-08-16	Board Of Supervisors Of Louisiana State University And Agricutural And Mechanical College	Diagnosis of Fasciola infections by detection of antigens in feces or intestinal content
US5965379A (en) *	1991-07-19	1999-10-12	Cytimmune Sciences Inc.	Method for measuring endogenous cytokines
AU2392692A (en) *	1991-07-19	1993-02-23	Assay Research, Inc.	Method and kit for measuring endogenous cytokines
US6007999A (en) *	1991-07-31	1999-12-28	Idexx Laboratories, Inc.	Reversible flow chromatographic binding assay
US5726010A (en) *	1991-07-31	1998-03-10	Idexx Laboratories, Inc.	Reversible flow chromatographic binding assay
US5369006A (en) *	1991-08-20	1994-11-29	E. I. Du Pont De Nemours And Company	Determination of CK isoenzymes and CK isoforms
CA2116453A1 (en)	1991-08-28	1993-03-18	Basil Rapoport	Disease associated human autoantibodies specific for human thyroid peroxidase
DE4134297A1 (de) *	1991-10-17	1993-04-22	Behringwerke Ag	Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung
DK0625048T4 (da) *	1991-10-23	2006-02-20	Fibrogen Inc	Syntese af human procollagener og collagener i rekombinant DNA-systemer
WO1993008473A1 (en) *	1991-10-24	1993-04-29	Beth Israel Hospital Association	Assay for malignant effusions
US5525461A (en) *	1991-11-01	1996-06-11	T Cell Diagnostics, Inc.	Therapeutic and diagnostic methods using total leukocyte surface antigens
EP0623214A1 (en) *	1992-01-17	1994-11-09	Selective Antibodies Limited	Determination of haptens
DE69302719T2 (de) *	1992-02-17	1996-09-19	Akzo Nv	Kalibrator und Verwendung davon in einer Immuntest
US5851787A (en) *	1992-04-20	1998-12-22	The General Hospital Corporation	Nucleic acid encoding amyloid precursor-like protein and uses thereof
US5708141A (en) *	1992-05-11	1998-01-13	Corvas International, Inc.	Neutrophil inhibitors
DE4218257A1 (de) *	1992-06-03	1993-12-09	Behringwerke Ag	Verfahren zur immunchemischen Bestimmung eines Analyten
US5688936A (en) *	1992-06-11	1997-11-18	The Regents Of The University Of California	Vesicle membrane transport proteins
US5395754A (en) *	1992-07-31	1995-03-07	Hybritech Incorporated	Membrane-based immunoassay method
US5447838A (en) *	1992-08-05	1995-09-05	Hybritech Incorporated	Protein-dye conjugate for confirmation of correct dilution of calibrators
US5789183A (en) *	1992-08-14	1998-08-04	University Of Arkansas	Serological detection and identification of rice blast
US5354692A (en) *	1992-09-08	1994-10-11	Pacific Biotech, Inc.	Analyte detection device including a hydrophobic barrier for improved fluid flow
AU689091B2 (en) *	1992-12-18	1998-03-26	Cell Med, Inc.	Assay and treatment for demyelinating diseases such as multiple sclerosis
EP0606516B1 (en) *	1993-01-13	1998-12-30	Idemitsu Kosan Company Limited	Anti-human ceruloplasmin monoclonal antibody
US5914241A (en) *	1993-01-19	1999-06-22	Biosite Diagnostics, Inc.	Assays and kits for detecting analytes in the presence of cross-reacting substances
FR2700855B1 (fr) *	1993-01-28	1995-03-03	Commissariat Energie Atomique	Dosage immunométrique d'un antigène ou d'un haptène.
US7713528B1 (en)	1993-02-18	2010-05-11	Enzo Therapeutics, Inc.	Method for in vivo delivery of active compounds using reagent conjugate
US5374531A (en) *	1993-03-22	1994-12-20	Zynaxis, Inc.	Immunoassay for determination of cells
DE4314254A1 (de) *	1993-04-30	1994-11-03	Boehringer Mannheim Gmbh	Monoklonale Antikörper gegen CK-MB
AU7170994A (en) *	1993-06-08	1995-01-03	Chronomed, Inc.	Two-phase optical assay method and apparatus
SG63596A1 (en) *	1993-07-29	1999-03-30	Cor Therapeutics Inc	Receptor function assays
US5837546A (en) *	1993-08-24	1998-11-17	Metrika, Inc.	Electronic assay device and method
AU7732894A (en) *	1993-09-22	1995-04-10	Nichols Institute Diagnostics	Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
JP3356556B2 (ja) *	1993-10-22	2002-12-16	第一化学薬品株式会社	変性リポプロテイン類の測定法
US7312052B1 (en) *	1993-12-08	2007-12-25	Stratagene California	Polymerase compositions and uses thereof
US5695928A (en)	1993-12-10	1997-12-09	Novartis Corporation	Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
US6045797A (en) *	1994-03-14	2000-04-04	New York University Medical Center	Treatment or diagnosis of diseases or conditions associated with a BLM domain
US5877016A (en)	1994-03-18	1999-03-02	Genentech, Inc.	Human trk receptors and neurotrophic factor inhibitors
US6660842B1 (en) *	1994-04-28	2003-12-09	Tripep Ab	Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) *	1996-12-27	2005-08-23	Tripep Ab	Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6040137A (en) *	1995-04-27	2000-03-21	Tripep Ab	Antigen/antibody specification exchanger
US6417324B1 (en) *	2000-04-21	2002-07-09	Tripep Ab	Synthetic peptides that bind to the hepatitis B virus core and e antigens
US6140099A (en) *	1994-05-20	2000-10-31	The Trustees Of The University Of Pennsylvania	Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
US5708142A (en)	1994-05-27	1998-01-13	Genentech, Inc.	Tumor necrosis factor receptor-associated factors
US6107045A (en)	1994-06-30	2000-08-22	Oklahoma Medical Research Foundation	Antibodies to lipoproteins and apolipoproteins and methods of use thereof
PT699754E (pt)	1994-08-12	2001-04-30	Us Health	Metodo para diagnosticar uma predisposicao para cancro da mama e do ovario
EP0705903B2 (en)	1994-08-12	2009-08-12	The University of Utah Research Foundation	Mutations in the 17q-linked breast and ovarian cancer susceptibility gene
US8236493B2 (en) *	1994-10-21	2012-08-07	Affymetrix, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5556752A (en)	1994-10-24	1996-09-17	Affymetrix, Inc.	Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en)	1994-10-21	2005-12-13	Appymetric, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
JP2729159B2 (ja) *	1994-10-31	1998-03-18	日清製粉株式会社	ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法
EP1985703A3 (en)	1994-11-02	2009-04-08	Allelix Neuroscience, Inc.	Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
US5837524A (en) *	1994-12-15	1998-11-17	Sugen, Inc.	PYK2 related polynucleotide products
IL114615A0 (en)	1995-07-16	1995-11-27	Yeda Res & Dev	Modulators of the function of fas receptors and other proteins
US5837815A (en) *	1994-12-15	1998-11-17	Sugen, Inc.	PYK2 related polypeptide products
US5807989A (en) *	1994-12-23	1998-09-15	New York University	Methods for treatment or diagnosis of diseases or disorders associated with an APB domain
US6300482B1 (en)	1995-01-03	2001-10-09	Max-Flanck-Gesellschaft Zuer For{Overscore (D)}Erung Der	MDKI, a novel receptor tyrosine kinase
US5569608A (en) *	1995-01-30	1996-10-29	Bayer Corporation	Quantitative detection of analytes on immunochromatographic strips
US5731153A (en) *	1996-08-26	1998-03-24	The Regents Of The University Of California	Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
US5783387A (en) *	1995-02-06	1998-07-21	The Regents Of The University Of California	Method for identifying and quantifying nucleic acid sequence aberrations
US6331273B1 (en)	1995-04-25	2001-12-18	Discovery Partners International	Remotely programmable matrices with memories
US6329139B1 (en)	1995-04-25	2001-12-11	Discovery Partners International	Automated sorting system for matrices with memory
US6416714B1 (en) *	1995-04-25	2002-07-09	Discovery Partners International, Inc.	Remotely programmable matrices with memories
US5751629A (en) *	1995-04-25	1998-05-12	Irori	Remotely programmable matrices with memories
US6017496A (en) *	1995-06-07	2000-01-25	Irori	Matrices with memories and uses thereof
US5874214A (en) *	1995-04-25	1999-02-23	Irori	Remotely programmable matrices with memories
US5741462A (en) *	1995-04-25	1998-04-21	Irori	Remotely programmable matrices with memories
US5686257A (en) *	1995-04-26	1997-11-11	Schering Corporation	Binding compositions for mammalian T cell antigens and related reagents
US6147106A (en) *	1997-08-20	2000-11-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5977322A (en)	1995-06-14	1999-11-02	The Regents Of The University Of California	High affinity human antibodies to tumor antigens
US5616465A (en)	1995-08-09	1997-04-01	The Regents Of The University Of California	Detection and isolation of nucleic acid sequences using competitive hybridization probes
US7635597B2 (en) *	1995-08-09	2009-12-22	Bayer Healthcare Llc	Dry reagent particle assay and device having multiple test zones and method therefor
US6027879A (en) *	1995-08-09	2000-02-22	The Regents Of The University Of California	Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
US5660990A (en) *	1995-08-18	1997-08-26	Immunivest Corporation	Surface immobilization of magnetically collected materials
US5733728A (en) *	1995-08-18	1998-03-31	Regents Of The University Of Colorado	Detecting and treating heart failure
US7455964B1 (en)	1996-07-15	2008-11-25	The Hospital For Sick Children	Genes from the 20q13 amplicon and their uses
US5837492A (en)	1995-12-18	1998-11-17	Myriad Genetics, Inc.	Chromosome 13-linked breast cancer susceptibility gene
US6716575B2 (en)	1995-12-18	2004-04-06	Sugen, Inc.	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US7119174B2 (en) *	1995-12-18	2006-10-10	Sugen, Inc.	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
EP0876491B1 (en)	1995-12-22	2009-04-08	University Of Utah Research Foundation	A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK
US7888466B2 (en)	1996-01-11	2011-02-15	Human Genome Sciences, Inc.	Human G-protein chemokine receptor HSATU68
US5770086A (en) *	1996-01-25	1998-06-23	Eureka\| Science Corp.	Methods and apparatus using hydrogels
US5942385A (en) *	1996-03-21	1999-08-24	Sugen, Inc.	Method for molecular diagnosis of tumor angiogenesis and metastasis
US6531578B1 (en)	1996-04-12	2003-03-11	Robert Webber	Immunoassay method employing monoclonal antibody reactive to human iNOS
US5968839A (en) *	1996-05-13	1999-10-19	Metrika, Inc.	Method and device producing a predetermined distribution of detectable change in assays
JP2002512501A (ja)	1996-07-03	2002-04-23	メリアルインコーポレイテッド	外来性ｄｎａを含む組換えイヌアデノウィルス（ｃａｖ）
US6524578B1 (en)	1996-07-10	2003-02-25	Scott E. Tackett	Use of nuclease to reduce wrinkles and discolorations in humans
DE19629444A1 (de) *	1996-07-22	1998-01-29	Behringwerke Ag	Sensitivitätssteigerung bei der immunchemischen Bestimmung eines Analyten
US6277592B1 (en)	1996-07-31	2001-08-21	Purina Mills, Inc.	Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6297027B1 (en)	1996-07-31	2001-10-02	Purina Mills, Inc.	Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6159462A (en) *	1996-08-16	2000-12-12	Genentech, Inc.	Uses of Wnt polypeptides
US5851984A (en) *	1996-08-16	1998-12-22	Genentech, Inc.	Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US5945345A (en) *	1996-08-27	1999-08-31	Metrika, Inc.	Device for preventing assay interference using silver or lead to remove the interferant
US6001658A (en) *	1996-09-13	1999-12-14	Diagnostic Chemicals Limited	Test strip apparatus and method for determining presence of analyte in a fluid sample
US5795784A (en)	1996-09-19	1998-08-18	Abbott Laboratories	Method of performing a process for determining an item of interest in a sample
US5856194A (en)	1996-09-19	1999-01-05	Abbott Laboratories	Method for determination of item of interest in a sample
SG94355A1 (en)	1996-10-01	2003-02-18	Geron Corp	Human telomerase catalytic subunit
US6004791A (en) *	1996-11-13	1999-12-21	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.	Protein tyrosine phosphatase PTP20 and related products and methods
US6660481B2 (en) *	1996-12-09	2003-12-09	Osteometer Biotech A/S	Sandwich assays for collagen type I fragments
SI1019500T1 (sl)	1997-01-15	2007-02-28	Yeda Res & Dev	Proteini, ki vezejo receptor 1 za ifn, dna, ki jih kodira, in postopki za regulacijo celicnega odziva na interferone
US5879951A (en) *	1997-01-29	1999-03-09	Smithkline Diagnostics, Inc.	Opposable-element assay device employing unidirectional flow
AU729158B2 (en)	1997-01-31	2001-01-25	Genentech Inc.	O-fucosyltransferase
US20040241645A1 (en) *	1997-01-31	2004-12-02	Genentech, Inc.	O-fucosyltransferase
EP0966533B1 (en)	1997-02-07	2009-09-16	The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services	Activity dependent neurotrophic factor iii (adnf iii)
US20050101032A1 (en) *	1997-02-10	2005-05-12	Metrika, Inc.	Assay device, composition, and method of optimizing assay sensitivity
CA2283635A1 (en)	1997-03-21	1998-10-01	Stratagene	Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
US5914394A (en) *	1997-03-27	1999-06-22	Millenium Pharmaceuticals, Inc.	Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
US5939316A (en) *	1997-03-27	1999-08-17	Millennium Pharmaceuticals, Inc.	Chromosome 18 marker
US5866412A (en) *	1997-03-27	1999-02-02	Millennium Pharmaceuticals, Inc.	Chromosome 18 marker
US5955355A (en) *	1997-03-27	1999-09-21	Millennium Pharmaceuticals, Inc.	Chromosome 18 marker
SI2301580T1 (sl)	1997-04-07	2012-05-31	Genentech Inc	Vsebnik ki vsebuje anti VEGF protitelesa
DK1325932T5 (da)	1997-04-07	2005-10-03	Genentech Inc	Anti-VEGF antistoffer
CA2286305A1 (en)	1997-04-09	1998-10-15	Mindset Ltd.	Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
US6818440B2 (en) *	1997-04-28	2004-11-16	Sugen, Inc.	Diagnosis and treatment of alk-7 related disorders
US6103536A (en)	1997-05-02	2000-08-15	Silver Lake Research Corporation	Internally referenced competitive assays
US5939252A (en) *	1997-05-09	1999-08-17	Lennon; Donald J.	Detachable-element assay device
US6228641B1 (en)	1997-05-20	2001-05-08	Sugen, Inc.	Diagnosis and treatment of PTP04 related disorders
DE69842017D1 (de)	1997-06-10	2011-01-05	Lpath Inc	Verfahren zum frühzeitigen nachweis herzerkrankungen
US6342593B1 (en)	1997-06-11	2002-01-29	Sugen, Inc.	Diagnosis and treatment of ALP related disorders
EP0988371A4 (en)	1997-06-11	2002-11-04	Human Genome Sciences Inc	TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTOR
US7115710B2 (en) *	1997-06-11	2006-10-03	Sugen, Inc.	Diagnosis and treatment of PTP related disorders
US6388063B1 (en) *	1997-06-18	2002-05-14	Sugen, Inc.	Diagnosis and treatment of SAD related disorders
US6235769B1 (en)	1997-07-03	2001-05-22	Sugen, Inc.	Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
US6391547B1 (en) *	1997-09-09	2002-05-21	Center For The Application Of Molecular Biology To International Agriculture	Microbial β-glucuronidase genes, gene products and uses thereof
US7087420B1 (en)	1997-07-17	2006-08-08	Cambia	Microbial β-glucuronidase genes, gene products and uses thereof
US20040067531A1 (en) *	1997-08-20	2004-04-08	Sugen, Inc.	Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
US6960457B1 (en) *	1997-09-04	2005-11-01	Stanford University	Reversible immobilization of arginine-tagged moieties on a silicate surface
US20140080177A1 (en) *	1997-09-26	2014-03-20	Pieris Ag	Anticalins
EP1019086A4 (en) *	1997-09-29	2004-01-07	Univ Maryland	CHANGED DNA SYNTHESOM COMPONENTS AS A BIOMARKER IN CANCER
DE69838483T2 (de)	1997-10-14	2008-07-03	Darwin Molecular Corp.	Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
ES2316173T3 (es)	1997-10-29	2009-04-01	Genentech, Inc.	Genes inducibles por wnt-1.
EP2014770A3 (en)	1997-10-29	2009-02-18	Genentech, Inc.	WNT-1 Iinduced secreted polypeptide WISP-2
JP4441112B2 (ja)	1997-11-03	2010-03-31	ヒューマンジノームサイエンシーズ，インコーポレイテッド	新脈管形成および腫瘍増殖のインヒビターであるｖｅｇｉ
US6224882B1 (en)	1997-11-07	2001-05-01	Protein Science Corp.	Insect cells or fractions as adjuvant for antigens
PT1481990E (pt)	1997-11-21	2007-09-17	Genentech Inc	Antigénios relacionados com a-33 e suas utilizações farmacológicas
US7192589B2 (en)	1998-09-16	2007-03-20	Genentech, Inc.	Treatment of inflammatory disorders with STIgMA immunoadhesins
US6437563B1 (en)	1997-11-21	2002-08-20	Quantum Design, Inc.	Method and apparatus for making measurements of accumulations of magnetically susceptible particles combined with analytes
US6221585B1 (en) *	1998-01-15	2001-04-24	Valigen, Inc.	Method for identifying genes underlying defined phenotypes
AU2237899A (en) *	1998-01-21	1999-08-09	Sugen, Inc.	Human orthologues of wart
US6531502B1 (en)	1998-01-21	2003-03-11	Sugen, Inc.	3-Methylidenyl-2-indolinone modulators of protein kinase
US6764830B1 (en)	1998-01-23	2004-07-20	The Regents Of The University Of California	Thermomyces lanuginosus kinesin motor protein and methods of screening for modulators of kinesin proteins
US20040176572A1 (en) *	1998-03-16	2004-09-09	Freimer Nelson B.	Methods of compositions for diagnosing and treating chromosome-18p related disorders
US6342351B1 (en)	1998-03-16	2002-01-29	Millennium Pharmaceuticals, Inc.	Methods and compositions for diagnosing and treating chromosome-18p related disorders
DK2016951T3 (da)	1998-03-17	2012-09-24	Genentech Inc	VEGF- og BMP1-homologe polypeptider
US6274314B1 (en) *	1998-04-02	2001-08-14	Nyxis Neurotherapies, Inc.	Diagnostic assay for the modified nucleosides pseudouridine, 7-methyladenosine, or 1-methyladenosine
US6514981B1 (en)	1998-04-02	2003-02-04	Sugen, Inc.	Methods of modulating tyrosine protein kinase function with indolinone compounds
WO1999053036A2 (en)	1998-04-14	1999-10-21	Sugen, Inc.	Ste20-related protein kinases
US7157083B2 (en) *	1998-04-17	2007-01-02	Surrogate Pharmaceutical Pathways, Llc	Compositions and methods for treating retroviral infections
US20060019404A1 (en) *	1998-05-06	2006-01-26	Blatt Joel M	Quantitative assay with extended dynamic range
KR100785718B1 (ko)	1998-05-19	2007-12-18	리서치 디벨럽먼트 파운데이션	트리테르펜 조성물
US6432679B1 (en)	1998-06-12	2002-08-13	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220
EP1806362B1 (en)	1998-07-28	2010-07-21	The Regents of the University of California	Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
US7402400B2 (en)	2001-07-03	2008-07-22	Regents Of The University Of California	Mammalian sweet taste receptors
PT1105485E (pt) *	1998-08-21	2006-11-30	Immunex Corp	Dna e polipeptídeos de il-1 epsilon humana
AU5822399A (en)	1998-09-09	2000-03-27	Millennium Pharmaceuticals, Inc.	Essential bacterial genes and their use
US20070178475A1 (en) *	1998-09-17	2007-08-02	Nehls Michael C	Novel human polynucleotides and polypeptides encoded thereby
US6680335B2 (en)	1998-09-28	2004-01-20	Sugen, Inc.	Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
US6368793B1 (en) *	1998-10-14	2002-04-09	Microgenomics, Inc.	Metabolic selection methods
US7091324B2 (en)	1998-11-05	2006-08-15	Board Of Trustees Of Leland Stanford Junior University	Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
SI1135498T1 (sl)	1998-11-18	2008-06-30	Genentech Inc	Variante protitelesa z viĹˇjo vezavno afiniteto vprimerjavi z izvirnimi protitelesi
EP2261335B1 (en) *	1998-11-27	2017-06-14	UCB Pharma S.A.	Compositions and methods for increasing bone mineralisation
US20040009535A1 (en)	1998-11-27	2004-01-15	Celltech R&D, Inc.	Compositions and methods for increasing bone mineralization
US7273618B2 (en) *	1998-12-09	2007-09-25	Chiron Corporation	Method for administering agents to the central nervous system
IL143596A0 (en)	1998-12-22	2002-04-21	Genentech Inc	Vascular endothelial cell growth factor antagonists and uses thereof
US6861442B1 (en) *	1998-12-30	2005-03-01	Sugen, Inc.	PYK2 and inflammation
US20020031802A1 (en) *	2000-05-12	2002-03-14	Yi Hu	Novel seven transmembrane proteins and polynucleotides encoding the same
US20020055626A1 (en) *	2000-06-09	2002-05-09	Turner C. Alexander	Novel human seven transmembrane proteins and polynucleotides encoding the same
US20020038013A1 (en) *	2000-02-04	2002-03-28	Gregory Donoho	Novel human membrane proteins and polynucleotides encoding the same
US6570003B1 (en) *	2001-01-09	2003-05-27	Lexion Genetics Incorporated	Human 7TM proteins and polynucleotides encoding the same
US20020164784A1 (en) *	2000-10-27	2002-11-07	Walke D. Wade	Novel human 7TM proteins and polynucleotides encoding the same
US20020061556A1 (en) *	2000-04-27	2002-05-23	Walke D. Wade	Novel membrane proteins and polynucleotides encoding the same
US6579715B1 (en)	1999-01-19	2003-06-17	Lexicon Genetics Incorporated	Mammalian cortexin-like proteins and polynucleotides encoding the same
US7396810B1 (en) *	2000-08-14	2008-07-08	Oregon Health Sciences University	Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US7393823B1 (en)	1999-01-20	2008-07-01	Oregon Health And Science University	HER-2 binding antagonists
US7625859B1 (en) *	2000-02-16	2009-12-01	Oregon Health & Science University	HER-2 binding antagonists
US6303749B1 (en)	1999-01-29	2001-10-16	Amgen Inc.	Agouti and agouti-related peptide analogs
CA2359747A1 (en) *	1999-02-09	2000-08-17	Lexicon Genetics Incorporated	Human uncoupling proteins and polynucleotides encoding the same
GB9903841D0 (en) *	1999-02-20	1999-04-14	Imp College Innovations Ltd	Diagnosis and treatment of cancer
US6911429B2 (en) *	1999-04-01	2005-06-28	Transition Therapeutics Inc.	Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US6864235B1 (en) *	1999-04-01	2005-03-08	Eva A. Turley	Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
CA2366523C (en)	1999-04-12	2008-10-14	Yuji Matsuzawa	Method for analyzing the amount of intraabdominal adipose tissue
US20080145347A1 (en) *	1999-04-29	2008-06-19	Steiner Mitchell S	p-Hyde sequences in the Rat
US20020110809A1 (en) *	1999-04-30	2002-08-15	Nehls Michael C.	Novel human polynucleotides and polypeptides encoded thereby
US20020095031A1 (en) *	1999-05-04	2002-07-18	Nehls Michael C.	Novel human polynucleotides and polypeptides encoded thereby
US7566452B1 (en)	1999-05-04	2009-07-28	New York University	Cancer treatment with endothelin receptor antagonists
US20030186311A1 (en) *	1999-05-21	2003-10-02	Bioforce Nanosciences, Inc.	Parallel analysis of molecular interactions
IL130225A0 (en)	1999-05-31	2000-06-01	Yissum Res Dev Co	Novel uses of antibodies against ache and peptides thereof
JP2003507055A (ja) *	1999-08-24	2003-02-25	レキシコン・ジェネティクス・インコーポレーテッド	ヒト乳腺ｃＤＮＡライブラリーから得られた配列
NZ523206A (en) *	1999-08-31	2004-12-24	Genentech Inc	Antibodies that bind to tumor gene sequences
US6716614B1 (en) *	1999-09-02	2004-04-06	Lexicon Genetics Incorporated	Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
US20020049312A1 (en) *	2000-05-23	2002-04-25	Turner C. Alexander	Noel human thrombospondin-like proteins and polynucleotides encoding the same
US6448388B1 (en)	2000-08-16	2002-09-10	Lexicon Genetics Incorporated	Human proteases and polynucleotides encoding the same
US20030050464A1 (en) *	2000-07-28	2003-03-13	Yi Hu	Novel human proteases and polynucleotides encoding the same
US20080003673A1 (en) *	1999-09-02	2008-01-03	Alejandro Abuin	Novel human proteases and polynucleotides encoding the same
US20050153323A1 (en) *	2000-07-28	2005-07-14	Yi Hu	Novel human proteases and polynucleotides encoding the same
AU7101700A (en)	1999-09-02	2001-03-26	Lexicon Genetics Incorporated	Human calcium dependent proteases and polynucleotides encoding the same
US7408047B1 (en) *	1999-09-07	2008-08-05	Amgen Inc.	Fibroblast growth factor-like polypeptides
US7459540B1 (en)	1999-09-07	2008-12-02	Amgen Inc.	Fibroblast growth factor-like polypeptides
AU783968B2 (en) *	1999-09-08	2006-01-05	Lexicon Genetics Incorporated	Human G-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
US6500629B1 (en)	1999-09-13	2002-12-31	Equitech Laboratories, Inc.	Materials and methods for detection and quantitation of an analyte
US6900043B1 (en) *	1999-09-21	2005-05-31	Amgen Inc.	Phosphatases which activate map kinase pathways
US6867291B1 (en) *	2000-09-15	2005-03-15	Lexicon Genetics Incorporated	Human hemicentin proteins and polynucleotides encoding the same
US6790660B1 (en) *	2001-09-18	2004-09-14	Lexicon Genetics Incorporated	Human kielin-like proteins and polynucleotides encoding the same
WO2001021651A2 (en) *	1999-09-24	2001-03-29	Lexicon Genetics Incorporated	Novel human protease inhibitor-like proteins and polynucleotides encoding the same
JP2003531572A (ja)	1999-09-24	2003-10-28	レキシコン・ジェネティクス・インコーポレーテッド	エンドセリン変換酵素様の新規ヒトタンパク質およびそれをコードするポリヌクレオチド
US6734009B2 (en)	2000-12-27	2004-05-11	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
US6511840B1 (en)	2000-06-15	2003-01-28	Lexicon Genetics Incorporated	Human kinase proteins and polynucleotides encoding the same
US6797510B1 (en)	2001-05-24	2004-09-28	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
US6720173B1 (en)	1999-11-08	2004-04-13	Lexicon Genetics Incorporated	Human kinase protein and polynucleotides encoding the same
US20080050809A1 (en) *	1999-09-28	2008-02-28	Alejandro Abuin	Novel human kinases and polynucleotides encoding the same
US6841377B1 (en) *	2001-06-13	2005-01-11	Lexicon Genetics Incorporated	Human kinase and polynucleotides encoding the same
US6541252B1 (en)	2000-05-19	2003-04-01	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
US6602698B2 (en)	1999-12-07	2003-08-05	Lexicon Genetics Incorporated	Human kinase proteins and polynucleotides encoding the same
US6777545B2 (en)	2001-04-06	2004-08-17	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
US6759527B2 (en)	2001-03-20	2004-07-06	Lexicon Genetics Incorporated	Human kinase and polynucleotides encoding the same
US6586230B1 (en) *	2000-10-27	2003-07-01	Lexicon Genetics Incorporated	Human kinase and polynucleotides encoding the same
US6716616B1 (en)	1999-09-28	2004-04-06	Lexicon Genetics Incorporated	Human kinase proteins and polynucleotides encoding the same
DE60023928T2 (de) *	1999-09-29	2006-07-27	Lexicon Genetics Inc., The Woodlands	Humane carboxypeptidasen und diese kodierende polynukleotide
US20070111259A1 (en) *	1999-10-02	2007-05-17	Medarex, Inc.	Human antibodies
US7135287B1 (en)	1999-10-02	2006-11-14	Biosite, Inc.	Human antibodies
US6794132B2 (en)	1999-10-02	2004-09-21	Biosite, Inc.	Human antibodies
AU782326B2 (en)	1999-10-12	2005-07-21	Lexicon Pharmaceuticals, Inc.	Human LDL receptor family proteins and polynucleotides encoding the same
WO2001027275A1 (en) *	1999-10-13	2001-04-19	Lexicon Genetics Incorporated	Novel human membrane proteins
ATE402953T1 (de) *	1999-10-18	2008-08-15	Lexicon Pharmaceuticals Inc	Menschliches chordin und polynukleotiden die dafür kodieren
US6750054B2 (en)	2000-05-18	2004-06-15	Lexicon Genetics Incorporated	Human semaphorin homologs and polynucleotides encoding the same
US6743907B1 (en)	1999-10-19	2004-06-01	Lexicon Genetics Incorporated	Human proteins and polynucleotides encoding the same
US20080213878A1 (en) *	1999-10-19	2008-09-04	Gregory Donoho	Novel human membrane proteins and polynucleotides encoding the same
AU783313B2 (en)	1999-11-02	2005-10-13	Lexicon Pharmaceuticals, Inc.	Novel human transporter proteins and polynucleotides encoding the same
JP2004500054A (ja) *	1999-11-10	2004-01-08	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒトａｔｐアーゼタンパク質および該タンパク質をコードするポリヌクレオチド
JP2004504004A (ja)	1999-11-12	2004-02-12	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒトプロテアーゼおよび該プロテアーゼをコードするポリヌクレオチド
KR100749982B1 (ko)	1999-11-16	2007-08-16	제넨테크, 인크.	혈관 내피 성장 인자용 ｅｌｉｓａ
US6943010B1 (en) *	1999-11-19	2005-09-13	Hortense W. Dodo	Down-regulation and silencing of allergen genes in transgenic peanut seeds
PT1234031T (pt)	1999-11-30	2017-06-26	Mayo Foundation	B7-h1, uma nova molécula imunoregulatória
US6680209B1 (en) *	1999-12-06	2004-01-20	Biosite, Incorporated	Human antibodies as diagnostic reagents
WO2001042287A2 (en) *	1999-12-07	2001-06-14	Lexicon Genetics Incorporated	Putative human g-protein coupled receptors
JP2004500060A (ja) *	1999-12-09	2004-01-08	レキシコン・ジェネティクス・インコーポレーテッド	ヒトａｄａｍ−ｔｓプロテアーゼおよびそれをコードするポリヌクレオチド
AU784376B2 (en) *	1999-12-13	2006-03-23	Lexicon Pharmaceuticals, Inc.	Novel human transferase proteins and polynucleotides encoding the same
AU2092901A (en) *	1999-12-22	2001-07-03	Lexicon Genetics Incorporated	Polynucleotides encoding human protease homologs
EP1250427A2 (en) *	1999-12-22	2002-10-23	Lexicon Genetics Incorporated	Human membrane proteins and polynucleotides encodingthe same having homology to cd20 proteins and ige receptors
WO2001045689A2 (en)	1999-12-22	2001-06-28	Sugen, Inc.	Indolinone derivatives for modulation of c-kit tyrosine protein kinase
DK1897945T3 (da)	1999-12-23	2012-05-07	Genentech Inc	IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
EP1244795A1 (en) *	2000-01-06	2002-10-02	Lexicon Genetics Incorporated	Novel human proteases and polynucleotides encoding the same
WO2001053493A2 (en) *	2000-01-18	2001-07-26	Lexicon Genetics Incorporated	Human kinase protein and polynucleotides encoding the same
JP2004500084A (ja) *	2000-01-26	2004-01-08	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒトニューレキシン様タンパク質及び該タンパク質をコードするポリヌクレオチド
WO2001055394A1 (en) *	2000-01-28	2001-08-02	Lexicon Genetics Incorporated	Human membrane proteins and polynucleotides encoding the same
AU9256001A (en) *	2000-01-28	2001-12-17	Lexicon Genetics Incorporated	Novel human enzymes and polynucleotides encoding the same
AU3665901A (en) *	2000-02-04	2001-08-14	Lexicon Genetics Incorporated	Novel human enzymes and polynucleotides encoding the same
WO2001059134A1 (en) *	2000-02-11	2001-08-16	Lexicon Genetics Incorporated	Human proteases and polynucleotides encoding the same
PL211834B1 (pl)	2000-02-15	2012-06-29	Sugen	Związki 2-indolinonowe, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
AU2001238503A1 (en)	2000-02-17	2001-08-27	Lexicon Genetics Incorporated	Novel human thrombospondin repeat proteins and polynucleotides encoding the same
EP1259610A2 (en) *	2000-02-29	2002-11-27	Lexicon Genetics Incorporated	Human transporter proteins and polynucleotides encoding the same
AU2001245370A1 (en) *	2000-02-29	2001-09-12	Lexicon Genetics Incorporated	Novel human transferase proteins and polynucleotides encoding the same
US20040002068A1 (en)	2000-03-01	2004-01-01	Corixa Corporation	Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US20020082405A1 (en) *	2000-03-06	2002-06-27	Gregory Donoho	Novel human transporter proteins and polynucleotides encoding the same
TW201006846A (en)	2000-03-07	2010-02-16	Senomyx Inc	T1R taste receptor and genes encidung same
EP1263967A2 (en)	2000-03-10	2002-12-11	Lexicon Genetics Incorporated	Human g-coupled protein receptor kinases and polynucleotides encoding the same
AU4739501A (en) *	2000-03-13	2001-09-24	Lexicon Genetics Inc	Novel human phospholipases and polynucleotides encoding the same
WO2001071352A2 (en) *	2000-03-17	2001-09-27	The Salk Institute For Biological Studies	Compositions associated with complex formation
CA2403636A1 (en) *	2000-03-20	2001-09-27	Lexicon Genetics Incorporated	Human secreted proteins and polynucleotides encoding the same
AU2001218871A1 (en) *	2000-03-21	2001-10-03	Takao Arai	Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same
US7514239B2 (en)	2000-03-28	2009-04-07	Amgen Inc.	Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
JP5079962B2 (ja)	2000-03-31	2012-11-21	ノヴァークス	ＴＧＦβ阻害剤を発現する遺伝的に改変された細胞であって、肺癌細胞である細胞
EP1272634A1 (en) *	2000-04-03	2003-01-08	Lexicon Genetics Incorporated	Human ion channel protein and polynucleotides encoding the same
JP2003532391A (ja) *	2000-04-12	2003-11-05	レキシコン・ジェネティクス・インコーポレーテッド	ヒトメタロプロテアーゼ及び該タンパク質をコードするポリヌクレオチド
US7364867B2 (en) *	2000-04-17	2008-04-29	The Mount Sinai School Of Medicine	Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells
EP1276873A2 (en)	2000-04-25	2003-01-22	Lexicon Genetics Incorporated	Human kinase proteins and polynucleotides encoding the same
US7030219B2 (en) *	2000-04-28	2006-04-18	Johns Hopkins University	B7-DC, Dendritic cell co-stimulatory molecules
AU6110301A (en)	2000-04-29	2001-11-12	Univ Iowa Res Found	Diagnostics and therapeutics for macular degeneration-related disorders
EP1280909A2 (en) *	2000-05-12	2003-02-05	Lexicon Genetics Incorporated	Human lipocalin homologs and polynucleotides encoding the same
CA2410056A1 (en) *	2000-05-17	2001-11-22	Oregon Health Science University	Induction of apoptosis and cell growth inhibition by protein 4.33
US6790667B1 (en) *	2000-05-30	2004-09-14	Lexicon Genetics Incorporated	Human mitochondrial proteins and polynucleotides encoding the same
AU2001275337A1 (en) *	2000-06-07	2001-12-17	Lexicon Genetics Incorporated	Novel human transporter proteins and polynucleotides encoding the same
US6465632B1 (en)	2000-06-09	2002-10-15	Lexicon Genetics Incorporated	Human phosphatases and polynucleotides encoding the same
US20040168209A1 (en) *	2000-06-12	2004-08-26	Alejandro Abuin	Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
AU2001282856A1 (en)	2000-06-15	2001-12-24	Human Genome Sciences, Inc.	Human tumor necrosis factor delta and epsilon
MXPA02012743A (es)	2000-06-22	2003-04-25	Amgen Inc	Moleculas tipo il-17 y usos de las mismas.
EP2042597B1 (en)	2000-06-23	2014-05-07	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
CA2709771A1 (en)	2000-06-23	2002-01-03	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US20030032791A1 (en) *	2000-06-26	2003-02-13	Alan Robertson Scott	Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
US6528321B1 (en)	2000-06-26	2003-03-04	Beckman Coulter, Inc.	Opposable-element chromatographic assay device for detection of analytes in whole blood samples
AU7151601A (en) *	2000-06-27	2002-01-08	Lexicon Genetics Inc	Novel human gaba receptors and polynucleotides encoding the same
US20060024304A1 (en) *	2000-06-28	2006-02-02	Gerngross Tillman U	Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
US20060257399A1 (en) *	2000-06-28	2006-11-16	Glycofi, Inc.	Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
US20060034828A1 (en) *	2000-06-28	2006-02-16	Gerngross Tillman U	Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
US20060034830A1 (en) *	2000-06-28	2006-02-16	Gerngross Tillman U	Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
US20060029604A1 (en) *	2000-06-28	2006-02-09	Gerngross Tillman U	Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
EP1294879B1 (en)	2000-06-28	2008-12-31	Amgen Inc.	Thymic stromal lymphopoietin receptor molecules and uses thereof
JP2004515220A (ja) *	2000-07-21	2004-05-27	インサイト・ゲノミックス・インコーポレイテッド	プロテアーゼ
US6632681B1 (en)	2000-07-24	2003-10-14	Ey Laboratories	Reagent delivery device and method of use
US6887685B1 (en)	2000-07-25	2005-05-03	Lexicon Genetics Incorporated	Human thymosin protein and polynucleotides encoding the same
US20020076780A1 (en) *	2000-08-16	2002-06-20	Turner C. Alexander	Novel human ion channel proteins and polynucleotides encoding the same
AU9215101A (en)	2000-08-17	2002-02-25	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) *	2000-08-17	2006-04-04	Tripep Ab	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) *	2000-08-29	2004-01-20	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) *	2000-08-17	2005-02-22	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
AU2001288339B2 (en) *	2000-08-22	2005-09-29	Lexicon Pharmaceuticals, Inc.	Novel human proteases and polynucleotides encoding the same
WO2002016435A2 (en) *	2000-08-22	2002-02-28	Lexicon Genetics Incorporated	Human 7tm proteins and polynucleotides encoding the same
JP2003000268A (ja) *	2000-08-25	2003-01-07	Pfizer Prod Inc	血管新生にかかわる疾患を診断および治療するための方法および組成物
EP1197550A3 (en) *	2000-08-25	2002-11-20	Pfizer Products Inc.	Methods and compositions for diagnosing and treating disorders involving angiogenesis
ATE497007T1 (de)	2000-08-25	2011-02-15	Basf Plant Science Gmbh	Polynukleotide, die für prenylproteasen aus pflanzen kodieren
AU2001285326A1 (en) *	2000-08-31	2002-03-13	Lexicon Genetics Incorporated	Human kinase proteins and polynucleotides encoding the same
WO2002020753A2 (en) *	2000-09-01	2002-03-14	Lexicon Genetics Incorporated	Human gaba transporter protein and polynucleotides encoding the same
JP2004529849A (ja) *	2000-09-01	2004-09-30	インターナショナルバイオイムンシステムズ，インコーポレーテッド	扁平上皮癌に対する特異的モノクローナル抗体の同定と開発
US20030176344A1 (en) *	2000-09-14	2003-09-18	Decode Genetics Ehf.	Human osteoporosis gene
EP1326997A4 (en) *	2000-09-25	2006-01-11	Univ	MODEL FOR NEURODEGENERATIVE DISEASES WITH AMYLOIDAC CUMULATION
AU9301901A (en)	2000-09-27	2002-04-08	Lexicon Genetics Inc	Novel human ion-exchanger proteins and polynucleotides encoding the same
WO2002026981A2 (en) *	2000-09-27	2002-04-04	Lexicon Genetics Incorporated	Human protease inhibitor proteins and polynucleotides encoding the same
US6777232B1 (en) *	2000-10-02	2004-08-17	Lexicon Genetics Incorporated	Human membrane proteins and polynucleotides encoding the same
AU2002230390A1 (en) *	2000-10-05	2002-04-29	The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Ixodes scapularis tissue factor pathway inhibitor
AU2002213183A1 (en)	2000-10-12	2002-04-22	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
JP2004511802A (ja) *	2000-10-17	2004-04-15	ベッスト−テスト　アンパーツゼルスカブ	体液サンプル中の炎症の指標の直接的検出のためのアッセイ
US7001763B1 (en)	2000-10-17	2006-02-21	Lexicon Genetics Incorporated	Human semaphorin proteins and polynucleotides encoding the same
WO2002034916A2 (en) *	2000-10-27	2002-05-02	Oregon Health And Science University	Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor
AU2002232936A1 (en) *	2000-10-30	2002-05-15	Lexicon Genetics Incorporated	Human 7TM proteins and polynucleotides encoding the same
EP1390477B1 (en) *	2000-11-01	2006-08-16	Lexicon Genetics Incorporated	Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases
JP2004535154A (ja) *	2000-11-15	2004-11-25	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒト分泌タンパク質およびそれをコードするポリヌクレオチド
US20060148732A1 (en) *	2000-11-17	2006-07-06	Gutterman Jordan U	Inhibition of NF-kappaB by triterpene compositions
AU2002228633A1 (en) *	2000-11-20	2002-06-03	Lexicon Genetics Incorporated	Human kinases and polynucleotides encoding the same
US6989247B2 (en)	2000-11-28	2006-01-24	Celltech R & D, Inc.	Compositions and methods for diagnosing or treating psoriasis
US7393921B2 (en) *	2000-12-04	2008-07-01	Institute For Systems Biology	Prostate-specific polypeptide pamp and encoding nucleic acid molecules
US20060057651A1 (en)	2000-12-08	2006-03-16	Bowdish Katherine S	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US20040198661A1 (en) *	2000-12-08	2004-10-07	Bowdish Katherine S.	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US9249229B2 (en) *	2000-12-08	2016-02-02	Alexion Pharmaceuticals, Inc.	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
JP4280803B2 (ja) *	2000-12-08	2009-06-17	アレクシオンファーマシューティカルズ，インコーポレイテッド	慢性リンパ性白血病細胞株および抗体を産生するためのその使用
US7408041B2 (en) *	2000-12-08	2008-08-05	Alexion Pharmaceuticals, Inc.	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
WO2002055685A2 (en)	2000-12-11	2002-07-18	Lexicon Genetics Incorporated	Novel human kinase and polynucleotides encoding the same
AU2002232642B2 (en) *	2000-12-12	2007-02-01	Lexicon Pharmaceuticals, Inc.	Novel human kinases and uses thereof
US6583269B1 (en)	2000-12-18	2003-06-24	Lexicon Genetics Incorporated	Human protease inhibitor and polynucleotides encoding the same
CA2432737A1 (en) *	2000-12-20	2002-06-27	Lexicon Genetics Incorporated	Human ion channel protein and polynucleotides encoding the same
US6852844B1 (en)	2000-12-20	2005-02-08	Lexicon Genetics Incorporated	Human protocadherin proteins and polynucleotides encoding the same
IL140537A0 (en) *	2000-12-25	2002-02-10	Hadasit Med Res Service	Educated nk t cells and their uses in the treatment of immune-related disorders
US7445802B2 (en) *	2000-12-26	2008-11-04	Yeda Research And Development Co. Ltd	Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases
AU2001297533A1 (en) *	2000-12-28	2002-09-12	Lexicon Genetics Incorporated	Novel human ion channel-related proteins and polynucleotides encoding the same
TW201022287A (en)	2001-01-03	2010-06-16	Senomyx Inc	T1R taste receptors and genes encoding same
WO2002053753A2 (en) *	2001-01-05	2002-07-11	Lexicon Genetics Incorporated	Novel human lipase and polynucleotides encoding the same
AU2002236717A1 (en) *	2001-01-08	2002-07-16	Lexicon Genetics Incorporated	Human protease and polynucleotides encoding the same
JP2004524835A (ja) *	2001-01-23	2004-08-19	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒトキナーゼおよびそれをコードするポリヌクレオチド
WO2002059328A1 (en) *	2001-01-24	2002-08-01	Lexicon Genetics Incorporated	Human lipase and polynucleotides encoding the same
US20020127674A1 (en) *	2001-02-02	2002-09-12	Xuanchuan Yu	Novel human transporter protein and polynucleotides encoding the same
EP2316918B1 (en)	2001-02-14	2015-07-01	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
AR042586A1 (es) *	2001-02-15	2005-06-29	Sugen Inc	3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
JP2004529623A (ja) *	2001-02-20	2004-09-30	レキシコン・ジェネティクス・インコーポレーテッド	新規プロテアーゼおよびそれをコードするポリヌクレオチド
US20020117169A1 (en)	2001-02-27	2002-08-29	Kurz Daniel R.	Cover and applicator for a portion of a mammalian body
JP3929250B2 (ja) *	2001-03-08	2007-06-13	株式会社ルネサステクノロジ	半導体装置
US20020164627A1 (en) *	2001-03-12	2002-11-07	Wilganowski Nathaniel L.	Novel human transporter proteins and polynucleotides encoding the same
WO2002072603A2 (en) *	2001-03-12	2002-09-19	Lexicon Genetics Incorporated	Novel human dectin proteins and polynucleotides encoding the same
CA2440563A1 (en) *	2001-03-12	2002-09-19	Lexicon Genetics Incorporated	Novel human egf-family proteins and polynucleotides encoding the same
DE60238987D1 (de)	2001-03-15	2011-03-03	Neogenix Oncology Inc	Behandlung von bauchspeicheldrüsenkrebs mit einem monoklonalen antikörper
US6994995B1 (en) *	2001-03-16	2006-02-07	Lexicon Genetics Incorporated	Human synaptotagmin and polynucleotides encoding the same
US20030228639A1 (en) *	2001-03-19	2003-12-11	Wright George L	Prostate cancer markers
US6613534B2 (en)	2001-03-20	2003-09-02	Wake Forest University Health Sciences	MAP-2 as a determinant of metastatic potential
US7071303B2 (en)	2001-03-28	2006-07-04	Institute For Systems Biology	Androgen regulated prostate specific nucleic acids
WO2002081671A1 (en)	2001-04-06	2002-10-17	Lexicon Genetics Incorporated	Novel human kinase and polynucleotides encoding the same
JP4541645B2 (ja)	2001-04-12	2010-09-08	インペリアル・イノベイションズ・リミテッド	Ｉ型癌の診断および治療
US20070128229A1 (en) *	2002-04-12	2007-06-07	Wyeth	Surface proteins of Streptococcus pyogenes
CN101124237A (zh) *	2001-04-13	2008-02-13	惠氏	酿脓链球菌的表面蛋白
WO2002083706A1 (en) *	2001-04-16	2002-10-24	Lexicon Genetics Incorporated	Nucleic acid encoding a human adenylosuccinate synthetase
AU2002305218B2 (en) *	2001-04-20	2007-10-18	Mount Sinai School Of Medicine	T1R3 a novel taste receptor
US7803982B2 (en)	2001-04-20	2010-09-28	The Mount Sinai School Of Medicine Of New York University	T1R3 transgenic animals, cells and related methods
US20030166893A1 (en) *	2001-04-30	2003-09-04	Yi Hu	Novel human nuclear transporters and polynucleotides encoding the same
US20030211464A1 (en) *	2001-05-02	2003-11-13	Charles Pidgeon	Method and compositions for drug discovery
EP1967525B1 (en)	2001-05-08	2012-11-14	Darwin Molecular Corporation	A method for regulating immune function in primates using the foxp3 protein
JP2004537986A (ja) *	2001-05-09	2004-12-24	レキシコン・ジェネティクス・インコーポレーテッド	新規キナーゼおよびそれをコードするポリヌクレオチド
US20020193585A1 (en) *	2001-05-25	2002-12-19	Walke D. Wade	Novel human transporter proteins and polynucleotides encoding the same
DE60225064T2 (de)	2001-05-29	2009-01-29	Lexicon Pharmaceuticals, Inc., The Woodlands	Neue menschliche hydroxylasen und diese codierende polynukleotide
IL158969A0 (en)	2001-06-01	2004-05-12	Cornell Res Foundation Inc	Modified antibodies to prostate-specific membrane antigen and uses thereof
US20070160576A1 (en)	2001-06-05	2007-07-12	Genentech, Inc.	IL-17A/F heterologous polypeptides and therapeutic uses thereof
US6905827B2 (en) *	2001-06-08	2005-06-14	Expression Diagnostics, Inc.	Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) *	2001-06-08	2007-06-26	Expression Diagnostics, Inc.	Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) *	2001-06-08	2006-04-11	Expression Diagnostics, Inc.	Methods and compositions for diagnosing and monitoring transplant rejection
JP2004531268A (ja) *	2001-06-14	2004-10-14	レキシコン・ジェネティクス・インコーポレーテッド	新規ヒトトランスポータータンパクおよびそれをコードするポリヌクレオチド
US20020197694A1 (en) *	2001-06-20	2002-12-26	Weiping Shao	Conjugates of reduced antibodies and biomolecules
WO2003000010A2 (en) *	2001-06-20	2003-01-03	Mayo Foundation For Medical Education And Research	Adenosyl-cobalamin fortified compositions
ATE440869T1 (de) *	2001-06-20	2009-09-15	Fibron Ltd	Fgfr3 blockierende antikírper, verfahren zum screening darauf und verwendungen davon
CN100489102C (zh)	2001-06-26	2009-05-20	塞诺米克斯公司	T1r异源寡聚的味觉受体和表达所述受体的细胞系及其在鉴定味觉化合物中的用途
AU2002318186A1 (en) *	2001-07-03	2003-01-21	Lexicon Genetics Incorporated	Novel human kielin-like proteins and polynucleotides encoding the same
US7300633B2 (en) *	2001-07-25	2007-11-27	Oakville Hong Kong Company Limited	Specimen collection container
US7270959B2 (en)	2001-07-25	2007-09-18	Oakville Hong Kong Company Limited	Specimen collection container
JP4265149B2 (ja) *	2001-07-25	2009-05-20	セイコーエプソン株式会社	電気光学装置、電気光学装置の製造方法
AUPR673001A0 (en)	2001-07-31	2001-08-23	Prince Henry's Institute Of Medical Research	Pregnancy-related enzyme activity
US7744888B2 (en)	2001-08-03	2010-06-29	Abgenomics Cooperatief U.A.	Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
WO2003062785A2 (en)	2001-08-09	2003-07-31	Syracuse Bioanalytical, Inc.	Detection of bovine viral diarrhea virus in hair samples
EP1425382A4 (en) *	2001-08-14	2004-10-06	Lexicon Genetics Inc	NEW HUMAN COLLAGEN PROTEINS AND THESE CODING POLYNUCLEOTIDS
US20030099985A1 (en) *	2001-08-27	2003-05-29	Jing Li	Amplified gene involved in cancer
CA2459183A1 (en) *	2001-08-27	2003-03-06	Tularik Inc.	Amplified oncogenes and their involvement in cancer
AU2002331180A1 (en) *	2001-08-27	2003-03-10	Novartis Pharma Gmbh	Nogo receptor homologues and their use
JP2003076656A (ja) *	2001-09-05	2003-03-14	Sony Corp	情報処理システム、情報処理装置および方法、記録媒体、並びにプログラム
US20030113816A1 (en)	2001-09-18	2003-06-19	Weitz Stephen L.	Methods of assaying connective tissue growth factor
ATE443259T1 (de)	2001-09-20	2009-10-15	Univ Texas	Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
ATE354370T1 (de) *	2001-09-27	2007-03-15	Gangagen Inc	Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
EP1961293A3 (en)	2001-09-27	2009-01-28	Pioneer Hi-Bred International, Inc.	Phytate polynucleotides and methods of use
JP4849772B2 (ja) *	2001-09-27	2012-01-11	ガンガゲンインコーポレーティッド	免疫原性が低いリシン欠損バクテリオファージ
US20030110518A1 (en) *	2001-09-28	2003-06-12	Houseknecht Karen L.	Melanocortin-5 receptor sequences and uses thereof
US7393696B2 (en) *	2001-09-28	2008-07-01	Aspenbio Pharma, Inc.	Bovine pregnancy test
DE60232742D1 (de)	2001-10-04	2009-08-06	Immunex Corp	Ul16-bindungsprotein 4
US6642232B2 (en)	2001-10-10	2003-11-04	Sugen, Inc.	3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
DE10151511A1 (de)	2001-10-18	2003-05-08	Basf Lynx Bioscience Ag	ee3-Proteinfamilie und zugrundeliegende DNA-Sequenzen
US20050221420A1 (en) *	2001-10-22	2005-10-06	Carmen Barske	Nogo receptor homologues and their use
GB0126378D0 (en)	2001-11-02	2002-01-02	Oxford Biomedica Ltd	Antigen
CA2466443A1 (en) *	2001-11-09	2003-05-15	Neopharm, Inc.	Selective treatment of il-13 expressing tumors
US20040067512A1 (en) *	2001-11-09	2004-04-08	Neurogenetics, Inc.	Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US20030162202A1 (en) *	2001-11-09	2003-08-28	Becker Kenneth David	Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US20030148341A1 (en) *	2001-11-15	2003-08-07	Sin Wun Chey	Gene amplification and overexpression in cancer
US20030099621A1 (en)	2001-11-29	2003-05-29	Robert Chow	Stem cell screening and transplantation therapy for HIV infection
EP2002827A2 (en)	2001-12-05	2008-12-17	The Baylor College Of Medicine	Methods and compositions for control of bone formation via modulation of sympathetic tone
ATE503845T1 (de) *	2001-12-10	2011-04-15	Novartis Pharma Gmbh	Verfahren zur behandlung von psychosen und schizophrenie auf der basis eines polymorphismus im cntf gen
WO2003054512A2 (en) *	2001-12-20	2003-07-03	Tularik Inc.	Identification of an amplified gene and target for drug intervention
US20060034829A1 (en) *	2001-12-27	2006-02-16	Gerngross Tillman U	Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
US20060024292A1 (en) *	2001-12-27	2006-02-02	Gerngross Tillman U	Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
US20040137440A1 (en) *	2002-01-15	2004-07-15	Biaoyang Lin	Androgen regulated nucleic acid molecules and encoded proteins
US7462491B2 (en) *	2002-01-31	2008-12-09	Baylor College Of Medicine	Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
US7704700B2 (en) *	2002-02-12	2010-04-27	Burnham Institute For Medical Research	Methods for determining the prognosis for patients with a prostate neoplastic condition using inhibitor of apoptosis polypeptides
EP1563302B1 (en)	2002-02-13	2011-09-14	American Diagnostica, Inc.	Methods for selecting treatment regimens and predicting outcomes in cancer patients
AU2003211157A1 (en) *	2002-02-21	2003-09-09	Eastern Virginia Medical School	Protein biomarkers that distinguish prostate cancer from non-malignant cells
AU2003217693A1 (en) *	2002-02-22	2003-09-09	Board Of Trustees Of The University Of Illinois	Beta chain-associated regulator of apoptosis
US7662924B2 (en) *	2002-02-22	2010-02-16	The Board Of Trustees Of The University Of Illinois	Beta chain-associated regulator of apoptosis
JP2005535290A (ja)	2002-02-22	2005-11-24	ジェネンテック・インコーポレーテッド	免疫関連疾患の治療のための組成物と方法
US7294471B2 (en) *	2002-02-27	2007-11-13	Cskeys, Llc	Method for purifying cancer-specific proliferating cell nuclear antigen
WO2003076455A2 (en)	2002-03-05	2003-09-18	Ramot At Tel-Aviv University Ltd.	Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
US6974672B2 (en) *	2002-03-19	2005-12-13	Amgen Inc.	Gene amplification in cancer
AU2003221506A1 (en)	2002-03-19	2003-09-29	Novartis Ag	Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
US7799523B2 (en)	2002-04-03	2010-09-21	Celltech R & D, Inc.	Association of polymorphisms in the SOST gene region with bone mineral density
WO2004040398A2 (en) *	2002-05-06	2004-05-13	Dana-Farber Cancer Institute, Inc.	Use of a computer to design a molecule
WO2003094841A2 (en) *	2002-05-06	2003-11-20	Functional Genetics, Inc.	Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
AU2003239544A1 (en) *	2002-05-24	2003-12-12	Tularik Inc.	Amplification and overexpression of oncogenes
EP2305710A3 (en)	2002-06-03	2013-05-29	Genentech, Inc.	Synthetic antibody phage libraries
GB0213745D0 (en)	2002-06-14	2002-07-24	Univ Edinburgh	Enzyme
CA2489588A1 (en)	2002-07-08	2004-01-15	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
US20040219609A1 (en) *	2002-07-12	2004-11-04	Day Anthony G.	Methods for modulating proteins not previously known as proteases
WO2004007692A2 (en) *	2002-07-17	2004-01-22	U.S.Genomics, Inc.	Methods and compositions for analyzing polymers using chimeric tags
EP2436774A3 (en)	2002-08-01	2012-06-13	The Regents of The University of California	Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2004015063A2 (en) *	2002-08-07	2004-02-19	Tularik Inc.	Amplification and overexpression of oncogenes
MXPA05001832A (es)	2002-08-13	2005-08-16	N Dia Inc	Dispositivos y metodos para detectar fluido amniotico en secreciones vaginales.
WO2004020581A2 (en) *	2002-08-15	2004-03-11	Functional Genetics, Inc.	Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
AU2003268135A1 (en) *	2002-08-15	2004-03-19	Functional Genetics, Inc.	Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
EP1569514A4 (en)	2002-08-16	2007-10-31		SPECIFIC ANTIGEN OF TUMORS, PEPTIDES ASSOCIATED THERETO AND USE THEREOF AS IMMUNOMINAL VACCINES
CA2745731C (en)	2002-08-23	2015-05-12	Bayer Schering Pharma Aktiengesellschaft	Biomarkers for diagnosing alzheimer's disease
US7785608B2 (en) *	2002-08-30	2010-08-31	Wyeth Holdings Corporation	Immunogenic compositions for the prevention and treatment of meningococcal disease
JP4601426B2 (ja)	2002-09-06	2010-12-22	アレクシオンファーマシューティカルズ，インコーポレイテッド	補体成分ｃ５に対する抗体を使用する喘息の処置の方法
WO2004024068A2 (en)	2002-09-11	2004-03-25	Genentech, Inc.	Novel composition and methods for the treatment of immune related diseases
WO2004024072A2 (en)	2002-09-11	2004-03-25	Genentech, Inc.	Novel compositions and methods for the treatment of immune related diseases
EP1562587A4 (en)	2002-09-11	2006-07-19	Genentech Inc	COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES OF THE IMMUNE SYSTEM
US20070010434A1 (en)	2002-09-16	2007-01-11	Genetech, Inc.	Novel compositions and methods for the treatment of immune related diseases
US7094551B2 (en) *	2002-09-17	2006-08-22	Zahradnik Richard J	Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
EP2500438A3 (en)	2002-09-25	2012-11-28	Genentech, Inc.	Novel compositions and methods for the treatment of psoriasis
JP2006518982A (ja) *	2002-10-02	2006-08-24	エフ．ホフマン−ラ　ロシュ　アーゲー	Ｍｈｃｉｉ結合ペプチド
US7432351B1 (en)	2002-10-04	2008-10-07	Mayo Foundation For Medical Education And Research	B7-H1 variants
DE60320821D1 (it) *	2002-10-11	2008-06-19	Sentina Biotechnology Inc
US20080293750A1 (en) *	2002-10-17	2008-11-27	Anna Helgadottir	Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
EP2322201A3 (en)	2002-10-29	2011-07-27	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
JP3447009B1 (ja) *	2002-10-29	2003-09-16	實平垣	構築物用構成体およびその製造方法
ES2463420T3 (es)	2002-11-01	2014-05-27	Iris International, Inc.	Inmuno-PCR sándwich por desplazamiento
AU2003295401B2 (en)	2002-11-08	2010-04-29	Genentech, Inc.	Compositions and methods for the treatment of natural killer cell related diseases
US20050129711A1 (en) *	2002-11-14	2005-06-16	Janakiraman Ramachandran	Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
JP4555089B2 (ja)	2002-11-15	2010-09-29	モーフオテク・インコーポレーテツド	ｉｎｖｉｔｒｏ免疫感作により創製されたハイブリドーマからの抗体の高生産量の生成方法
EP2308968A1 (en)	2002-11-26	2011-04-13	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
US20040101860A1 (en) *	2002-11-27	2004-05-27	Jones Alison M.	Predicting animal performance
US20040259226A1 (en) *	2003-05-30	2004-12-23	Robey W. Wade	Monitoring for and detecting microbes used in bioterrorism
WO2004050873A1 (en) *	2002-11-29	2004-06-17	The University Of Hong Kong	Genetically modified plants expressing proteinase inhibitors, sapina2a or sapin2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities
EP1570075A2 (en) *	2002-12-03	2005-09-07	Aarhus Universitet	Method for determing predisposition to manifestation of immune system related diseases
WO2004057940A2 (en) *	2002-12-31	2004-07-15	Pharmacia & Upjohn Company Llc	Canine dioxin/aryl hydrocarbon receptor sequences
AU2003288649A1 (en) *	2002-12-31	2004-07-22	Pharmacia & Upjohn Company Llc	Canine cyp1a2 sequences
AU2003285724A1 (en) *	2002-12-31	2004-07-22	Pharmacia & Upjohn Company Llc	Canine l-pbe sequences
US7560272B2 (en)	2003-01-04	2009-07-14	Inverness Medical Switzerland Gmbh	Specimen collection and assay container
WO2004065551A2 (en) *	2003-01-21	2004-08-05	Bristol-Myers Squibb Company	Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
US7449321B2 (en) *	2003-01-22	2008-11-11	National University Of Singapore	Molecules, compositions, methods and kits for applications associated with flaviviruses
US7531169B2 (en)	2003-02-01	2009-05-12	Tanox, Inc.	High affinity anti-human IgE antibodies
US7335359B2 (en)	2003-02-06	2008-02-26	Tripep Ab	Glycosylated specificity exchangers
KR20050099536A (ko)	2003-02-06	2005-10-13	트리펩 아베	글리코실화된 특이성 교환체
WO2004071462A2 (en) *	2003-02-12	2004-08-26	Johns Hopkins University	Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
US7157551B2 (en) *	2003-02-14	2007-01-02	Cephalon, Inc.	Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
GB0304515D0 (en) *	2003-02-27	2003-04-02	Dakocytomation Denmark As	Standard
US20040178714A1 (en) *	2003-03-11	2004-09-16	Pan Wun Fang	Decorative bulb of a series connected light string
US20040185446A1 (en) *	2003-03-18	2004-09-23	Jones Alison M.	Cpn60 targets for quantification of microbial species
US20040185454A1 (en) *	2003-03-21	2004-09-23	Jones Alison M.	Identification and quantification of microbial species in a sample
US20040185434A1 (en) *	2003-03-21	2004-09-23	Robey W. Wade	Detecting microbial contamination in animal by-products
WO2004087758A2 (en) *	2003-03-26	2004-10-14	Neopharm, Inc.	Il 13 receptor alpha 2 antibody and methods of use
DK1616184T4 (en) *	2003-03-27	2018-08-13	Childrens Hospital Med Ct	Method and kit for detecting early onset of renal tubular cell damage
MXPA05011110A (es) *	2003-04-16	2006-01-24	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
US7321065B2 (en) *	2003-04-18	2008-01-22	The Regents Of The University Of California	Thyronamine derivatives and analogs and methods of use thereof
US7892745B2 (en) *	2003-04-24	2011-02-22	Xdx, Inc.	Methods and compositions for diagnosing and monitoring transplant rejection
US20070248978A1 (en) *	2006-04-07	2007-10-25	Expression Diagnostics, Inc.	Steroid responsive nucleic acid expression and prediction of disease activity
US20060263813A1 (en) *	2005-05-11	2006-11-23	Expression Diagnostics, Inc.	Methods of monitoring functional status of transplants using gene panels
KR100531760B1 (ko)	2003-04-28	2005-11-29	대한민국(관리부서 : 농림부 국립수의과학검역원)	구제역 바이러스의 감염여부를 진단하는 방법 및 이를구현하기 위한 진단키트
US7892563B2 (en)	2003-05-20	2011-02-22	Wyeth Holdings Corporation	Methods for treatment of severe acute respiratory syndrome (SARS)
EP1629014A2 (en) *	2003-05-30	2006-03-01	Genentech, Inc.	Polypeptides that bind an anti-tissue factor antibody and uses thereof
US20050250094A1 (en) *	2003-05-30	2005-11-10	Nanosphere, Inc.	Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
US20040241662A1 (en) *	2003-05-30	2004-12-02	Robey W. Wade	Detecting microbial contamination in grain and related products
US7405274B2 (en)	2003-06-04	2008-07-29	Fibrogen, Inc.	Connective tissue growth factor antibodies
MXPA05013334A (es) *	2003-06-12	2006-05-19	Vexgen Inc	Glucoproteinas de envoltura de vih-1 que tienen estructuras de disulfuro inusuales.
AU2004262640B2 (en)	2003-06-16	2010-12-23	Ucb Manufacturing, Inc.	Antibodies specific for sclerostin and methods for increasing bone mineralization
IL156495A0 (en) *	2003-06-17	2004-01-04	Prochon Biotech Ltd	Use of fgfr3 antagonists for treating t cell mediated diseases
AU2004269320B2 (en)	2003-06-20	2009-12-24	Protein Sciences Corporation	Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
EP1636384A4 (en) *	2003-06-20	2007-03-07	Amgen Inc	GENEAVIFICATION AND OVEREXPRESSION IN CANCER
GB0315991D0 (en) *	2003-07-08	2003-08-13	Dakocytomation Denmark As	Standard
EP2277908A3 (en)	2003-07-08	2011-12-14	Genentech, Inc.	IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof
US20050014734A1 (en) *	2003-07-18	2005-01-20	Genovate Biotechnology Co., Ltd.	Modulation of interleukin-10 by DHEA
WO2005012530A2 (en)	2003-07-25	2005-02-10	Amgen Inc.	Antagonists and agonists of ldcam and methods of use
WO2005012537A2 (en) *	2003-07-25	2005-02-10	Genvec, Inc.	Adenoviral vector-based vaccines
GB0317592D0 (en) *	2003-07-26	2003-08-27	Astrazeneca Ab	Method
US20050106667A1 (en)	2003-08-01	2005-05-19	Genentech, Inc	Binding polypeptides with restricted diversity sequences
SG145745A1 (en)	2003-08-06	2008-09-29	Senomyx Inc	Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
WO2005019258A2 (en)	2003-08-11	2005-03-03	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
ES2428321T3 (es)	2003-08-20	2013-11-07	University Of Miami	Composiciones y métodos para tratar la enfermedad del pulmón inflamado
US20050048589A1 (en) *	2003-08-25	2005-03-03	Moncef Jendoubi	Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer
US7517495B2 (en) *	2003-08-25	2009-04-14	Inverness Medical Switzerland Gmbh	Biological specimen collection and analysis system
AU2004268145B2 (en)	2003-08-29	2010-09-16	Takeda Pharmaceutical Company Limited	Poly-PEGylated protease inhibitors
US7604994B2 (en) *	2003-09-03	2009-10-20	Morphotek, Inc.	Genetically altered antibody-producing cell lines with improved antibody characteristics
AU2004270721A1 (en) *	2003-09-05	2005-03-17	The Scripps Research Institute	Detection of cholesterol ozonation products
EP1680518A2 (en) *	2003-09-19	2006-07-19	Decode Genetics EHF.	Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar
US20050214279A1 (en) *	2003-09-19	2005-09-29	Silverstein Samuel C	Methods for stimulating human leukocytes to kill bacteria, yeast and fungi in biofilms that have formed in/on prosthetic devices, catheters, tissues and organs in vivo
US20050069958A1 (en) *	2003-09-26	2005-03-31	Mills Rhonda A.	Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US20050069546A1 (en)	2003-09-30	2005-03-31	Yaron Ilan	Educated NKT cells and their uses in the treatment of immune-related disorders
IL158287A0 (en)	2003-10-07	2004-05-12	Yeda Res & Dev	Antibodies to nik, their preparation and use
EP1689887B1 (en)	2003-10-21	2012-03-21	Orion Genomics, LLC	Methods for quantitative determination of methylation density in a dna locus
WO2005052006A2 (en)	2003-11-25	2005-06-09	The Government Of The United States, As Represented By The Secretary Of Health And Human Services	Mutated anti-cd22 antibodies and immunoconjugates
US20050118727A1 (en) *	2003-12-01	2005-06-02	Carsten Schelp	Conjugates and their use in detection methods
CA2547351A1 (en)	2003-12-01	2005-07-07	Dade Behring Marburg Gmbh	Homogeneous detection method
AU2004303448A1 (en)	2003-12-23	2005-07-07	Mount Sinai Hospital	Methods for detecting markers associated with endometrial disease or phase
KR20150064250A (ko)	2003-12-23	2015-06-10	제넨테크, 인크.	신규 항-ｉｌ１３ 항체 및 그 용도
US7150995B2 (en) *	2004-01-16	2006-12-19	Metrika, Inc.	Methods and systems for point of care bodily fluid analysis
WO2005071058A2 (en) *	2004-01-27	2005-08-04	Compugen Ltd.	Methods and systems for annotating biomolecular sequences
US8158362B2 (en) *	2005-03-30	2012-04-17	Decode Genetics Ehf.	Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) *	2004-01-30	2010-08-26	Decode Genetics Ehf.	Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US20050271650A1 (en) *	2004-02-17	2005-12-08	Cellmatrix, Inc.	Method and composition for angiogenesis inhibition
DE602005018325D1 (de)	2004-02-19	2010-01-28	Genentech Inc	Antikörper mit korrigierten cdr
US7604956B2 (en) *	2004-03-01	2009-10-20	Biotraces, Inc.	Supersensitive immunoassays
KR20070002044A (ko) *	2004-03-05	2007-01-04	뿌리마하무가부시끼가이샤	알레르겐의 검출방법
US20050227370A1 (en) *	2004-03-08	2005-10-13	Ramel Urs A	Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
SI2712617T1 (sl)	2004-03-12	2017-01-31	Intercept Pharmaceuticals, Inc.	Zdravljenje fibroze z uporabo Fxr ligandov
US20050221408A1 (en) *	2004-03-19	2005-10-06	U.S. Genomics, Inc.	Compositions and methods for detection of single molecules
US7794713B2 (en)	2004-04-07	2010-09-14	Lpath, Inc.	Compositions and methods for the treatment and prevention of hyperproliferative diseases
EP2207033B1 (en)	2004-04-15	2014-06-18	University of Florida Research Foundation, Inc.	Neural proteins as biomarkers for nervous system injury and other neural disorders
ZA200608572B (en) *	2004-04-16	2008-06-25	Genentech Inc	Assay for antibodies
WO2005115394A2 (en) *	2004-04-20	2005-12-08	New York University School Of Medicine	Prenyl-electrostatic switch, and methods of use
AU2005240002B2 (en)	2004-04-23	2009-06-18	Zoetis Services Llc	Cellular permissivity factor for viruses, and uses thereof
CA2565063A1 (en)	2004-04-29	2005-11-24	Otsuka Pharmaceutical Co., Ltd.	Glycoprotein vi antibodies and method thereof
JP4836942B2 (ja) *	2004-04-30	2011-12-14	コーセラ，インコーポレイテッド	リラキシンの調節による胎仔の発育の制御のための方法および組成物
US20050272101A1 (en) *	2004-06-07	2005-12-08	Prasad Devarajan	Method for the early detection of renal injury
US7939251B2 (en)	2004-05-06	2011-05-10	Roche Molecular Systems, Inc.	SENP1 as a marker for cancer
UY28886A1 (es)	2004-05-10	2005-12-30	Boehringer Ingelheim Int	Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
AU2005244081B2 (en)	2004-05-11	2011-10-06	Abgenomics Cooperatief U.A.	T-cell death-inducing epitopes
EP1769243A2 (en) *	2004-05-15	2007-04-04	Genentech, Inc.	Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
US7504205B2 (en) *	2004-05-17	2009-03-17	The Burnham Institute	Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
US7604947B2 (en) *	2004-06-09	2009-10-20	Cornell Research Foundation, Inc.	Detection and modulation of cancer stem cells
US20060003410A1 (en)	2004-06-10	2006-01-05	Lee-Ming Chuang	Prostaglandin reductase
US8415298B2 (en)	2004-06-21	2013-04-09	The Board Of Trustees Of The Leland Stanford Junior University Of Stanford	Administration of FGF2 for treamtent of anxiety
US8034553B2 (en)	2004-06-24	2011-10-11	Kimberly-Clark Worldwide, Inc.	Biomarkers for wound healing
US7973134B2 (en) *	2004-07-07	2011-07-05	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
AU2005267062C1 (en)	2004-07-22	2013-01-17	Five Prime Therapeutics, Inc.	Compositions and methods of use for MGD-CSF in disease treatment
US7342093B2 (en)	2004-07-23	2008-03-11	University Of Massachusetts	Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
US20060024744A1 (en) *	2004-07-28	2006-02-02	Mills Rhonda A	Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US7510858B2 (en) *	2004-08-02	2009-03-31	Janssen Pharmaceutica N.V.	IRAK 1c splice variant and its use
WO2006023312A2 (en) *	2004-08-20	2006-03-02	Carl Deirmengian	Diagnostic assay for source of inflammation
US7893197B2 (en) *	2004-08-25	2011-02-22	Janssen Pharmaceutica N.V.	Relaxin-3 chimeric polypeptides and their preparation and use
WO2006039045A2 (en) *	2004-09-01	2006-04-13	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Adenoviral vectors able to transduce apcs, potential use in immune response generation
US7645575B2 (en) *	2004-09-08	2010-01-12	Xdx, Inc.	Genes useful for diagnosing and monitoring inflammation related disorders
FI20041204A0 (fi)	2004-09-16	2004-09-16	Riikka Lund	Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
GB0421639D0 (en)	2004-09-29	2004-10-27	Proteome Sciences Plc	Methods and compositions relating to alzheimer's disease
US7935790B2 (en) *	2004-10-04	2011-05-03	Cell Singaling Technology, Inc.	Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
EP1807106A2 (en) *	2004-10-05	2007-07-18	Oregon Health and Science University	Compositions and methods for treating disease
FI3428191T3 (fi)	2004-10-06	2025-01-21	Mayo Found Medical Education & Res	B7-h1 ja pd-1 munuaissolukarsinooman hoidossa
US8969291B2 (en)	2004-10-08	2015-03-03	Enzo Therapeutics, Inc.	Methods for decreasing leptin levels or activity for treating inflammation
WO2006047417A2 (en)	2004-10-21	2006-05-04	University Of Florida Research Foundation, Inc.	Detection of cannabinoid receptor biomarkers and uses thereof
EP3061461A1 (en)	2004-10-29	2016-08-31	ratiopharm GmbH	Remodeling and glycopegylation of fibroblast growth factor (fgf)
CA2585781A1 (en)	2004-11-03	2006-12-28	Iris Molecular Diagnostics, Inc.	Homogeneous analyte detection
CN103091485A (zh) *	2004-11-03	2013-05-08	艾瑞斯国际有限公司	用于亲和分离的微泡
WO2006048877A2 (en) *	2004-11-04	2006-05-11	Fibron Limited	Treatment of b-cell malignancies with fgfr3 inhibitors
WO2006055665A2 (en)	2004-11-16	2006-05-26	Trustees Of Boston University	Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis
US20070207496A1 (en) *	2004-11-19	2007-09-06	Larsen Oeistein	Diagnostic control system
CA2587985C (en)	2004-11-24	2016-05-10	Neopro Labs, Llc	Peptides for use in treatment in fever or pain
WO2006060484A2 (en) *	2004-12-01	2006-06-08	Gene Therapy Systems, Inc.	Tuberculosis nucleic acids, polypeptides and immunogenic compositions
EP3208616B1 (en) *	2004-12-20	2018-09-26	Antibodyshop A/S	Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
US7807789B2 (en) *	2004-12-21	2010-10-05	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
EP2290088A1 (en)	2004-12-22	2011-03-02	Genentech, Inc.	Methods for producing soluble multi-menbrane-spanning proteins
CA2531616A1 (en) *	2004-12-28	2006-06-28	Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.)	High strength thin steel sheet having high hydrogen embrittlement resisting property and high workability
US8697674B2 (en) *	2004-12-29	2014-04-15	Naturon, Inc.	Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
KR20070082597A (ko)	2004-12-30	2007-08-21	에이전시 포 사이언스, 테크놀로지 앤드 리서치	유전자
JP2008528060A (ja)	2005-01-27	2008-07-31	ザリージェンツオブザユニバーシティオブカリフォルニア	ボツリヌス神経毒素を中和する治療的モノクローナル抗体
ATE408828T1 (de) *	2005-02-16	2008-10-15	Dana Farber Cancer Inst Inc	Verfahren zur erkennung eines ovarialkarzinoms
US20080213237A1 (en) *	2005-03-10	2008-09-04	Hadasit Medical Research Services And Development Ltd.	Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof
CA2601400A1 (en)	2005-03-19	2006-09-28	Medical Research Council	Improvements in or relating to treatment and prevention of viral infections
US20070092886A1 (en) *	2005-03-22	2007-04-26	Raymond Tabibiazar	Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
EP1866338B1 (en)	2005-03-23	2016-09-21	Genmab A/S	Antibodies against cd38 for treatment of multiple myeloma
WO2006104677A2 (en)	2005-03-24	2006-10-05	Millennium Pharmaceuticals, Inc.	Antibodies that bind ov064 and methods of use therefor
US20070037232A1 (en) *	2005-03-31	2007-02-15	Barasch Jonathan M	Detection of NGAL in chronic renal disease
CA2635198C (en)	2005-04-01	2019-11-12	University Of Florida Research Foundation, Inc	Biomarkers of liver injury
US8048638B2 (en) *	2005-04-01	2011-11-01	University Of Florida Research Foundation, Inc.	Biomarkers of liver injury
PT3264094T (pt)	2005-04-04	2020-11-24	Biogen Ma Inc	Método para avaliar uma resposta imune a um agente terapêutico
EP2386571B1 (en)	2005-04-08	2016-06-01	ratiopharm GmbH	Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
RU2451074C2 (ru)	2005-04-11	2012-05-20	Савиент Фармасьютикалз, Инк.	Вариантные формы уратоксидазы и их применение
US20090099340A1 (en) *	2007-10-12	2009-04-16	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
CA2606721A1 (en) *	2005-05-02	2006-11-09	The Curators Of The University Of Missouri	Detection of carbohydrate biomarkers
US7592429B2 (en)	2005-05-03	2009-09-22	Ucb Sa	Sclerostin-binding antibody
US8003108B2 (en) *	2005-05-03	2011-08-23	Amgen Inc.	Sclerostin epitopes
WO2006125021A2 (en) *	2005-05-16	2006-11-23	Dana Farber Cancer Institute, Inc.	Fibrinogen alpha and hemoglobin polypeptides as cancer markers
CA2608567A1 (en)	2005-05-18	2006-11-23	Decode Genetics Ehf.	Variants at chr8q24.21 confer risk of cancer
KR101255400B1 (ko) *	2005-05-23	2013-04-17	파디아 에이비	2 단계 횡 유동 검사 방법 및 장치
CA2618429A1 (en) *	2005-05-25	2007-03-22	Tripep Ab	A hepatitis c virus non-structural ns3/4a fusion gene
KR101804078B1 (ko)	2005-06-08	2017-12-01	다나-파버 캔서 인스티튜트 인크.	예정 세포사 1(ｐｄ-1) 경로를 억제함으로써 지속 감염 및 암을 치료하기 위한 방법 및 조성물
EA016397B1 (ru) *	2005-06-20	2012-04-30	Декоуд Дженетикс Ехф.	Генетические варианты гена tcf7l2 как диагностические маркеры риска возникновения сахарного диабета ii типа
WO2007008604A2 (en) *	2005-07-08	2007-01-18	Bristol-Myers Squibb Company	Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof
US7906297B2 (en)	2005-07-20	2011-03-15	Cell Signaling Technology, Inc.	Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof
EP1945257A4 (en) *	2005-08-08	2009-05-06	Onconon Llc	ANTIBODY COMPOSITIONS, METHODS OF TREATING NEOPLASTIC DISEASE, AND METHOD FOR REGULATING FERTILITY
US20070202512A1 (en) *	2005-08-19	2007-08-30	Bristol-Myers Squibb Company	Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
ES2611307T3 (es)	2005-08-30	2017-05-08	University Of Miami	Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25)
EP1929003A4 (en)	2005-08-31	2009-04-29	Cell Signaling Technology Inc	REAGENTS FOR DETECTION OF PROTEIN PHOSPORYLATION IN CARCINOMA SIGNALING PATHWAYS
EP1934867A2 (en) *	2005-08-31	2008-06-25	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in leukemia signaling pathways
US20100151495A9 (en) *	2005-08-31	2010-06-17	Cell Signaling Technolgy, Inc.	Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
WO2007030560A2 (en) *	2005-09-08	2007-03-15	Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine	Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
AU2005336263A1 (en) *	2005-09-09	2007-03-15	Glycofi, Inc.	Immunoglobulin comprising predominantly a man7GlcNAc2, Man8GlcNAc2 glycoform
US7611834B2 (en) *	2005-09-30	2009-11-03	Sandia Corporation	Methods and devices for protein assays
IL172297A (en)	2005-10-03	2016-03-31	Compugen Ltd	Soluble vegfr-1 variants for the diagnosis of preeclampsia
AU2006302031A1 (en)	2005-10-11	2007-04-19	Tethys Bioscience, Inc.	Diabetes-associated markers and methods of use thereof
US8119358B2 (en)	2005-10-11	2012-02-21	Tethys Bioscience, Inc.	Diabetes-related biomarkers and methods of use thereof
US20080090304A1 (en) *	2006-10-13	2008-04-17	Barasch Jonathan Matthew	Diagnosis and monitoring of chronic renal disease using ngal
US20090074720A1 (en) *	2005-10-28	2009-03-19	Sabbadini Roger A	Methods for decreasing immune response and treating immune conditions
WO2007053524A2 (en) *	2005-10-28	2007-05-10	The Florida International University Board Of Trustees	Horse: human chimeric antibodies
US20080213274A1 (en) *	2005-10-28	2008-09-04	Sabbadini Roger A	Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
AU2006308863A1 (en) *	2005-10-31	2007-05-10	Janssen Pharmaceutica N.V.	A polypeptide complex of TRPM8 and calmodulin and its uses thereof
AU2006308765B2 (en)	2005-11-02	2013-09-05	Arbutus Biopharma Corporation	Modified siRNA molecules and uses thereof
BRPI0619657A2 (pt)	2005-11-04	2011-11-08	Genentech Inc	métodos de prevenção ou melhoria de doença ocular, uso de um inibidor de complemento, uso de um sirna especìfico para uma proteìna do sistema complemento e uso de um ácido nucleico que codifica um inibidor do sistema complemento
AU2006311661B2 (en)	2005-11-07	2011-05-26	The Scripps Research Institute	Compositions and methods for controlling tissue factor signaling specificity
US20070161089A1 (en) *	2005-11-08	2007-07-12	Genentech, Inc.	Method of Producing Pan-Specific Antibodies
UA96139C2 (uk)	2005-11-08	2011-10-10	Дженентек, Інк.	Антитіло до нейропіліну-1 (nrp1)
US20090233842A1 (en)	2005-11-12	2009-09-17	Prtzker Neuropsychiatric Research Fund Llc	Fgf2-related methods for diagnosing and treating depression
AU2006314528A1 (en)	2005-11-16	2007-05-24	Novartis Ag	Biomarkers for anti-nogo-A antibody treatment in spinal cord injury
RS54111B1 (en)	2005-11-18	2015-12-31	Glenmark Pharmaceuticals S.A.	ANTI-ALPHA 2 INTEGRIN ANTIBODIES AND THEIR USES
EP2805971A1 (en)	2005-11-28	2014-11-26	ZymoGenetics, Inc.	IL-21 antagonists
EP2463388B1 (en)	2005-11-29	2017-11-22	Cambridge Enterprise Limited	Markers for breast cancer
US7822474B2 (en) *	2005-11-30	2010-10-26	Cedars-Sinai Medical Center	Methods for the prediction of arrhythmias and prevention of sudden cardiac death
RU2426742C2 (ru)	2005-12-02	2011-08-20	Дженентек, Инк.	Составы и способы лечения заболеваний и нарушений, связанных с передачей сигналов цитокинами
US20070134814A1 (en) *	2005-12-09	2007-06-14	Kajander E O	Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
US9347945B2 (en)	2005-12-22	2016-05-24	Abbott Molecular Inc.	Methods and marker combinations for screening for predisposition to lung cancer
US20070178504A1 (en)	2005-12-22	2007-08-02	Tracey Colpitts	Methods and marker combinations for screening for predisposition to lung cancer
US20100015642A1 (en) *	2006-01-05	2010-01-21	Kwon Eugene D	B7-h1 and survivin in cancer
US20090215084A1 (en) *	2006-01-05	2009-08-27	Mayo Foundation For Medical Education And Research	B7-h1 and b7-h4 in cancer
US7575888B2 (en) *	2006-01-12	2009-08-18	Ortho-Mcneil Pharmaceutical, Inc.	Method of determining chymase activity with secretory leukocyte protease inhibitor
EP2463305B1 (en)	2006-01-12	2016-05-11	Alexion Pharmaceuticals, Inc.	Antibodies to OX-2/CD200 and uses thereof
US20100184021A1 (en)	2006-01-16	2010-07-22	Compugen Ltd.	Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
CN101528921B (zh)	2006-01-20	2013-11-20	细胞信号技术有限公司	人非小细胞肺癌中的易位和突变的ros激酶
US20120208824A1 (en)	2006-01-20	2012-08-16	Cell Signaling Technology, Inc.	ROS Kinase in Lung Cancer
CA2642984A1 (en) *	2006-02-22	2007-09-07	The Texas A & M University System	Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
EP1991246B1 (en)	2006-02-22	2013-09-11	Zhenglun Zhu	Treatment of development-related disorders
EP2676967B1 (en)	2006-02-28	2019-08-14	Biogen MA Inc.	Methods of treating inflammatory and autoimmune diseases with natalizumab
ES2663377T3 (es)	2006-03-03	2018-04-12	Biogen Ma Inc.	Métodos para el tratamiento de enfermedades inflamatorias y autoinmunes con natalizumab
US8293500B2 (en)	2006-03-22	2012-10-23	Viral Logic Systems Technology Corp.	Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
US8129334B2 (en)	2006-03-31	2012-03-06	The Regents Of The University Of California	Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
WO2007118214A2 (en) *	2006-04-07	2007-10-18	The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Antibody compositions and methods for treatment of neoplastic disease
CN101622270B (zh) *	2006-04-12	2014-01-01	萨文特医药公司	用阳离子表面活性剂纯化蛋白质的方法
ES2637592T3 (es)	2006-04-14	2017-10-13	Cell Signaling Technology, Inc.	Defectos de genes y quinasa ALK mutante en tumores sólidos humanos
WO2007124361A2 (en) *	2006-04-20	2007-11-01	Mayo Foundation For Medical Education And Research	Soluble b7-h1
TWI674069B (zh)	2006-04-21	2019-10-11	美商賽諾米克斯公司	包含高度鮮味風味劑之可食用組合物及其製造方法
WO2007127335A2 (en) *	2006-04-27	2007-11-08	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
US20100150928A1 (en)	2006-05-04	2010-06-17	Geneetech, Inc.	Methods and compositions relating to zpa polypeptides
BRPI0712084A2 (pt) *	2006-05-09	2012-01-03	Musc Found For Res Dev	detecÇço de insuficiÊncia cardÍaca diastàlica por identificaÇço do perfil plasmÁtico de protease e de inibidor de protease
AU2007249709A1 (en) *	2006-05-15	2007-11-22	Viral Logic Systems Technology Corp.	CD47 related compositions and methods for treating immunological diseases and disorders
US8377448B2 (en) *	2006-05-15	2013-02-19	The Board Of Trustees Of The Leland Standford Junior University	CD47 related compositions and methods for treating immunological diseases and disorders
US7745584B2 (en) *	2006-05-22	2010-06-29	California Institute Of Technology	Antibodies to sulfated carbohydrates
WO2007137300A2 (en)	2006-05-23	2007-11-29	Bellicum Pharmaceuticals, Inc.	Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
EP1862538A1 (en) *	2006-05-29	2007-12-05	IMBA-Institut für Molekulare Biotechnologie GmbH	siRNA kinase and methods of use
US20090197280A1 (en)	2006-05-30	2009-08-06	Kristian Bangert	Methods and Devices for Rapid Assessment of Severity of Injury
US7862812B2 (en) *	2006-05-31	2011-01-04	Lpath, Inc.	Methods for decreasing immune response and treating immune conditions
CA2659082A1 (en)	2006-06-07	2007-12-21	Tethys Bioscience, Inc.	Markers associated with arteriovascular events and methods of use thereof
EP2046384A4 (en) *	2006-06-15	2009-12-02	Fibron Ltd	ANTIBODIES BLOCKING FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATION AND METHODS OF USING THE SAME
NZ573624A (en)	2006-06-23	2011-03-31	Myriad Genetics Inc	Dpyd gene variants and use thereof
JP5576657B2 (ja)	2006-06-28	2014-08-20	イエダリサーチアンドディベロップメントカンパニーリミテッド	カスパーゼ−８ならびに炎症、感染および創傷治癒
US7572618B2 (en)	2006-06-30	2009-08-11	Bristol-Myers Squibb Company	Polynucleotides encoding novel PCSK9 variants
US20080004410A1 (en) *	2006-06-30	2008-01-03	Yu-Chin Lai	Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
CN101512010A (zh) *	2006-07-11	2009-08-19	南卡罗来纳州医科大学研究发展基金会	利用蛋白酶和蛋白酶抑制剂分析预测心肌梗塞后的心力衰竭
MY150687A (en)	2006-07-21	2014-02-28	Femalon S P R L	Assay and kit for predicting implantation success in assisted fertilisation
DE602006013809D1 (de)	2006-07-24	2010-06-02	Facultad De Medicina Universid	Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden
US20100210031A2 (en) *	2006-08-07	2010-08-19	Antibodyshop A/S	Diagnostic Test to Exclude Significant Renal Injury
EP2053961A4 (en) *	2006-08-09	2013-05-01	Biogen Idec Inc	METHOD FOR DISPENSING A MEDICAMENT
US7939636B2 (en) *	2006-08-11	2011-05-10	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US7993832B2 (en) *	2006-08-14	2011-08-09	Xdx, Inc.	Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US20090258442A1 (en) *	2006-08-31	2009-10-15	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
US20090203602A1 (en) *	2006-09-01	2009-08-13	Cohava Gelber	Compositions and methods for diagnosis and treatment of type 2 diabetes
US20100267052A1 (en) *	2006-09-01	2010-10-21	American Type Culture Collection	Compositions and methods for diagnosis and treatment of type 2 diabetes
US20080300170A1 (en) *	2006-09-01	2008-12-04	Cohava Gelber	Compositions and methods for diagnosis and treatment for type 2 diabetes
US7951776B2 (en)	2006-09-01	2011-05-31	American Type Culture Collection	Methods for treatment of type 1 diabetes
US7569396B1 (en)	2006-09-08	2009-08-04	Purplecow Llc	Caffeine detection using internally referenced competitive assays
EP2560001B1 (en)	2006-09-21	2016-04-13	University of Rochester	Compositions and methods related to protein displacement therapy for myotonic distrophy
HUE044136T2 (hu)	2006-09-26	2019-09-30	Genmab As	Anti-CD38 plusz kortikoszteroidok plusz nem-kortikoszteroid kemoterápiás szer daganatok kezelésére
BRPI0715239A2 (pt)	2006-10-04	2013-06-25	Genentech Inc	mÉtodo para detectar formas de fator de crescimento endotelial vascular (vegf) seletivas (vegf110+), kit de imunoensaio, anticorpo 5c3 e hibridoma 5c3.1.1
US9532980B2 (en) *	2006-10-25	2017-01-03	The Rockefeller University	Methods for the treatment of A-β related disorders and compositions therefor
EP2083862A4 (en)	2006-10-27	2012-09-19	Lpath Inc	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS
CA2703795A1 (en)	2006-10-27	2008-05-02	Mount Sinai Hospital	Endometrial phase or endometrial cancer biomarkers
CN101679506B (zh) *	2006-10-27	2015-02-25	勒帕斯公司	用于结合鞘氨醇-1-磷酸的组合物和方法
US20080125368A1 (en) *	2006-10-31	2008-05-29	Imperial Innovations Limited	Methods
CN106188304A (zh)	2006-11-02	2016-12-07	健泰科生物技术公司	人源化的抗‑d因子抗体
WO2008053486A1 (en) *	2006-11-02	2008-05-08	Sylvie Luria	Methods for screening for therapeutic molecules and use of the molecules therefrom
US8148067B2 (en) *	2006-11-09	2012-04-03	Xdx, Inc.	Methods for diagnosing and monitoring the status of systemic lupus erythematosus
EP2097450A2 (en) *	2006-11-10	2009-09-09	Amgen Inc.	Antibody-based diagnostics and therapeutics
EP2094731A2 (en) *	2006-11-10	2009-09-02	UCB Pharma S.A.	Anti human sclerostin antibodies
WO2008061130A2 (en) *	2006-11-15	2008-05-22	Ucp Biosciences, Inc.	An improved collecting and testing device and method of use
US20100104511A1 (en) *	2006-11-22	2010-04-29	The Board Of Regents Of The University Of Texas System	Methods and compositions using chelator-antibody conjugates
US20100086921A1 (en) *	2006-11-30	2010-04-08	Valgerdur Steinthorsdottir	Genetic susceptibility variants of type 2 diabetes mellitus
JP2010511382A (ja) *	2006-12-01	2010-04-15	エージェンシーフォーサイエンス，テクノロジーアンドリサーチ	癌関連タンパク質キナーゼ
JP5646174B2 (ja) *	2006-12-05	2014-12-24	デコード・ジェネティクス・イーエイチエフ	心臓不整脈のリスクマネージメント用の遺伝マーカー
EP2610267A1 (en)	2006-12-18	2013-07-03	Genentech, Inc.	Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
US20090186034A1 (en) *	2006-12-19	2009-07-23	Genetech, Inc.	Gene expression markers for inflammatory bowel disease
WO2008079322A1 (en) *	2006-12-22	2008-07-03	Beckman Coulter, Inc.	Methods, kits and materials for diagnosing disease states by measuring isoforms or proforms of myeloperoxidase
AR064642A1 (es) *	2006-12-22	2009-04-15	Wyeth Corp	Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
EP2097448A4 (en)	2006-12-22	2010-07-21	Univ Utah Res Found	PROCEDURE FOR THE EVIDENCE OF EYE DISEASES AND SUFFERINGS AND THEIR TREATMENT
US7931896B2 (en)	2006-12-27	2011-04-26	The Johns Hopkins University	Compositions and methods for treating inflammation and auto-immune diseases
US7989173B2 (en)	2006-12-27	2011-08-02	The Johns Hopkins University	Detection and diagnosis of inflammatory disorders
US20090142342A1 (en) *	2006-12-27	2009-06-04	Johns Hopkins University	B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
WO2008085895A2 (en) *	2007-01-04	2008-07-17	Musc Foundation For Research Development	Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
US8930178B2 (en)	2007-01-04	2015-01-06	Children's Hospital Medical Center	Processing text with domain-specific spreading activation methods
EP2111412A2 (en) *	2007-02-02	2009-10-28	Amgen, Inc	Hepcidin and hepcidin antibodies
EP2522743A3 (en)	2007-02-07	2013-08-07	Decode Genetics EHF.	Genetic variants contributing to risk of prostate cancer
DK2471954T3 (en) *	2007-02-21	2016-09-12	Decode Genetics Ehf	Susceptibility genetic variants associated with cardiovascular diseases
US20090081659A1 (en)	2007-03-07	2009-03-26	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
JP2010521694A (ja) *	2007-03-21	2010-06-24	バイオポルト・ダイアグノスティクス・アクティーゼルスカブ	腎傷害のための診断テスト
US7960139B2 (en)	2007-03-23	2011-06-14	Academia Sinica	Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
MX2009010439A (es) *	2007-03-26	2009-10-20	Decode Genetics Ehf	Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.
US20090068684A1 (en) *	2007-03-26	2009-03-12	Cell Signaling Technology, Inc.	Serine and threoninephosphorylation sites
US20090092631A1 (en) *	2007-03-26	2009-04-09	Tripep Ab	Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
WO2008118324A2 (en)	2007-03-26	2008-10-02	Macrogenics, Inc.	Composition and method of treating cancer with an anti-uroplakin ib antibody
US20100105571A1 (en)	2007-03-27	2010-04-29	Carl Arne Krister Borrebaeck	Protein Signature/Markers for the Detection of Adenocarcinoma
US20080238709A1 (en) *	2007-03-28	2008-10-02	Faramarz Vaziri	One-way communication apparatus with dynamic key generation
CA2682093A1 (en)	2007-03-29	2008-10-09	Technion Research & Development Foundation Ltd.	Antibodies, methods and kits for diagnosing and treating melanoma
DK2132339T3 (da) *	2007-04-04	2011-06-27	Chimera Biotec Gmbh	Fremgangsmåde til detektering af en analyt i en biologisk matrix
TW200902025A (en) *	2007-04-11	2009-01-16	Alcon Res Ltd	Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20090182035A1 (en) *	2007-04-11	2009-07-16	Alcon Research, Ltd.	Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
TW200849035A (en)	2007-04-18	2008-12-16	Tethys Bioscience Inc	Diabetes-related biomarkers and methods of use thereof
EP2145902A3 (en)	2007-04-19	2010-09-29	Peter Hornbeck	Tyrosine phosphorylation sites and antibodies specific for them
US7977462B2 (en)	2007-04-19	2011-07-12	Cell Signaling Technology, Inc.	Tyrosine phosphorylation sites
EP1983003A3 (en)	2007-04-19	2009-03-11	Peter Hornbeck	Tyrosine phosphorylation sites and antibodies specific for them
EP2139916A1 (en)	2007-04-26	2010-01-06	Opsona Therapeutics Limited	Toll-like receptor binding epitope and compositions for binding thereto
US20090004677A1 (en) *	2007-04-27	2009-01-01	The Board Of Trustees Of The University Of Illinois	Quantitative determination of bcl10
US20090053831A1 (en)	2007-05-01	2009-02-26	Cell Signaling Technology, Inc.	Tyrosine phosphorylation sites
CA2685875C (en) *	2007-05-01	2015-10-06	Hill's Pet Nutrition, Inc.	Methods and compositions for diagnosing osteoarthritis in a feline
GB0709092D0 (en) *	2007-05-11	2007-06-20	Borrebaeck Carl	Diagnosis and method of disease
WO2008141318A1 (en) *	2007-05-14	2008-11-20	Dr. Susan Love Research Foundation	Device for determining risk of developing breast cancer and method thereof
US8580501B2 (en)	2007-05-25	2013-11-12	Decode Genetics Ehf.	Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
US9163091B2 (en) *	2007-05-30	2015-10-20	Lpath, Inc.	Compositions and methods for binding lysophosphatidic acid
WO2008150841A1 (en)	2007-05-30	2008-12-11	Lpath, Inc.	Compositions and methods for binding lysophosphatidic acid
CA2688558A1 (en)	2007-06-04	2009-03-26	Diagnoplex	Biomarker combinations for colorectal cancer
CN103694351A (zh)	2007-06-05	2014-04-02	耶鲁大学	受体酪氨酸激酶抑制剂及其使用方法
EP2592156B1 (en)	2007-06-08	2016-04-20	Genentech, Inc.	Gene expression markers of tumor resistance to HER2 inhibitor treatment
WO2009009127A2 (en) *	2007-07-12	2009-01-15	U.S. Genomics, Inc.	Method and system for transferring and/or concentrating a sample
EP2514762B1 (en)	2007-07-13	2015-04-08	The Johns Hopkins University	B7-DC variants
AU2008279618B2 (en) *	2007-07-25	2014-05-22	Alexion Pharmaceuticals, Inc.	Methods and compositions for treating autoimmune disease
CN101848724A (zh)	2007-08-03	2010-09-29	奥普索纳医疗有限公司	Trl-2拮抗剂在治疗再灌注损伤和组织损伤中的用途
US8071561B2 (en) *	2007-08-16	2011-12-06	Chrontech Pharma Ab	Immunogen platform
NZ583605A (en) *	2007-08-29	2012-10-26	Sanofi Aventis	Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
JP5607530B2 (ja)	2007-09-04	2014-10-15	コンピュゲンエルティーディー．	ポリペプチド並びにポリヌクレオチド、並びに薬剤および生物製剤生産のための薬剤標的としてのその利用
US20090111131A1 (en) *	2007-09-13	2009-04-30	Seth Fishman	Method of detecting protein losing enteropathy in animals
CL2008002775A1 (es) *	2007-09-17	2008-11-07	Amgen Inc	Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
WO2009048530A2 (en)	2007-10-05	2009-04-16	Panomics, Inc.	Highly multiplexed particle-based assays
CA2702169A1 (en) *	2007-10-12	2009-04-16	Decode Genetics Ehf	Sequence variants for inferring human pigmentation patterns
EP2050764A1 (en)	2007-10-15	2009-04-22	sanofi-aventis	Novel polyvalent bispecific antibody format and uses thereof
JP5769968B2 (ja)	2007-10-18	2015-08-26	セル・シグナリング・テクノロジー・インコーポレイテツド	ヒト非小細胞肺癌における転座および変異ｒｏｓキナーゼ
CN102177176B (zh)	2007-10-23	2014-05-07	克里夫兰临床基金会	氧化剂耐受性载脂蛋白a-1及模拟肽
US8361465B2 (en) *	2007-10-26	2013-01-29	Lpath, Inc.	Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
KR20160129099A (ko)	2007-11-07	2016-11-08	제넨테크, 인크.	미생물 질환의 치료를 위한 조성물 및 방법
CA2700197C (en)	2007-11-08	2020-09-08	Neogenix Oncology, Inc.	Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
ES2475990T5 (es) *	2007-11-15	2017-07-06	Bioporto Diagnostics A/S	Uso diagnóstico de formas moleculares individuales de un biomarcador
EP2728017B1 (en)	2007-11-19	2016-08-24	Celera Corporation	Lung cancer markers and uses thereof
US20090203043A1 (en)	2007-11-21	2009-08-13	Peter Hornbeck	Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
US8912149B1 (en)	2007-11-28	2014-12-16	California Institute Of Technology	Glycosaminoglycan mimetics
WO2009073565A2 (en)	2007-11-29	2009-06-11	Genentech, Inc.	Gene expression markers for inflammatory bowel disease
US8697360B2 (en)	2007-11-30	2014-04-15	Decode Genetics Ehf.	Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
HUE027828T2 (en)	2007-12-07	2016-11-28	Zymogenetics Inc	Anti-human IL-21 monoclonal antibodies
AP3226A (en)	2007-12-13	2015-04-30	Philip Morris Products Sa	Transgenic plants modifier for reducede cadmium transport, derivative products, and related methods
EA201070740A1 (ru) *	2007-12-14	2010-12-30	Эмджен Инк.	Способ лечения перелома кости антителами против склеростина
ES2535419T3 (es)	2007-12-27	2015-05-11	Protiva Biotherapeutics Inc.	Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
DE202008000834U1 (de)	2008-01-21	2008-05-29	Chin, Li-Te	Zusammensetzung und Reagenz für CTLA-4 und Verwendungen derselben
EP2574628B1 (en)	2008-01-25	2015-05-20	Amgen Inc.	Ferroportin antibodies and methods of use
CA2713667A1 (en) *	2008-01-31	2009-08-06	Compugen Ltd.	Cd55 isoform and uses therof in cancer detection, monitoring and therapy
CA2618163A1 (en)	2008-02-07	2009-08-07	K. W. Michael Siu	Head and neck cancer biomarkers
EP2247755B1 (en)	2008-02-14	2015-01-28	Decode Genetics EHF	Susceptibility variants for lung cancer
CN102016588B (zh) *	2008-02-21	2014-05-14	艾瑞斯国际有限公司	早期确定前列腺癌治疗后复发的方法
US20090220991A1 (en) *	2008-02-29	2009-09-03	Cell Signaling Technology, Inc.	Reagents for the detection of protein phosphorylation in leukemia signaling pathways
US20110020325A1 (en) *	2008-02-29	2011-01-27	Kwon Eugene D	Methods for reducing granulomatous inflammation
JP2011519413A (ja)	2008-03-14	2011-07-07	イースタンバージニアメディカルスクール	改良された前立腺癌診断学のための質量顕微鏡法
US8993231B2 (en) *	2008-03-18	2015-03-31	Marshall University Research Corporation	Methods for stem cell production and therapy
NZ588905A (en)	2008-04-01	2012-08-31	Decode Genetics Ehf	Genetic testing method for determining susceptibility to abdominal aortic aneurysm by assay for selected polymorphisms associated with the disease
US8669349B2 (en)	2008-04-02	2014-03-11	Macrogenics, Inc.	BCR-complex-specific antibodies and methods of using same
WO2009123894A2 (en)	2008-04-02	2009-10-08	Macrogenics, Inc.	Her2/neu-specific antibodies and methods of using same
EP3208612B1 (en)	2008-04-09	2019-09-18	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
EP2274437B1 (en)	2008-04-10	2015-12-23	Cell Signaling Technology, Inc.	Compositions and methods for detecting egfr mutations in cancer
ES2638448T3 (es)	2008-04-15	2017-10-20	Protiva Biotherapeutics Inc.	Novedosas formulaciones de lípidos para la administración de ácidos nucleicos
WO2009129319A2 (en)	2008-04-15	2009-10-22	Protiva Biotherapeutics, Inc.	Silencing of csn5 gene expression using interfering rna
WO2009130588A2 (en) *	2008-04-22	2009-10-29	Tripep Ab	Immunogen platform
EP3348573B1 (en)	2008-04-25	2020-04-22	Dyax Corp.	Method of producing antibodies against fcrn and use thereof
CR20170001A (es)	2008-04-28	2017-08-10	Genentech Inc	Anticuerpos anti factor d humanizados
CA2722600C (en)	2008-05-01	2014-01-21	Amgen Inc.	Anti-hepcidin antibodies and methods of use
EP2116261A1 (en)	2008-05-07	2009-11-11	Institut Pasteur	Sub-region of a plasmodium protein with improved vaccine potential and medical uses thereof
US8168755B2 (en)	2008-05-07	2012-05-01	Eutropics Pharmaceuticals, Inc.	Antibodies specific to heterodimers of Bcl-2 family and uses thereof
SG176464A1 (en)	2008-05-09	2011-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
EP2599793A1 (en)	2008-05-29	2013-06-05	Nuclea Biotechnologies, Inc.	Anti-phospho-akt antibodies
JOP20190083A1 (ar)	2008-06-04	2017-06-16	Amgen Inc	بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
CA2726845C (en)	2008-06-04	2017-09-26	Macrogenics, Inc.	Antibodies with altered binding to fcrn and methods of using same
US20110123542A1 (en) *	2008-06-24	2011-05-26	Hadasit Medical Research Services And Development Ltd.	Ccl20-specific antibodies for cancer therapy
MX2011000075A (es)	2008-06-25	2011-03-02	Esbatech Alcon Biomed Res Unit	Anticuerpos estables y solubles que inhiben el tnfa.
MX347972B (es)	2008-06-25	2017-05-22	Esbatech Alcon Biomed Res Unit	Anticuerpos estables y solubles que inhiben el vegf.
CA2728674A1 (en) *	2008-06-26	2009-12-30	Dana-Farber Cancer Institute, Inc.	Signatures and determinants associated with metastasis methods of use thereof
EP2307456B1 (en)	2008-06-27	2014-10-15	Amgen Inc.	Ang-2 inhibition to treat multiple sclerosis
CN102137938B (zh) *	2008-07-04	2015-01-21	解码遗传学私营有限责任公司	预测精神分裂症的风险的拷贝数变异
KR20110036608A (ko)	2008-07-07	2011-04-07	디코드 제네틱스 이에이치에프	유방암 위험도 평가를 위한 유전적 변이
US20120009581A1 (en)	2008-07-08	2012-01-12	Bankaitis-Davis Danute M	Gene Expression Profiling for Predicting the Survivability of Prostate Cancer Subjects
JP5986745B2 (ja)	2008-07-15	2016-09-06	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
AU2009272369B2 (en)	2008-07-17	2016-04-14	Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh	Biomarkers for cardiodiabetes
WO2010009438A1 (en)	2008-07-17	2010-01-21	Andreas Pfuetzner	Biomarkers for insulin resistance and beta-cell dysfunction
US20100021472A1 (en) *	2008-07-25	2010-01-28	Geetha Srikrishna	Methods for diagnosing and treating cancer
US8795981B2 (en) *	2008-08-08	2014-08-05	Molecular Devices, Llc	Cell detection
EP3336551B1 (en)	2008-08-11	2023-05-31	Banyan Biomarkers, Inc.	Biomarker detection process and assay of neurological condition
CN102177252B (zh) *	2008-08-12	2014-12-24	解码遗传学私营有限责任公司	用于甲状腺癌症的风险评估的遗传变型
US20110212855A1 (en) *	2008-08-15	2011-09-01	Decode Genetics Ehf.	Genetic Variants Predictive of Cancer Risk
CA2734892A1 (en)	2008-08-18	2010-02-25	Seoul National University Industry Foundation	Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase
EP2328920A2 (en) *	2008-08-25	2011-06-08	Amplimmune, Inc.	Targeted costimulatory polypeptides and methods of use to treat cancer
EA201500417A1 (ru)	2008-08-25	2015-11-30	Эмплиммьюн, Инк.	Композиции антагонистов pd-1 и способы применения
EP2324060B1 (en)	2008-09-07	2015-07-22	Glyconex Inc.	Anti-extended type i glycosphingolipid antibody, derivatives thereof and use
CN102149728B (zh)	2008-09-10	2014-10-15	霍夫曼-拉罗奇有限公司	抑制眼部血管生成的方法
US20110236314A1 (en)	2008-09-12	2011-09-29	Cancer Research Initiatives Foundation	Method of detection and diagnosis of oral and nasopharyngeal cancers
US8417011B2 (en) *	2008-09-18	2013-04-09	Molecular Devices (New Milton) Ltd.	Colony detection
US20110200525A1 (en) *	2008-10-09	2011-08-18	Patz Jr Edward F	Vhh antibody fragments for use in the detection and treatment of cancer
UA105016C2 (uk)	2008-10-10	2014-04-10	Амген Інк.	Fgf21 мутанти і їх застосування
JP2012505900A (ja)	2008-10-14	2012-03-08	ダイアクスコーポレーション	全身性強皮症に伴う肺線維症の治療および予防のためのｉｇｆ−ｉｉ／ｉｇｆ−ｉｉｅ結合タンパク質の使用
US8147847B2 (en) *	2008-10-21	2012-04-03	International Vaccine Institute	Shigella protein antigens and methods
US8871202B2 (en)	2008-10-24	2014-10-28	Lpath, Inc.	Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
CN102203122A (zh) *	2008-11-05	2011-09-28	惠氏有限责任公司	用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物
EP2352517A4 (en)	2008-11-10	2013-01-16	Alexion Pharma Inc	METHOD AND COMPOSITIONS FOR TREATING COMPLEMENT ASSOCIATED ILLNESSES
AT507604A1 (de)	2008-11-19	2010-06-15	Affiris Forschungs & Entwicklungs Gmbh	Behandlung von atherosklerose
ATE523603T1 (de) *	2008-11-21	2011-09-15	Chimera Biotec Gmbh	Konjugatkomplexe zum analytnachweis
RU2011121042A (ru)	2008-11-26	2013-01-10	Файв Прайм Терапеутикс, Инк.	Композиции и способы регулирования экспрессии коллагена и актина гладких мышц посредством serpine2
WO2010061393A1 (en)	2008-11-30	2010-06-03	Compugen Ltd.	He4 variant nucleotide and amino acid sequences, and methods of use thereof
BRPI0923249A2 (pt)	2008-12-03	2016-01-26	Inst Pasteur Ct Nat De La Rech Scient Cnrs	uso de modulinas solúveis em fenol no desenvolvimento de vacinas
US8431775B2 (en)	2008-12-04	2013-04-30	Pioneer Hi Bred International Inc	Methods and compositions for enhanced yield by targeted expression of knotted1
US20100256196A1 (en)	2008-12-04	2010-10-07	Ikfe	Biomarkers for Atherosclerosis
EP2383294A1 (en)	2008-12-04	2011-11-02	Yeda Research And Development Co. Ltd.	Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
CN102300874B (zh)	2008-12-08	2015-08-05	卡姆普根有限公司	Tmem154多肽和多核苷酸及其作为产生药物和生物制品的药物靶标的用途
EP2376926A1 (en)	2008-12-11	2011-10-19	IKFE GmbH	Biomarkers for insulin sensitizer drug response
WO2010076655A1 (en)	2008-12-30	2010-07-08	Ikfe Gmbh	Biomarkers for adipose tissue activity
EP2382475A2 (en)	2009-01-07	2011-11-02	IKFE GmbH	Biomarkers for appetite regulation
WO2010087131A1 (ja)	2009-01-28	2010-08-05	学校法人東海大学	Ｈｉｖ複製抑制剤、及びその利用
PT2391653E (pt)	2009-01-28	2015-02-13	Ind Tech Res Inst	Biomarcadores associados a nefropatia
DK3301446T3 (da)	2009-02-11	2020-06-29	Caris Mpi Inc	Molekylær tumorprofilering
US20110014190A1 (en)	2009-02-12	2011-01-20	Human Genome Sciences, Inc.	Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
HUE035769T2 (en)	2009-02-12	2018-05-28	Cell Signaling Technology Inc	Mutant ROS expression in human liver cancer
PT2939683T (pt)	2009-02-16	2017-04-07	Cerenis Therapeutics Holding Sa	Miméticos da apolipoproteína a-i
US20100248265A1 (en) *	2009-02-27	2010-09-30	The Salk Institute For Biological Studies	Compositions and methods for diagnosis and treatment of cancer
WO2010107991A2 (en)	2009-03-18	2010-09-23	Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
EP2233496A1 (en)	2009-03-26	2010-09-29	Ruhr-Universität Bochum	Fluorescent proteins
AU2010241947B2 (en)	2009-03-27	2014-01-16	Gojo Industries, Inc.	Compositions and methods for screening and using compounds antagonizing spore-surface interactions
WO2010112033A2 (en)	2009-03-31	2010-10-07	Østjysk Innovation A/S	Method for estimating the risk of having or developing multiple sclerosis using sequence polymorphisms in a specific region of chromosome x
WO2010113185A1 (en)	2009-04-03	2010-10-07	Decode Genetics Ehf	Genetic markers for risk management of atrial fibrillation and stroke
EP4353247A3 (en)	2009-05-05	2024-07-17	Amgen Inc.	Fgf21 mutants and uses thereof
US20120052069A1 (en)	2009-05-05	2012-03-01	Amgen Inc	Fgf21 mutants and uses thereof
US20110301093A1 (en)	2009-05-06	2011-12-08	Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science	Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
EP2451975A4 (en) *	2009-05-08	2013-08-14	Decode Genetics Ehf	GENETIC VARIANTS CONTRIBUTING TO A RISK OF PROSTATE CANCER
MX2011013903A (es)	2009-06-17	2012-05-08	Amgen Inc	Polipeptidos quimericos y usos de los mismos.
NZ597089A (en)	2009-06-25	2014-05-30	Savient Pharmaceuticals Inc	Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
IL199618A0 (en)	2009-06-29	2010-04-29	Two To Biotech Ltd	Novel antibodies and their use in diagnostic methods
WO2011000805A1 (en)	2009-06-29	2011-01-06	INSERM (Institut National de la Santé et de la Recherche Médicale)	Biomarkers of oocyte competency and method of use
ES2613498T3 (es)	2009-07-01	2017-05-24	Protiva Biotherapeutics Inc.	Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
IE20090514A1 (en)	2009-07-06	2011-02-16	Opsona Therapeutics Ltd	Humanised antibodies and uses therof
CA2767360A1 (en)	2009-07-10	2011-01-13	Decode Genetics Ehf.	Genetic markers associated with risk of diabetes mellitus
WO2011004379A1 (en)	2009-07-10	2011-01-13	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Compositions and methods for treating cancer
US8716464B2 (en)	2009-07-20	2014-05-06	Thomas W. Geisbert	Compositions and methods for silencing Ebola virus gene expression
CN102639710A (zh)	2009-07-20	2012-08-15	基因泰克公司	克罗恩病的基因表达标记
US9493834B2 (en)	2009-07-29	2016-11-15	Pharnext	Method for detecting a panel of biomarkers
IL200202A0 (en)	2009-08-02	2010-05-31	Orly Devary	Novel proteins
CA2806840C (en)	2009-08-03	2019-08-27	Eckhard R. Podack	Method for in vivo expansion of t regulatory cells
US20120148604A1 (en)	2009-08-20	2012-06-14	Transposagen Biopharmaceuticals, Inc.	Trp inhibitors and uses thereof
US20120183981A1 (en) *	2009-08-28	2012-07-19	Inova Diagnostics, Inc.	Methoed for detecting circulating cartilage oligomeric matrix protein in the diagnosis and monitoring of cirrhosis
IN2012DN02753A (it)	2009-08-31	2015-09-18	Amplimmune Inc
ES2538007T3 (es)	2009-09-16	2015-06-16	Vaxart, Inc.	Estrategia de inmunización para prevenir una infección por H1N1
WO2011038160A2 (en)	2009-09-23	2011-03-31	Protiva Biotherapeutics, Inc.	Compositions and methods for silencing genes expressed in cancer
EP2480888B1 (en)	2009-09-25	2016-11-30	XOMA Technology Ltd.	Screening methods
US8926976B2 (en)	2009-09-25	2015-01-06	Xoma Technology Ltd.	Modulators
AU2010300421B2 (en) *	2009-10-01	2014-01-23	Alcon Research, Ltd.	Olopatadine compositions and uses thereof
EP3349010B1 (en)	2009-10-11	2024-08-28	Biogen MA Inc.	Anti-vla-4 related assays
KR20120105444A (ko)	2009-10-15	2012-09-25	오클라호마 메디컬 리써치 화운데이션	염증성 질병의 활성 측정 및 모니터링을 위한 바이오마커 및 방법
WO2011048598A1 (en)	2009-10-22	2011-04-28	Yeda Research And Development Co. Ltd.	Compositions and methods for treating aspergillosis
AR078751A1 (es)	2009-10-23	2011-11-30	Millennium Pharm Inc	Moleculas de anticuerpo anti-gcc (guanililo ciclasa c) y composiciones y metodos relacionados
CA2778810C (en) *	2009-10-26	2018-09-04	Genentech, Inc.	Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
CA2779223A1 (en)	2009-10-27	2011-05-12	Caris Mpi, Inc.	Molecular profiling for personalized medicine
JP2013509588A (ja)	2009-10-29	2013-03-14	テシスバイオサイエンス，インコーポレイテッド	２型糖尿病の予防に対して一貫した改善をもたらすタンパク質バイオマーカーおよび脂質代謝物バイオマーカー
EP2494483A2 (en)	2009-10-29	2012-09-05	Tethys Bioscience, Inc.	Method for determining risk of diabetes
WO2011058367A2 (en)	2009-11-13	2011-05-19	Astrazeneca Ab	Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor
US8592151B2 (en) *	2009-11-17	2013-11-26	Musc Foundation For Research Development	Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
WO2011067711A2 (en)	2009-12-01	2011-06-09	Compugen Ltd	Novel heparanase splice variant
US11377485B2 (en)	2009-12-02	2022-07-05	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US8372952B2 (en) *	2009-12-02	2013-02-12	Amgen Inc.	Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho
US10087236B2 (en)	2009-12-02	2018-10-02	Academia Sinica	Methods for modifying human antibodies by glycan engineering
UA109888C2 (uk)	2009-12-07	2015-10-26		ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
CN102770764B (zh)	2009-12-07	2016-04-20	皮里斯股份公司	对给定靶标具有亲和力的人脂质运载蛋白2（Lcn2，hNGAL）的突变蛋白
US9689801B2 (en)	2009-12-22	2017-06-27	Agency For Science, Technology And Research	SERS-based analyte detection
WO2011076922A1 (en)	2009-12-23	2011-06-30	Synimmune Gmbh	Anti-flt3 antibodies and methods of using the same
CA2786019C (en)	2010-01-06	2018-12-18	Dyax Corp.	Plasma kallikrein binding proteins
AU2011203879A1 (en)	2010-01-11	2012-08-02	Alexion Pharmaceuticals, Inc.	Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodies
US11287423B2 (en)	2010-01-11	2022-03-29	Biogen Ma Inc.	Assay for JC virus antibodies
SMT201800148T1 (it)	2010-01-11	2018-05-02	Biogen Ma Inc	Saggio per anticorpi del virus jc
WO2011089211A1 (en)	2010-01-22	2011-07-28	Synimmune Gmbh	Anti-cd133 antibodies and methods of using the same
EP2531224B1 (en)	2010-01-26	2019-06-05	Bioregency, Inc.	Compositions and methods relating to argininosuccinate synthetase
EP2528949A1 (en)	2010-01-27	2012-12-05	Yeda Research And Development Co. Ltd.	Antibodies that inhibit metalloproteins
WO2011094731A2 (en)	2010-02-01	2011-08-04	The Board Of Trustees Of The Leland Stanford Junior University	Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
TWI518325B (zh)	2010-02-04	2016-01-21	自治醫科大學	對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
JP4686639B1 (ja) *	2010-02-25	2011-05-25	田中貴金属工業株式会社	生豚肉検出法およびその検出キット
WO2011106738A2 (en)	2010-02-25	2011-09-01	Fred Hutchinson Cancer Research Center	Use of tcr clonotypes as biomarkers for disease
WO2011106723A2 (en) *	2010-02-26	2011-09-01	Lpath, Inc.	Anti-paf antibodies
US20130058915A1 (en)	2010-03-02	2013-03-07	Children's Medica Center Corporation	Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20110237000A1 (en) *	2010-03-11	2011-09-29	Agency For Science, Technology And Research	Method for detecting an analyte molecule
US20150231215A1 (en)	2012-06-22	2015-08-20	Randolph J. Noelle	VISTA Antagonist and Methods of Use
US10745467B2 (en)	2010-03-26	2020-08-18	The Trustees Of Dartmouth College	VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
AU2011230537C1 (en)	2010-03-26	2018-08-02	Trustees Of Dartmouth College	Vista regulatory T cell mediator protein, vista binding agents and use thereof
EP2556169B1 (en)	2010-04-07	2018-02-14	Imperial Innovations Limited	Methods for categorising cancer such as breast cancer
WO2011130332A1 (en)	2010-04-12	2011-10-20	Academia Sinica	Glycan arrays for high throughput screening of viruses
WO2011130417A2 (en)	2010-04-15	2011-10-20	Amgen Inc.	HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
US8785385B2 (en)	2010-04-19	2014-07-22	Research Development Foundation	RTEF-1 variants and uses thereof
CN103119444B (zh)	2010-04-21	2016-10-26	米密德诊断学有限公司	区分细菌与病毒感染的标记物和决定因素以及其使用方法
KR20130133120A (ko)	2010-05-14	2013-12-06	백스터 인터내셔널 인코포레이티드	Ｏｓｐａ 키메라 및 백신에서 그의 용도
SMT202000095T1 (it)	2010-05-14	2020-03-13	Amgen Inc	Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
WO2011146479A1 (en)	2010-05-18	2011-11-24	The Texas A&M University System	Method and composition for the diagnosis and monitoring of inflammatory diseases
WO2011146725A1 (en)	2010-05-19	2011-11-24	Bayer Healthcare Llc	Biomarkers for a multikinase inhibitor
WO2011145085A2 (en)	2010-05-21	2011-11-24	Procognia (Israel) Ltd	Novel antibodies and methods of use for the treatment and diagnosis of cancer
WO2011161545A2 (en)	2010-06-04	2011-12-29	The Netherlands Cancer Institute	Non-hydrolyzable protein conjugates, methods and compositions related thereto
US8383580B2 (en)	2010-06-10	2013-02-26	The Regents Of The University Of Michigan	Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
GB201009798D0 (en)	2010-06-11	2010-07-21	Immunovia Ab	Method,array and use thereof
US20130189268A1 (en)	2010-06-22	2013-07-25	Precision Biologics, Inc.	Colon and pancreas cancer specific antigens and antibodies
BR112013000985A2 (pt)	2010-07-15	2017-09-05	Technion Res & Dev Foundation	Entidades isoladas de alta afinidade com especificidade semelhante à do receptor de célula t em relação a complexos nativos de mhc classe ii e peptídeos autoantigênicos de descarboxilase do ácido glutâmico (gad)
CA2805478A1 (en)	2010-07-15	2012-01-19	Technion Research & Development Foundation Ltd.	Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
WO2012017208A1 (en)	2010-08-04	2012-02-09	Cizzle Biotechnology Limited	Methods and compounds for the diagnosis and treatment of
US20120101108A1 (en)	2010-08-06	2012-04-26	Cell Signaling Technology, Inc.	Anaplastic Lymphoma Kinase In Kidney Cancer
US8956859B1 (en)	2010-08-13	2015-02-17	Aviex Technologies Llc	Compositions and methods for determining successful immunization by one or more vaccines
WO2012021969A1 (en)	2010-08-16	2012-02-23	Mount Sinai Hospital	Markers of the male urogenital tract
EP3636778B1 (en)	2010-08-18	2022-01-12	Fred Hutchinson Cancer Research Center	Agents for use in treating facioscapulohumeral dystrophy (fshd)
US10088490B2 (en)	2010-08-20	2018-10-02	Siemens Healthcare Diagnostics Inc.	Assay for analytes using multiple receptors
CA2808975C (en)	2010-08-23	2018-10-30	Wyeth Llc	Stable formulations of neisseria meningitidis rlp2086 antigens
WO2012030738A2 (en)	2010-08-30	2012-03-08	Beckman Coulter, Inc.	Complex phosphoprotein activation profiles
US9982304B2 (en)	2010-09-03	2018-05-29	The Johns Hopkins University	ARID1A and PPP2R1A mutations in cancer
GB201014837D0 (en)	2010-09-07	2010-10-20	Immunovia Ab	Biomarker signatures and uses thereof
ES2864635T3 (es)	2010-09-10	2021-10-14	Wyeth Llc	Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
WO2012035518A1 (en)	2010-09-17	2012-03-22	Compugen Ltd.	Compositions and methods for treatment of drug resistant multiple myeloma
WO2012038744A2 (en)	2010-09-22	2012-03-29	Genome Research Limited	Detecting mutations
EP2622091B1 (en)	2010-09-23	2019-03-13	Precision Biologics, Inc.	Colon and pancreas cancer peptidomimetics
US8497138B2 (en)	2010-09-30	2013-07-30	Genetix Limited	Method for cell selection
US9006458B2 (en)	2010-10-12	2015-04-14	Agency For Science, Technology And Research	Surface Enhanced Raman Spectroscopy (SERS) compounds and methods of their preparation
EP2444084A1 (en)	2010-10-21	2012-04-25	Centro Nacional de Investigaciones Oncológicas (CNIO)	Use of PI3K inibitors for the treatment of obesity
WO2012054870A2 (en)	2010-10-21	2012-04-26	Vertex Pharmaceuticals Incorporated	Biomarkers for hcv infected patients
UY33679A (es)	2010-10-22	2012-03-30	Esbatech	Anticuerpos estables y solubles
GB201018014D0 (en)	2010-10-26	2010-12-08	Senzagen Ab	Analytical methods and arrays for use in the same
WO2012056455A1 (en)	2010-10-28	2012-05-03	Yeda Research And Development Co. Ltd.	Methods of generating antibodies to metalloenzymes
WO2012068355A2 (en)	2010-11-18	2012-05-24	Tufts Medical Center, Inc.	Treating aortic aneurysm by modulating toll-like receptors
CA2818813C (en)	2010-11-23	2020-10-06	Alder Biopharmaceuticals, Inc.	Anti-il-6 antibodies for the treatment of oral mucositis
CN103533958B (zh)	2010-11-23	2015-07-08	潘瑟里克公司	用于在广谱、未分化或混合临床应用中治疗的组合物和方法
WO2012099576A1 (en)	2011-01-18	2012-07-26	Baxter International Inc.	Measurement of anti-amyloid antibodies in human blood
EP2477032A1 (en)	2011-01-18	2012-07-18	Baxter International Inc	Measurement of anti-amyloid antibodies in human blood
TW201244737A (en)	2011-02-03	2012-11-16	Alexion Pharma Inc	Use of an anti-CD200 antibody for prolonging the survival of allografts
FR2971257B1 (fr)	2011-02-09	2020-12-04	Bio Rad Pasteur	Combinaison de biomarqueurs pour le pronostic d'une reponse ou non-reponse a un traitement anti-vhc
FR2971258B1 (fr)	2011-02-09	2020-12-04	Bio Rad Pasteur	Combinaison de biomarqueurs pour le pronostic d'une reponse ou non-reponse a un traitement anti-vhc
FR2971256B1 (fr)	2011-02-09	2024-09-27	Bio Rad Pasteur	Combinaison de biomarqueurs pour la detection et l'evaluation d'une fibrose hepatique
US20120263754A1 (en)	2011-02-15	2012-10-18	Immune Design Corp.	Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
CN102675460B (zh)	2011-02-28	2015-08-19	珠海市丽珠单抗生物技术有限公司	抗肿瘤坏死因子α的人源化抗体
US8658171B2 (en)	2011-02-28	2014-02-25	Livzon Mabpharm Inc.	Humanized anti-TNFα antibodies
AU2012223358A1 (en)	2011-03-01	2013-09-05	Amgen Inc.	Sclerostin and DKK-1 bispecific binding agents
GB201103726D0 (en)	2011-03-04	2011-04-20	Immunovia Ab	Method, array and use thereof
WO2012125623A2 (en)	2011-03-14	2012-09-20	Ludwig Institute For Cancer Research Ltd.	Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
TWI719112B (zh)	2011-03-16	2021-02-21	賽諾菲公司	雙重ｖ區類抗體蛋白質之用途
US9145457B2 (en)	2011-03-25	2015-09-29	Amgen Inc.	Sclerostin antibody crystals and formulations thereof
EP2694975A1 (en)	2011-04-08	2014-02-12	Biogen Idec MA Inc.	Biomarkers predictive of therapeutic responsiveness to ifnbeta and uses thereof
CA2832307A1 (en)	2011-04-08	2012-10-18	Immune Design Corp.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
WO2012142164A1 (en)	2011-04-12	2012-10-18	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
NZ713461A (en)	2011-04-15	2017-02-24	Compugen Ltd	Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
WO2012149320A1 (en)	2011-04-29	2012-11-01	Bristol-Myers Squibb Company	Ip-10 antibody dosage escalation regimens
MY161394A (en)	2011-05-06	2017-04-14	Nexvet Australia Pty Ltd	Anti-nerve growth factor antibodies and methods of preparing and using the same
SI3498732T1 (sl)	2011-05-06	2022-04-29	Zoetis Services Llc	Protitelesa proti živčnemu rastnemu faktorju ter postopki za pripravo in uporabo le-teh
CA2835094C (en)	2011-05-06	2020-12-22	David Gearing	Anti-nerve growth factor antibodies and methods of preparing and using the same
KR101833465B1 (ko)	2011-05-06	2018-02-28	넥스베트 오스트레일리아 피티와이 리미티드	항신경 성장 인자 항체 및 그의 제조방법과 이용방법
GB201114858D0 (en)	2011-08-29	2011-10-12	Nvip Pty Ltd	Anti-nerve growth factor antibodies and methods of using the same
WO2012156825A1 (en)	2011-05-17	2012-11-22	Genoscience Pharma	Peptide-based hiv pre-integration complex inhibitors
US9067997B2 (en)	2011-05-25	2015-06-30	Innate Pharma Sa	Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders
EP2715352B1 (en)	2011-05-31	2019-04-24	Biogen MA Inc.	Method of assessing risk of pml
JP6104897B2 (ja)	2011-06-02	2017-04-05	ダイアックスコーポレーション	Ｆｃレセプター結合タンパク質
CN103765212A (zh)	2011-06-27	2014-04-30	杰克逊实验室	治疗癌症和自体免疫性疾病的方法和组合物
CA2836855C (en)	2011-06-30	2020-07-14	Compugen Ltd.	Polypeptides and uses thereof for treatment of autoimmune disorders and infection
EP2734543B1 (en)	2011-07-24	2018-10-03	Carmel-Haifa University Economic Corp.	Lactoferrin fragments and use thereof
US20140223588A1 (en)	2011-07-27	2014-08-07	Bio-Rad Innovations	A2m fragments and applications thereof
KR20140041906A (ko)	2011-08-02	2014-04-04	화이자 인코포레이티드	암의 치료에 사용하기 위한 크리조티닙
EP2739975B1 (en)	2011-08-03	2015-06-17	Quidel Corporation	N-acetyl-d-glucosamine for enhanced specificity of strep a immunoassay
AU2012290083B2 (en)	2011-08-04	2017-07-20	Amgen Inc.	Method for treating bone gap defects
AU2012298884B2 (en)	2011-08-23	2017-11-16	Foundation Medicine, Inc.	Novel KIF5B-RET fusion molecules and uses thereof
AU2012300632A1 (en)	2011-08-30	2014-03-13	Nvip Pty Ltd	Caninised tumour necrosis factor antibodies and methods of using the same
JP6166263B2 (ja)	2011-09-22	2017-07-19	メディシナルバイオコンバージェンスリサーチセンター	ロイシンｔＲＮＡ合成酵素の新規用途（ＮｏｖｅｌｕｓｅｏｆｌｅｕｃｙｌｔＲＮＡｓｙｎｔｈｅｔａｓｅ）
WO2013045863A1 (fr)	2011-09-29	2013-04-04	Institut Pasteur	Detection de souches e.coli de serotype o104
EP2581384A1 (en)	2011-10-11	2013-04-17	Institut Pasteur	Products useful for the treatment of malignant neoplasms of the human nervous system
WO2013056178A2 (en)	2011-10-14	2013-04-18	Foundation Medicine, Inc.	Novel estrogen receptor mutations and uses thereof
WO2013055998A1 (en)	2011-10-14	2013-04-18	Genentech, Inc.	ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
WO2013057092A1 (en)	2011-10-17	2013-04-25	Westfaelische Wilhelms-Universitaet Muenster	Methods of risk assessment of pml and related apparatus
BR112014011127A2 (pt)	2011-11-10	2017-05-16	Genentech Inc	métodos para tratar, diagnosticar e monitorar doença de alzheimer
WO2013071066A1 (en)	2011-11-11	2013-05-16	The Broad Institute, Inc.	Signatures associated with the response to cancer therapy
BR112014010718B1 (pt)	2011-11-16	2020-12-22	Becton, Dickinson And Company	métodos, sistemas, dispositivos e kits para detecção de analito em amostra
US9554736B2 (en)	2011-11-29	2017-01-31	Teleflex Medical Incorporated	Device with integrated allergy testing
EP2786141B1 (en)	2011-11-29	2016-05-18	Teleflex Medical Incorporated	Device with integrated allergy testing
CA2857114A1 (en)	2011-11-30	2013-06-06	Genentech, Inc.	Erbb3 mutations in cancer
US9944985B2 (en)	2011-11-30	2018-04-17	Children's Hospital Medical Center	Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
JP2015500345A (ja)	2011-12-16	2015-01-05	トランスポサジェン・バイオファーマシューティカルズ・インコーポレイテッドＴｒａｎｓｐｏｓａｇｅｎＢｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	疼痛の治療または予防に使用されるｔｒｐｃ４調節因子
US9035039B2 (en)	2011-12-22	2015-05-19	Protiva Biotherapeutics, Inc.	Compositions and methods for silencing SMAD4
CN104039805B (zh)	2011-12-22	2016-11-16	糖模拟物有限公司	E-选择蛋白拮抗剂化合物、组合物及使用方法
AU2012362898B2 (en)	2011-12-28	2017-11-09	Amgen, Inc.	Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
CN104080480A (zh)	2012-01-01	2014-10-01	奇比艾企业有限公司	用于选择性递送治疗剂和诊断剂的endo180靶向微粒
PL2804878T3 (pl)	2012-01-20	2019-03-29	Genzyme Corporation	Przeciwciała anty-CXCR3
EP2807271B1 (en)	2012-01-24	2018-08-22	CD Diagnostics, Inc.	System for detecting infection in synovial fluid
BR112014018481A2 (pt)	2012-02-01	2017-07-04	Compugen Ltd	anticorpo monoclonal ou policlonal ou um fragmento de ligação a antígeno do mesmo, polinucleotídeo, anticorpo monoclonal, vetor, hibridoma, anticorpo, hibridoma 5166-2 e/ou 5166-9, anticorpo ou fragmento de ligação a antígeno, composição farmacêutica, uso do anticorpo ou fragmento de ligação a anticorpo, método para tratar câncer, método para diagnosticar câncer em um indivíduo, anticorpo, método, composição ou uso
IN2014MN01780A (it)	2012-02-09	2015-07-03	Memed Diagnostics Ltd
CN104321304A (zh)	2012-02-24	2015-01-28	普洛体维生物治疗公司	三烷基阳离子脂质及其使用方法
SA115360586B1 (ar)	2012-03-09	2017-04-12	فايزر انك	تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
KR101716557B1 (ko)	2012-03-09	2017-03-14	화이자 인코포레이티드	수막염균 조성물 및 이의 사용 방법
WO2013142796A2 (en)	2012-03-23	2013-09-26	Bristol-Myers Squibb Company	Methods of treatments using ctla4 antibodies
US9592289B2 (en)	2012-03-26	2017-03-14	Sanofi	Stable IgG4 based binding agent formulations
BR112014024023A2 (pt)	2012-03-28	2017-07-18	Genentech Inc	anticorpos idiotípicos anti-hcmv e usos dos mesmos
ES2529018T3 (es)	2012-04-02	2015-02-16	F. Hoffmann-La Roche Ag	Métodos y uso para la evaluación de la gravedad de la enfermedad pulmonar obstructiva crónica (EPOC)
US10130714B2 (en)	2012-04-14	2018-11-20	Academia Sinica	Enhanced anti-influenza agents conjugated with anti-inflammatory activity
PT2838998T (pt)	2012-04-18	2018-01-16	Cell Signaling Technology Inc	Egfr e ros1 cinase no cancro
US9156915B2 (en)	2012-04-26	2015-10-13	Thomas Jefferson University	Anti-GCC antibody molecules
GB201207297D0 (en)	2012-04-26	2012-06-06	Senzagen Ab	Analytical methods and arrays for use in the same
US20140315283A1 (en)	2012-05-09	2014-10-23	David A. Calderwood	Sample cartridge and sample stage
SG11201407402TA (en)	2012-05-11	2014-12-30	Reset Therapeutics Inc	Carbazole-containing sulfonamides as cryptochrome modulators
EP2855360B1 (en)	2012-05-31	2018-02-28	Agency For Science, Technology And Research	Surface enhanced raman spectroscopy (sers) marker conjugates and methods of their preparation
US10155987B2 (en)	2012-06-12	2018-12-18	Dana-Farber Cancer Institute, Inc.	Methods of predicting resistance to JAK inhibitor therapy
US9890215B2 (en)	2012-06-22	2018-02-13	King's College London	Vista modulators for diagnosis and treatment of cancer
TWI705073B (zh)	2012-06-22	2020-09-21	達特茅斯學院基金會	新穎之vista-ig構築體及vista-ig用於治療自體免疫、過敏及發炎病症之用途
EP2869844B2 (en)	2012-07-05	2023-06-21	UCB Pharma S.A.	Treatment for bone diseases
DE102012013888A1 (de)	2012-07-09	2014-05-22	Schebo Biotech Ag	Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
DE202012012084U1 (de)	2012-07-09	2013-04-15	Schebo Biotech Ag	Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
WO2014011908A1 (en)	2012-07-11	2014-01-16	Esperion Therapeutics, Inc.	Apolipoprotein mixtures
EP2687850A1 (en)	2012-07-19	2014-01-22	Roche Diagniostics GmbH	Methods of stratifying for respiratory support therapy
WO2014015217A1 (en)	2012-07-19	2014-01-23	Vertex Pharmaceuticals Incorporated	Biomarkers for hcv infected patients
WO2014018375A1 (en)	2012-07-23	2014-01-30	Xenon Pharmaceuticals Inc.	Cyp8b1 and uses thereof in therapeutic and diagnostic methods
KR20150038380A (ko)	2012-07-27	2015-04-08	백스터 인터내셔널 인코포레이티드	키메라 ospa 분자를 포함하는 조성물 및 이의 사용 방법
WO2014022830A2 (en)	2012-08-03	2014-02-06	Foundation Medicine, Inc.	Human papilloma virus as predictor of cancer prognosis
SG10201701165TA (en)	2012-08-14	2017-03-30	Univ Nanyang Tech	Angiopoietin-like 4 antibody and a method of its use in cancer treatment
EP2885426B1 (en)	2012-08-15	2020-10-07	The Procter and Gamble Company	Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
CA2880701A1 (en)	2012-08-18	2014-02-27	Academia Sinica	Cell-permeable probes for identification and imaging of sialidases
US20140056901A1 (en)	2012-08-21	2014-02-27	The Institute For Molecular Medicine	Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
AU2013312211B2 (en)	2012-09-07	2018-03-29	King's College London	VISTA modulators for diagnosis and treatment of cancer
WO2014037588A2 (en)	2012-09-10	2014-03-13	Westfaelische Wilhelms-Universitaet Muenster	Methods and compounds for preventing, treating and diagnosing an inflammatory condition
US10288626B2 (en)	2012-09-14	2019-05-14	University Of Kentucky Research Foundation	Secreted tumor-associated cytochrome as a blood-based biomarker for cancer
EP2895623B1 (en)	2012-09-17	2018-08-22	Agios Pharmaceuticals, Inc.	Use of e-cadherin and vimentin for selection of treatment responsive patients
US9671405B2 (en)	2012-09-19	2017-06-06	Cornell University	Identifying taxane sensitivity in prostate cancer patients
US11105809B2 (en)	2012-10-09	2021-08-31	Ramot At Tel-Aviv University Ltd.	Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
EP2911692B1 (en)	2012-10-26	2019-08-21	The University of Queensland	Use of endocytosis inhibitors and antibodies for cancer therapy
US20150299803A1 (en)	2012-11-05	2015-10-22	Pronai Therapeutics, Inc.	Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 Expression
EP2914621B1 (en)	2012-11-05	2023-06-07	Foundation Medicine, Inc.	Novel ntrk1 fusion molecules and uses thereof
UY35148A (es)	2012-11-21	2014-05-30	Amgen Inc	Immunoglobulinas heterodiméricas
MX369691B (es)	2012-11-21	2019-11-19	Agios Pharmaceuticals Inc	Inhibidores de glutaminasa y métodos de empleo.
WO2014079011A1 (en)	2012-11-22	2014-05-30	Agios Pharmaceuticals, Inc.	Heterocyclic compounds for inhibiting glutaminase and their methods of use
PL2928476T3 (pl)	2012-12-07	2018-07-31	Glycomimetics, Inc.	Związki, kompozycje i sposoby wykorzystujące antagonistów e-selektyny do mobilizacji komórek hematopoietycznych
GB201223053D0 (en)	2012-12-20	2013-02-06	Medical Res Council	Receptor
WO2014106176A1 (en)	2012-12-28	2014-07-03	Precision Biologics, Inc.	Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
JP6465812B2 (ja) *	2013-01-02	2019-02-06	キアゲン・サイエンシズ・エル・エル・シー	妊婦において分娩までの時間を予測するための方法
KR20150136047A (ko)	2013-01-09	2015-12-04	유니버시티 오브 마이애미	TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
WO2014113729A2 (en)	2013-01-18	2014-07-24	Foundation Mecicine, Inc.	Methods of treating cholangiocarcinoma
WO2014122166A1 (en)	2013-02-06	2014-08-14	Pieris Ag	Novel lipocalin-mutein assays for measuring hepcidin concentration
ES2685894T3 (es)	2013-03-08	2018-10-15	Pfizer Inc.	Polipéptidos de fusión inmunogénicos
US10545140B2 (en)	2013-03-14	2020-01-28	Kasaac Laboratories, Corp.	Test strip housing system
US9151747B1 (en)	2013-03-14	2015-10-06	Mercyhurst University	Sucralose antibody and immunoassay
US9302005B2 (en)	2013-03-14	2016-04-05	Mayo Foundation For Medical Education And Research	Methods and materials for treating cancer
US9052314B2 (en)	2013-03-14	2015-06-09	Silver Lake Research Corporation	Biomarkers for detecting the presence of bacteria
PT2970980T (pt)	2013-03-15	2018-11-19	Janssen Biotech Inc	Métodos de produção para controlor o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes
EP2968986A4 (en)	2013-03-15	2017-01-18	Velo Bio, LLC	Method for treating eclampsia and preeclampsia
CA2903968A1 (en)	2013-03-15	2014-09-18	Westfaelische Wilhelms-Universitaet Muenster	Detection of acute renal allograft rejection
WO2014153385A2 (en)	2013-03-21	2014-09-25	The Regents Of The University Of Michigan	Methods of treating metabolic disorders
GB201305940D0 (en)	2013-04-02	2013-05-15	Immunovia Ab	Methods and arrays for use in the same
GB201306147D0 (en)	2013-04-05	2013-05-22	Univ Ha Il	Novel biomarker signature and uses thereof
AR096203A1 (es)	2013-05-06	2015-12-16	Alnylam Pharmaceuticals Inc	Dosificaciones y métodos para administrar moléculas de ácido nucleico formuladas en lípidos
EP3004334A4 (en)	2013-05-28	2016-12-21	Biogen Ma Inc	METHOD FOR ASSESSING A PML RISK
CN105658206A (zh)	2013-06-03	2016-06-08	诺华股份有限公司	抗pd-l1抗体与mek抑制剂和/或braf抑制剂的组合
WO2014195899A1 (en) *	2013-06-06	2014-12-11	Koninklijke Philips N.V.	Reagents, methods and devices to prevent aggregation in particle based tests for the detection of multimeric target molecules
EP3013365B1 (en)	2013-06-26	2019-06-05	Academia Sinica	Rm2 antigens and use thereof
EP3013347B1 (en)	2013-06-27	2019-12-11	Academia Sinica	Glycan conjugates and use thereof
WO2015000014A1 (en)	2013-07-01	2015-01-08	Newsouth Innovations Pty Limited	Diagnosis and treatment of autoimmune diseases
WO2015009831A2 (en)	2013-07-17	2015-01-22	Foundation Medicine, Inc.	Methods of treating urothelial carcinomas
US9770461B2 (en)	2013-08-02	2017-09-26	California Institute Of Technology	Tailored glycopolymers as anticoagulant heparin mimetics
US10227370B2 (en)	2013-08-02	2019-03-12	California Institute Of Technology	Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
EP3042208A4 (en)	2013-09-06	2017-04-19	Theranos, Inc.	Systems and methods for detecting infectious diseases
EP3041484B1 (en)	2013-09-06	2021-03-03	Academia Sinica	Human inkt cell activation using glycolipids with altered glycosyl groups
CA2923129C (en)	2013-09-08	2020-06-09	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
EP3055695A1 (en)	2013-09-12	2016-08-17	Institut National de la Santé et de la Recherche Médicale	Method for in vitro quantifying allo-antibodies, auto-antibodies and/or therapeutic antibodies
SMT202300039T1 (it)	2013-09-13	2023-03-17	Beigene Switzerland Gmbh	Anticorpi anti-pd1 e loro uso come terapia e per diagnostica
SG11201601823TA (en)	2013-09-13	2016-04-28	Genentech Inc	Methods and compositions comprising purified recombinant polypeptides
ES2915378T3 (es)	2013-09-13	2022-06-22	Hoffmann La Roche	Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
WO2015050663A1 (en)	2013-10-01	2015-04-09	Mayo Foundation For Medical Education And Research	Methods for treating cancer in patients with elevated levels of bim
WO2015050959A1 (en)	2013-10-01	2015-04-09	Yale University	Anti-kit antibodies and methods of use thereof
EP3650023A1 (en)	2013-10-04	2020-05-13	Aptose Biosciences Inc.	Compositions for treating cancers
WO2015063604A2 (en)	2013-11-01	2015-05-07	Imberti Luisa	BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNβ AND USES THEREOF
GB201319878D0 (en)	2013-11-11	2013-12-25	Immunovia Ab	Method, Array and use thereof
ES2720728T3 (es)	2013-11-15	2019-07-24	Pasteur Institut	Un marcador molecular de Plasmodium falciparum de resistencia a artemisinina
WO2015078711A2 (en)	2013-11-18	2015-06-04	Westfaelische Wilhelms-Universitaet Muenster	Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition
NZ720311A (en)	2013-12-02	2022-10-28	Baylor College Medicine	Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose
US9309314B2 (en)	2013-12-03	2016-04-12	Agency For Science, Technology And Research (A*Star)	Polypeptides, nucleic acids and uses thereof
GB201322094D0 (en)	2013-12-13	2014-01-29	Electrophoretics Ltd	Methods and compositions relating to alzheimers disease
WO2015091653A2 (en)	2013-12-17	2015-06-25	Westfaelische Wilhelms-Universitaet Muenster	Means and methods for treating a pruritus-like skin-disease
EP2960252A1 (en)	2014-06-26	2015-12-30	Institut Pasteur	Phospholipase for treatment of immunosuppression
SG10201912797XA (en)	2013-12-24	2020-02-27	Janssen Pharmaceutica Nv	Anti-vista antibodies and fragments
US11014987B2 (en)	2013-12-24	2021-05-25	Janssen Pharmaceutics Nv	Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
US9944648B2 (en)	2014-01-09	2018-04-17	Intra-Cellular Therapies, Inc.	Organic compounds
CA2935903A1 (en)	2014-01-09	2015-07-16	Hadasit Medical Research Services And Development Ltd.	Improved cell compositions and methods for cancer therapy
TW201620939A (zh)	2014-01-16	2016-06-16	中央研究院	治療及檢測癌症之組合物及方法
US10150818B2 (en)	2014-01-16	2018-12-11	Academia Sinica	Compositions and methods for treatment and detection of cancers
ES2803217T3 (es)	2014-01-17	2021-01-25	Minomic Int Ltd	Antígeno de superficie de células de cáncer de próstata para el diagnóstico
CR20160369A (es)	2014-01-21	2016-10-05	Immune Desing Corp	Composiciones para uso en el tratamiento de afecciones alérgicas
EP3542816A1 (en)	2014-02-14	2019-09-25	Immune Design Corp.	Immunotherapy of cancer through combination of local and systemic immune stimulation
GB201403115D0 (en)	2014-02-21	2014-04-09	Qbd Qs Ip Ltd	Red blood cell detection
CN106460042A (zh)	2014-02-24	2017-02-22	儿童医院医学中心	用于个性化疼痛管理的方法与组合物
ES2818823T3 (es)	2014-02-27	2021-04-14	Biogen Ma Inc	Método de evaluación del riesgo de LMP
MX2016012244A (es)	2014-03-21	2017-05-08	Agios Pharmaceuticals Inc	Compuestos y sus metodos de uso.
EP3129767B1 (en)	2014-03-27	2021-09-01	Academia Sinica	Reactive labelling compounds and uses thereof
BR112016022620A2 (pt)	2014-03-31	2017-10-10	Debiopharm Int Sa	cdna que codifica um polipeptídeo de fusão, vetor, célula procariotica ou eucariotica, sequência polinucleotídica, polipeptídeo de fusão, anticorpo ou fragmento de ligação, par de primers, sonda oligonucleotídica, oligonucleotídeo, sirna dirigido a um rna mensageiro, inibidor da atividade quinase fgfr, método de terapia e método para identificar um composto
EP3126846A4 (en)	2014-04-02	2017-08-30	Crescendo Bioscience	Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
TWI690521B (zh)	2014-04-07	2020-04-11	美商同步製藥公司	作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
US9176113B1 (en)	2014-04-11	2015-11-03	Synapdx Corporation	Methods and systems for determining autism spectrum disorder risk
EP3134439B1 (en)	2014-04-21	2018-12-26	Millennium Pharmaceuticals, Inc.	Anti-psyk antibody molecules and use of same for syk-targeted therapy
EP2942627A1 (en)	2014-05-05	2015-11-11	MicroBPlex, Inc.	Media elaborated with newly synthesized antibodies (mensa) from recently proliferated antibody secreting cells (asc) and uses thereof
WO2015169884A2 (en)	2014-05-07	2015-11-12	Westfaelische Wilhelms-Universitaet Muenster	Compounds and methods for the treatment of itch
WO2015172083A1 (en)	2014-05-08	2015-11-12	Biogen Ma Inc.	Dimethylfumarate and prodrugs for treatment of multiple sclerosis
US20170269075A1 (en)	2014-05-12	2017-09-21	Biogen Ma Inc.	Biomarkers predictive of lupus progression and uses thereof
ES2851451T3 (es)	2014-05-13	2021-09-07	Bavarian Nordic As	Terapia de combinación para tratar cáncer con un poxvirus que expresa un antígeno de tumor y un anticuerpo monoclonal contra TIM-3
US10302653B2 (en)	2014-05-22	2019-05-28	Mayo Foundation For Medical Education And Research	Distinguishing antagonistic and agonistic anti B7-H1 antibodies
US10118969B2 (en)	2014-05-27	2018-11-06	Academia Sinica	Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102512592B1 (ko)	2014-05-27	2023-03-21	아카데미아 시니카	항-ｈｅｒ2 글리코항체 및 이의 용도
JP7093612B2 (ja)	2014-05-27	2022-06-30	アカデミアシニカ	Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法
KR20170003720A (ko)	2014-05-27	2017-01-09	아카데미아 시니카	항-ｃｄ20 글리코항체 및 이의 용도
KR102494193B1 (ko)	2014-05-28	2023-01-31	아카데미아 시니카	항-ｔｎｆ-알파 글리코항체 및 이의 용도
GB201410226D0 (en)	2014-06-09	2014-07-23	Immunovia Ab	Methods and arrays for use in the same
EP3155439A4 (en)	2014-06-10	2018-03-14	Crescendo Bioscience	Biomarkers and methods for measuring and monitoring axial spondyloarthritis disease activity
MX2016016310A (es)	2014-06-11	2017-10-20	A Green Kathy	Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
AU2015278659A1 (en)	2014-06-25	2017-02-02	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Identification of cancer stem cell markers and use of same for diagnosis and treatment
FR3023003B1 (fr)	2014-06-27	2016-07-15	Bio-Rad Innovations	Combinaison synergique de biomarqueurs pour la detection et l'evaluation d'une fibrose hepatique
MX2017000630A (es)	2014-07-15	2017-04-27	Immune Design Corp	Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral.
EP3171896A4 (en)	2014-07-23	2018-03-21	Mayo Foundation for Medical Education and Research	Targeting dna-pkcs and b7-h1 to treat cancer
US10752668B2 (en)	2014-07-25	2020-08-25	Theravectys	Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
EP3177738B1 (en)	2014-08-08	2019-10-09	Children's Hospital Medical Center	Diagnostic method for distinguishing forms of esophageal eosinophilia
CA2954601C (en)	2014-08-14	2023-04-18	Memed Diagnostics Ltd.	Computational analysis of biological data using manifold and a hyperplane
WO2016026978A1 (en)	2014-08-22	2016-02-25	Universite Nice Sophia Antipolis	Methods and pharmaceutical compositions for treating drug addiction
EP3191500A4 (en)	2014-09-08	2018-04-11	Academia Sinica	HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10184154B2 (en)	2014-09-26	2019-01-22	Mayo Foundation For Medical Education And Research	Detecting cholangiocarcinoma
US9688750B2 (en)	2014-10-07	2017-06-27	Ann And Robert H. Lurie Children's Hospital Of Chicago	Anti-nodal antibodies and methods of using same
EP3204777B1 (en)	2014-10-08	2024-06-12	Novartis AG	Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof
DE102015220401B4 (de)	2014-10-20	2022-12-29	Gen-Probe Incorporated	Erythrozyten-Lyselösung
US9815886B2 (en)	2014-10-28	2017-11-14	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
JP6788586B2 (ja)	2014-11-19	2020-11-25	コーニンクレッカフィリップスエヌヴェＫｏｎｉｎｋｌｉｊｋｅＰｈｉｌｉｐｓＮ．Ｖ．	Ｈｎｌを用いる診断方法
CN107405398A (zh)	2014-12-05	2017-11-28	伊穆奈克斯特股份有限公司	鉴定vsig8作为推定vista受体及其用以产生vista/vsig8激动剂和拮抗剂的用途
US20170269081A1 (en)	2014-12-11	2017-09-21	Memed Diagnostics Ltd.	Marker combinations for diagnosing infections and methods of use thereof
MA41142A (fr)	2014-12-12	2017-10-17	Amgen Inc	Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
US10495645B2 (en)	2015-01-16	2019-12-03	Academia Sinica	Cancer markers and methods of use thereof
US9975965B2 (en)	2015-01-16	2018-05-22	Academia Sinica	Compositions and methods for treatment and detection of cancers
TWI736523B (zh)	2015-01-24	2021-08-21	中央研究院	新穎聚醣結合物及其使用方法
CN107407677B (zh)	2015-01-28	2020-07-17	豪夫迈·罗氏有限公司	多发性硬化的基因表达标志和治疗
MX2017010705A (es)	2015-02-19	2017-12-04	Pfizer	Composiciones de neisseria meningitidis y metodos de la misma.
EP3636749B1 (en)	2015-03-06	2022-04-27	F. Hoffmann-La Roche AG	Ultrapurified dsbc and methods of making and using the same
GB201504432D0 (en)	2015-03-17	2015-04-29	Electrophoretics Ltd	Materials and methods for diagnosis and treatment of alzheimers disease
WO2016149537A1 (en)	2015-03-17	2016-09-22	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
US11279768B1 (en)	2015-04-03	2022-03-22	Precision Biologics, Inc.	Anti-cancer antibodies, combination therapies, and uses thereof
US9758575B2 (en)	2015-04-06	2017-09-12	Yung Shin Pharmaceutical Industrial Co. Ltd.	Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
EP3285811A1 (en)	2015-04-21	2018-02-28	Institut Gustave Roussy	Therapeutic methods, products and compositions inhibiting znf555
EP3292148B1 (en)	2015-05-04	2024-01-24	Pieris Pharmaceuticals GmbH	Anti-cancer fusion polypeptide
EP3292411A1 (en)	2015-05-04	2018-03-14	Westfälische Wilhelms-Universität Münster	Means and methods for diagnosing and treating inflammatory disorders
EP3294280A1 (en)	2015-05-11	2018-03-21	Yeda Research and Development Co., Ltd.	Citrin inhibitors for the treatment of cancer
EP3298038B1 (en)	2015-05-22	2021-08-04	Huahui Health Ltd.	Anti-pre-s1 hbv antibodies
NL2014935B1 (en)	2015-06-08	2017-02-03	Applied Immune Tech Ltd	T cell receptor like antibodies having fine specificity.
CN107922497B (zh)	2015-06-24	2022-04-12	詹森药业有限公司	抗vista抗体和片段
DK3341725T3 (da)	2015-08-25	2021-09-06	Prothena Biosciences Ltd	Fremgangsmåder til detektering af phosphoryleret alpha-synuklein
JP6914919B2 (ja)	2015-08-28	2021-08-04	ジェネンテック，インコーポレイテッド	抗ヒプシン抗体及びその使用
JP6905163B2 (ja)	2015-09-03	2021-07-21	ザトラスティーズオブザユニバーシティオブペンシルバニア	サイトカイン放出症候群を予測するバイオマーカー
GB201516801D0 (en)	2015-09-22	2015-11-04	Immunovia Ab	Method, array and use thereof
JP6959912B2 (ja)	2015-09-23	2021-11-05	ジェネンテック，インコーポレイテッド	抗ｖｅｇｆ抗体の最適化変異体
JP6830105B2 (ja)	2015-09-29	2021-02-17	クレッシェンドバイオサイエンスインコーポレイテッド	乾癬性関節炎の疾患活動性を評価するためのバイオマーカーおよび方法
WO2017058999A2 (en)	2015-09-29	2017-04-06	Crescendo Bioscience	Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
JP2018529729A (ja)	2015-10-01	2018-10-11	アムジエン・インコーポレーテツド	胆汁酸障害の処置
EP3362180B1 (en)	2015-10-15	2020-06-17	Inbios International Inc.	Multiplexed lateral flow assay systems and methods for their use
EP3998353A1 (en)	2015-10-30	2022-05-18	Exact Sciences Corporation	Multiplex amplification detection assay and isolation and detection of dna from plasma
WO2017075045A2 (en)	2015-10-30	2017-05-04	Mayo Foundation For Medical Education And Research	Antibodies to b7-h1
SG11201803356SA (en)	2015-10-30	2018-05-30	Genentech Inc	Anti-htra1 antibodies and methods of use thereof
EP3370724A2 (en)	2015-11-03	2018-09-12	GlycoMimetics, Inc.	Antibodies for targeting cancer stem cells and treating aggressive cancers
JP2019503985A (ja)	2015-11-03	2019-02-14	グリコミメティクス，インコーポレイテッド	モノクローナル抗体、造血幹細胞の産生のための方法および組成物、ならびにそれらを使用する方法
GB201520258D0 (en)	2015-11-17	2015-12-30	Academisch Ziekenhuis Leiden	Modulation of ciliogenesis
EP3391048B1 (en)	2015-12-15	2021-07-07	Case Western Reserve University	Oral squamous cell carcinoma evaluation using beta defensin
WO2017123401A1 (en)	2016-01-13	2017-07-20	Children's Hospital Medical Center	Compositions and methods for treating allergic inflammatory conditions
EP3410849B1 (en)	2016-02-05	2023-07-05	Institut Pasteur	Use of inhibitors of adam12 as adjuvants in tumor therapies
WO2017137830A1 (en)	2016-02-12	2017-08-17	Janssen Pharmaceutica Nv	Anti-vista (b7h5) antibodies
EP3423488A4 (en)	2016-02-29	2019-11-06	Foundation Medicine, Inc.	METHOD FOR THE TREATMENT OF CANCER
CN109195996A (zh)	2016-03-08	2019-01-11	中央研究院	N-聚醣及其阵列的模组化合成方法
GB201604124D0 (en)	2016-03-10	2016-04-27	Ucb Biopharma Sprl	Pharmaceutical formulation
CA3018066A1 (en)	2016-03-18	2017-09-21	Caris Science, Inc.	Oligonucleotide probes and uses thereof
GB201700138D0 (en)	2017-01-05	2017-02-22	Senzagen Ab	Analytical methods and arrays for use in the same
ES2745580T3 (es)	2016-03-23	2020-03-02	Senzagen Ab	Procedimientos de análisis y matrices para su uso en los mismos
WO2017175058A1 (en)	2016-04-07	2017-10-12	Janssen Pharmaceutica Nv	Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
UA125382C2 (uk)	2016-04-15	2022-03-02	Імьюнекст Інк.	Антитіла проти людського vista та їх застосування
EP3446127A4 (en)	2016-04-20	2020-01-22	Crescendo Bioscience, Inc.	BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE TREATMENT
EP3736332B1 (en)	2016-04-27	2025-02-12	Gen-Probe Incorporated	Blood cell lysis reagent
GB201608192D0 (en)	2016-05-10	2016-06-22	Immunovia Ab	Method, array and use thereof
AU2017271579B2 (en)	2016-05-25	2023-10-19	Caris Science, Inc.	Oligonucleotide probes and uses thereof
GB201609950D0 (en)	2016-06-07	2016-07-20	Immunovia Ab	Biomarkers signatures and uses thereof
GB201609951D0 (en)	2016-06-07	2016-07-20	Immunovia Ab	Biomarkers signatures and uses thereof
EP3264087B1 (en)	2016-06-27	2020-04-22	Chimera Biotec GmbH	Method and device for quantification of target molecules
WO2018001932A1 (en)	2016-06-30	2018-01-04	Koninklijke Philips N.V.	Device, system and method for detecting an analyte in a body fluid sample containing a plurality of cells
US11340223B2 (en)	2016-07-10	2022-05-24	Memed Diagnostics Ltd.	Early diagnosis of infections
CA3027341A1 (en)	2016-07-10	2018-01-18	Memed Diagnostics Ltd.	Protein signatures for distinguishing between bacterial and viral infections
EP3482202A4 (en)	2016-07-11	2020-03-18	Arizona Board of Regents on behalf of Arizona State University	USE OF SWEAT AS A BIOFLUID FOR THE ANALYSIS AND IDENTIFICATION OF DISEASES
US12168805B2 (en)	2016-08-10	2024-12-17	Institut Pasteur	Methods and reagents for detecting piperaquine-resistant plasmodium falciparum malaria
WO2018029690A1 (en)	2016-08-10	2018-02-15	Memed Diagnostics Ltd.	System and method for analysis of biological data
PT3500299T (pt)	2016-08-19	2024-02-21	Beigene Switzerland Gmbh	Combinação de zanubrutinib com um anticorpo anti-cd20 ou anti-pd-1 para utilização no tratamento do cancro
JP7213549B2 (ja)	2016-08-22	2023-01-27	シーエイチオーファーマインコーポレイテッド	抗体、結合性断片、および使用の方法
US11203637B2 (en)	2016-08-26	2021-12-21	Beigene, Ltd.	Anti-Tim-3 antibodies and use thereof
WO2018045162A1 (en)	2016-09-01	2018-03-08	Biogen Ma Inc.	Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
JP2020501506A (ja)	2016-09-07	2020-01-23	イッサムリサーチデベロップメントカンパニーオブザヘブリューユニバーシティーオブエルサレムエルティーディー．	抗ＮＫｐ４６抗体およびその治療的使用
WO2018075408A1 (en)	2016-10-17	2018-04-26	Alexion Pharmaceuticals, Inc.	Methods of treating acute myeloid leukemia (aml) with combinations of anti-cd200 antibodies, cytarabine, and daunorubicin
CN110366558A (zh)	2016-10-28	2019-10-22	班扬生物标记公司	针对泛素c末端水解酶l1(uch-l1)和胶质纤维酸性蛋白(gfap)的抗体及相关方法
US20180128545A1 (en)	2016-11-08	2018-05-10	Berry Metal Company	Modular furnace cooling wall
WO2018102594A1 (en)	2016-12-01	2018-06-07	Alexion Pharmaceuticals, Inc.	Methods of treating solid tumors with anti-cd200 antibodies
US10935555B2 (en)	2016-12-22	2021-03-02	Qiagen Sciences, Llc	Determining candidate for induction of labor
US10656164B2 (en)	2016-12-22	2020-05-19	Qiagen Sciences, Llc	Screening asymptomatic pregnant woman for preterm birth
MX2019008348A (es)	2017-01-18	2019-10-21	Genentech Inc	Anticuerpos idiotipo contra anticuerpos anti-pd-l1 y usos de estos solicitudes relacionadas.
EP3571309A4 (en)	2017-01-20	2020-11-25	Children's Hospital Medical Center	METHODS AND COMPOSITIONS RELATED TO THE METHYLATION OF OPRM1 DNA TO MANAGE PAIN IN PEOPLE
AU2018211956B2 (en)	2017-01-27	2024-06-20	Exact Sciences Corporation	Detection of colon neoplasia by analysis of methylated DNA
KR102567845B1 (ko)	2017-01-31	2023-08-17	화이자 인코포레이티드	네이세리아 메닌기티디스 조성물 및 그의 방법
GB201701572D0 (en)	2017-01-31	2017-03-15	Immunovia Ab	Methods, arrays and uses thereof
WO2018148180A2 (en)	2017-02-07	2018-08-16	Immune Design Corp.	Materials and methods for identifying and treating cancer patients
US11061026B2 (en)	2017-02-17	2021-07-13	MFB Fertility, Inc.	System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN110536969A (zh)	2017-04-24	2019-12-03	豪夫迈·罗氏有限公司	跨膜或近膜域中的erbb2/her2突变
GB201706464D0 (en)	2017-04-24	2017-06-07	Senzagen Ab	Analytical methods and arrays for use in the same
US20210156844A1 (en)	2017-05-02	2021-05-27	Bayer Aktiengesellschaft	TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)
WO2018209126A1 (en)	2017-05-10	2018-11-15	Rowan University	Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis
EP3682240B1 (en)	2017-09-14	2024-01-24	Laboratory Corporation of America Holdings	Assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
GB201715445D0 (en)	2017-09-25	2017-11-08	Senzagen Ab	Novel cell line and uses thereof
US20200225244A1 (en)	2017-09-26	2020-07-16	Sanford Burnham Prebys Medical Discovery Institute	Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
US11761963B2 (en)	2017-09-27	2023-09-19	Alexion Pharmaceuticals, Inc.	Biomarker signature for predicting tumor response to anti-CD200 therapy
US20200331975A1 (en)	2017-10-20	2020-10-22	Institut Curie	Dap10/12 based cars adapted for rush
WO2019086331A2 (en)	2017-11-02	2019-05-09	Bayer Aktiengesellschaft	Bispecific antibodies binding alk-1 and bmpr-2
US11591385B2 (en)	2017-11-09	2023-02-28	Pinteon Therapeutics Inc.	Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
US10648025B2 (en)	2017-12-13	2020-05-12	Exact Sciences Development Company, Llc	Multiplex amplification detection assay II
WO2019126536A1 (en)	2017-12-20	2019-06-27	Alexion Pharmaceuticals Inc.	Humanized anti-cd200 antibodies and uses thereof
WO2019126133A1 (en)	2017-12-20	2019-06-27	Alexion Pharmaceuticals, Inc.	Liquid formulations of anti-cd200 antibodies
US20200384118A1 (en)	2017-12-21	2020-12-10	Friedrich-Alexander-Universitat Erlangen-Nurnberg	Immunotoxin conjugates for use in therapy
TW202400654A (zh)	2017-12-30	2024-01-01	英屬開曼群島商百濟神州有限公司	抗tigit抗體及其作為治療和診斷的用途
SG11202005323SA (en)	2018-01-12	2020-07-29	Bristol Myers Squibb Co	Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer
EP3752252A4 (en)	2018-02-12	2021-11-17	Hadasit Medical Research Services and Development Ltd.	MODULATION OF SLAMF6 SPLICE VARIANTS FOR CANCER TREATMENT
US11859250B1 (en)	2018-02-23	2024-01-02	Children's Hospital Medical Center	Methods for treating eosinophilic esophagitis
EP3530282A1 (en)	2018-02-27	2019-08-28	Diaccurate	Therapeutic methods
JP7331000B2 (ja)	2018-03-26	2023-08-22	アレクシオンファーマシューティカルズ，インコーポレイテッド	補体ｃ３転換酵素のプロテアーゼ活性を測定するためのスループットの高い方法
WO2019191534A1 (en)	2018-03-30	2019-10-03	Amgen Inc.	C-terminal antibody variants
CN112334485B (zh)	2018-04-06	2024-09-27	百进生物科技公司	抗-四次穿膜蛋白33药剂及其组合物以及制备和使用方法
WO2019237119A1 (en)	2018-06-08	2019-12-12	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	New compositions and detection methods for onchocerca volvulus infection
CN113164563A (zh)	2018-07-23	2021-07-23	因柯利尔疗法公司	神经性病症的治疗方法
WO2020023418A1 (en)	2018-07-23	2020-01-30	Enclear Therapies, Inc.	Methods of treating neurological disorders
US12181465B2 (en)	2018-08-22	2024-12-31	MFB Fertility, Inc.	Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
WO2020043693A1 (en)	2018-08-29	2020-03-05	Westfälische Wilhelms-Universität Münster	Diagnosis of multiple sclerosis
CA3113676A1 (en)	2018-09-21	2020-03-26	President And Fellows Of Harvard College	Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins
WO2020068557A1 (en)	2018-09-25	2020-04-02	BioLegend, Inc.	Anti-tlr9 agents and compositions and methods for making and using the same
DE102018124022A1 (de)	2018-09-28	2020-04-02	Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen	Hyaluronsäurestabilisator
WO2020070303A1 (en)	2018-10-05	2020-04-09	Bavarian Nordic A/S	Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an immune checkpoint antagonist or agonist
US11674961B2 (en)	2018-10-12	2023-06-13	Quidel Corporation	Extraction reagent for use in an assay for detection of group A Streptococcus
WO2020081493A1 (en)	2018-10-16	2020-04-23	Molecular Templates, Inc.	Pd-l1 binding proteins
EP3883599A1 (en)	2018-11-20	2021-09-29	Bavarian Nordic A/S	Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l
EP3888021B1 (en)	2018-11-30	2024-02-21	Caris MPI, Inc.	Next-generation molecular profiling
WO2020118011A1 (en)	2018-12-06	2020-06-11	Alexion Pharmaceuticals, Inc.	Anti-alk2 antibodies and uses thereof
CA3123717A1 (en)	2019-01-03	2020-07-09	Senzagen Ab	Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method
WO2020160322A1 (en)	2019-01-30	2020-08-06	Horizon Pharma Rheumatology Llc	Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)
SG11202107720UA (en)	2019-01-31	2021-08-30	Agency Science Tech & Res	Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
EP3693063A1 (en)	2019-02-06	2020-08-12	Diaccurate	Methods and compositions for treating cancer
IL264768A (en)	2019-02-10	2020-08-31	Sagi Irit	ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
AU2020223293A1 (en)	2019-02-15	2021-08-19	Integral Molecular, Inc.	Claudin 6 antibodies and uses thereof
CA3129317A1 (en)	2019-02-15	2020-08-20	Integral Molecular, Inc.	Antibodies comprising a common light chain and uses thereof
WO2020176637A1 (en)	2019-02-26	2020-09-03	Pantheryx, Inc.	Compositions for management of disorders of the gastrointestinal tract
EP3938400A4 (en)	2019-03-11	2022-11-23	Memorial Sloan Kettering Cancer Center	Cd22 antibodies and methods of using the same
GB201904472D0 (en)	2019-03-29	2019-05-15	Immunovia Ab	Methods, arrays and uses thereof
WO2020210634A1 (en)	2019-04-11	2020-10-15	Enclear Therapies, Inc.	Methods of amelioration of cerebrospinal fluid and devices and systems therefor
WO2020237491A1 (en)	2019-05-28	2020-12-03	Shanghaitech University	Composition and methods to treat ectodermal dysplasia 2, clouston type
WO2020261281A1 (en)	2019-06-27	2020-12-30	Ramot At Tel-Aviv University Ltd.	Semaphorin 3a antibodies and uses thereof
CN112415184A (zh)	2019-08-22	2021-02-26	香港科技大学	用于细胞群体和单细胞的单分子分离系统及其方法和用途
EP4058477A2 (en)	2019-11-11	2022-09-21	IBI-AG Innovative Bio Insecticides Ltd.	Insect control nanobodies and uses thereof
CN114867491A (zh)	2019-11-20	2022-08-05	巴法里安诺迪克有限公司	用于肿瘤内和/或静脉内施用以治疗癌症的重组mva病毒
KR20220130108A (ko)	2019-12-02	2022-09-26	캐리스 엠피아이, 아이엔씨.	범-암 백금 반응 예측기
CN115298213A (zh)	2019-12-19	2022-11-04	奎多公司	单克隆抗体融合
WO2021146383A1 (en)	2020-01-17	2021-07-22	BioLegend, Inc.	Anti-tlr7 agents and compositions and methods for making and using the same
EP4484956A2 (en)	2020-01-29	2025-01-01	MeMed Diagnostics Ltd.	Methods of diagnosing and classifying viral infections
EP4121018A4 (en)	2020-03-17	2024-07-03	Genevant Sciences Gmbh	CATIONIC LIPIDS FOR LIPID DNANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLA CELLS
US20210311054A1 (en)	2020-04-01	2021-10-07	Institut Pasteur	Severe acute respiratory syndrome (sars) - associated coronavirus diagnostics
US11815513B2 (en)	2020-04-01	2023-11-14	Institut Pasteur	Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics
WO2021209824A1 (en)	2020-04-17	2021-10-21	Institut Pasteur	Methods and products for serological analysis of sars-cov-2 infection
BR112022022021A2 (pt)	2020-04-30	2022-12-13	Genentech Inc	Anticorpos, ácido(s) nucleico(s), vetor, célula hospedeira, processo para produzir um anticorpo, métodos para rastrear um anticorpo, detectar kras-gdp, obter um inibidor, detectar a alquilação de kras, tratar um câncer, rastrear compostos, medir a ligação de uma proteína e medir o engajamento do alvo de um inibidor, kit, chaperona de cristalização, método de cristalização e superfície de biossensor
WO2021239666A1 (en)	2020-05-26	2021-12-02	Diaccurate	Therapeutic methods
WO2021247457A2 (en)	2020-06-01	2021-12-09	Genentech, Inc.	Methods for making extracellular vesicles and uses thereof
TW202216771A (zh)	2020-06-26	2022-05-01	德商拜耳廠股份有限公司	用於治療應用之ccr8抗體
WO2022008976A1 (en)	2020-07-10	2022-01-13	Institut Pasteur	Use of gdf11 to diagnose and treat anxiety and depression
GB202010970D0 (en)	2020-07-16	2020-09-02	Immunovia Ab	Methods, arrays and uses thereof
WO2022058621A1 (en)	2020-09-21	2022-03-24	Theravectys	High throughput methods and products for sars-cov-2 sero-neutralization assay
WO2022093640A1 (en)	2020-10-30	2022-05-05	BioLegend, Inc.	Anti-nkg2c agents and compositions and methods for making and using the same
WO2022093641A1 (en)	2020-10-30	2022-05-05	BioLegend, Inc.	Anti-nkg2a agents and compositions and methods for making and using the same
KR20230122081A (ko)	2020-12-18	2023-08-22	제네반트 사이언시즈 게엠베하	Peg 지질 및 지질 나노입자
KR20230135107A (ko)	2021-01-22	2023-09-22	바이엘 악티엔게젤샤프트	Lrrc15 항체 및 그의 접합체
EP4046652A1 (en)	2021-02-23	2022-08-24	Johann Wolfgang Goethe-Universität Frankfurt	Compositions and methods for diagnosing, treating and preventing carrion's disease
CN117157317A (zh)	2021-02-26	2023-12-01	拜耳公司	用于治疗异常子宫出血的IL-11或IL-11Ra的抑制剂
GB202104422D0 (en)	2021-03-29	2021-05-12	Orre Lukas	Methods
WO2022207748A1 (en)	2021-03-30	2022-10-06	Westfälische Wilhelms-Universität Münster	Classification of neurological or psychiatric disease manifestations using multi-dimensional cerebrospinal fluid analysis
EP4070814A1 (en)	2021-04-07	2022-10-12	Lama France	Sars-cov-2 polypeptides and uses thereof
AR125344A1 (es)	2021-04-15	2023-07-05	Chugai Pharmaceutical Co Ltd	Anticuerpo anti-c1s
EP4452305A1 (en)	2021-12-23	2024-10-30	Bavarian Nordic A/S	Recombinant mva viruses for intraperitoneal administration for treating cancer
CN118922401A (zh)	2022-01-31	2024-11-08	盖纳万科学有限公司	用于脂质纳米颗粒的可电离阳离子脂质
WO2023192478A1 (en)	2022-04-01	2023-10-05	Bristol-Myers Squibb Company	Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer
WO2023223092A1 (en)	2022-05-18	2023-11-23	Institut Pasteur	Identification of a human circovirus
WO2024020051A1 (en)	2022-07-19	2024-01-25	BioLegend, Inc.	Anti-cd157 antibodies, antigen-binding fragments thereof and compositions and methods for making and using the same
WO2024040114A2 (en)	2022-08-18	2024-02-22	BioLegend, Inc.	Anti-axl antibodies, antigen-binding fragments thereof and methods for making and using the same
WO2024044675A1 (en)	2022-08-25	2024-02-29	Beigene, Ltd.	Methods of cancer treatment using anti-pd1 antibodies in combination with anti-tim3 antibodies
WO2024052517A2 (en)	2022-09-09	2024-03-14	Bayer Aktiengesellschaft	Medical use of ccr8 antibodies and dosing schedule
WO2024052922A1 (en)	2022-09-11	2024-03-14	Yeda Research And Development Co. Ltd.	Anti-klk4 antibodies and uses thereof
WO2024110905A1 (en)	2022-11-24	2024-05-30	Beigene, Ltd.	Anti-cea antibody drug conjugates and methods of use
WO2024118771A1 (en)	2022-11-30	2024-06-06	Integral Molecular, Inc.	Antibodies directed to claudin 6, including bispecific formats thereof
EP4379375A1 (en)	2022-12-01	2024-06-05	Universität Münster	Classification of connective tissue disease with neurological manifestation using multi-dimensional peripheral blood analysis
WO2024149703A1 (en)	2023-01-09	2024-07-18	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Diagnosis of alzheimer disease
WO2024153168A2 (en)	2023-01-19	2024-07-25	Beigene, Ltd.	Anti-cmet antibodies and methods of use
WO2024165468A1 (en)	2023-02-06	2024-08-15	Bayer Aktiengesellschaft	Combination of ccr8 antibodies with dgk inhibitors in the treatment of cancer
TW202436343A (zh)	2023-03-03	2024-09-16	瑞士商百濟神州瑞士有限責任公司	Muc1與cd16a抗體以及其使用方法
WO2024183636A1 (en)	2023-03-03	2024-09-12	Beigene Switzerland Gmbh	Cd16a antibodies and methods of use
WO2024183637A1 (en)	2023-03-03	2024-09-12	Beigene Switzerland Gmbh	Muc1 antibodies and methods of use
WO2024184811A1 (en)	2023-03-06	2024-09-12	Beigene Switzerland Gmbh	Anti-cd3 multispecific antibodies and methods of use
WO2024184810A1 (en)	2023-03-06	2024-09-12	Beigene Switzerland Gmbh	Anti-cldn6 and anti-cd3 multispecific antibodies and methods of use
WO2024184812A1 (en)	2023-03-06	2024-09-12	Beigene Switzerland Gmbh	Anti-cldn6 antibodies and methods of use
WO2024200655A1 (en)	2023-03-28	2024-10-03	Westfälische Wilhelms-Universität Münster	Predictive level of pd-l1 on microvesicles in the evaluation whether being a responder to a treatment of nsclc
WO2024243217A1 (en)	2023-05-25	2024-11-28	BioLegend, Inc.	Ceacam6 binding antibodies and antigen-binding fragments thereof
GB2630774A (en)	2023-06-07	2024-12-11	Curenetics Ltd	Lung cancer biomarkers
WO2024261762A2 (en)	2023-06-21	2024-12-26	Metasight Diagnostics Ltd	Liver fibrosis, nash and "at-risk" nash biomarkers and methods
WO2025008404A1 (en)	2023-07-04	2025-01-09	Universitaet Regensburg In Vertretung Des Freistaates Bayern	Use of soluble cd46 concentration from peripheral blood as a parameter for the diagnosis of non-alcoholic fatty liver disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3654090A (en) *	1968-09-24	1972-04-04	Organon	Method for the determination of antigens and antibodies
NL154600B (nl) *	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3867517A (en) *	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies
US4016043A (en) *	1975-09-04	1977-04-05	Akzona Incorporated	Enzymatic immunological method for the determination of antigens and antibodies
JPS5347518A (en) *	1976-10-07	1978-04-28	Mochida Pharm Co Ltd	Immunologically measuring method
US4098876A (en) *	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
NL185309C (nl) *	1980-07-28	1990-03-01	Akzo Nv	Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
US4376110A (en) *	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies

1980
- 1980-08-04 US US06/175,133 patent/US4376110A/en not_active Expired - Lifetime
1981
- 1981-07-29 IT IT8123231A patent/IT1225944B/it active
- 1981-07-31 CA CA000382964A patent/CA1281640C/en not_active Expired - Lifetime
- 1981-08-04 BE BE0/205580A patent/BE889855A/fr not_active IP Right Cessation
- 1981-08-04 JP JP56122347A patent/JPS57118159A/ja active Granted
1991
- 1991-12-09 JP JP3324583A patent/JPH0587816A/ja active Pending

Also Published As

Publication number	Publication date
CA1281640C (en)	1991-03-19
BE889855A (fr)	1982-02-04
JPH0421818B2 (it)	1992-04-14
US4376110A (en)	1983-03-08
JPH0587816A (ja)	1993-04-06
IT8123231A0 (it)	1981-07-29
JPS57118159A (en)	1982-07-22

Publication	Publication Date	Title
IT1225944B (it)	1990-12-10	Saggi immunometrici e di inibizione con l'impiego di anticorpi monoclonici
BR8305615A (pt)	1984-05-15	Emulsao anidra e emprego
GB2150288B (en)	1985-12-04	Immunometric and inhibition assays using monoclonal antibodies
FR2522171B1 (fr)	1987-02-27	Architecture d'addition en virgule flottante
BE887518A (fr)	1981-08-13	Cartothioates d'androstanes
TR21696A (tr)	1985-03-05	Yeni substituee n-fenil-n'-benzoil uereler ve bunlarin enssektisidler ve akarisidler olarak kullanimi
IT1127525B (it)	1986-05-21	Chiusura per estremita' di contenitori e metodo per la realizzazione della medesima
IT1167391B (it)	1987-05-13	Carbossi e carbossi sostituiti alcanoil e cicloalcanoil peptidi
IT1101280B (it)	1985-09-28	Prova immunochimica con l'impiego di reagenti marcati
DE3141464A1 (de)	1982-04-29	"kopiergeraet"
BR8200828A (pt)	1982-12-28	Carga propulsiva do tipo chamado "bloco trombeta"
FR2511165B1 (fr)	1986-07-18	Pendule offrant plusieurs modes d'utilisation
NO170691C (no)	1992-11-18	Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
IT1150266B (it)	1986-12-10	Girotrone con stabilita' migliorata
IT1138653B (it)	1986-09-17	Procedimento ed apparecchiatura per la realizzazione di cerniere lampo
FR2503818B1 (fr)	1986-04-25	Volant d'inertie
TR21851A (tr)	1986-09-12	Haloasetamidin'ler ve bunlarin herbisid olarak kullanilmasi
NO822578L (no)	1983-11-07	Tilhengerfeste
BE885171A (fr)	1981-03-10	Installation d'acenseur
IT8004808V0 (it)	1980-04-16	Endoprotesi d'anca
IT1179212B (it)	1987-09-16	Carburatore e compensazione di alti tudine
FR2737347B1 (fr)	1997-12-19	Structure pour l'absorption d'ondes electromagnetiques
SE8404977D0 (sv)	1984-10-04	Linlas samt anvendning av detsamma
BR8502444A (pt)	1986-12-30	Rape aprimorado e preparacao do mesmo
IT8304771V0 (it)	1983-03-04	Endoprotesi d'anca

Legal Events

Date	Code	Title	Description
1999-10-27	TA	Fee payment date (situation as of event date), data collected since 19931001	Effective date: 19950731